data_1kfz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kfz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.09 157.64 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.82 122.66 47.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.669 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -70.08 157.85 36.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.583 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.53 17.89 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.829 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.12 140.2 1.92 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.69 142.23 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.996 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.451 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 19.5 t80 -135.13 110.82 9.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -110.22 82.15 2.51 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.24 113.49 3.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.582 2.188 . . . . 0.0 112.327 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -76.49 -27.35 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.915 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.07 168.27 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.9 p -90.05 148.8 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.0 -35.05 4.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.406 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.15 137.35 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.308 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -79.45 149.44 31.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.39 112.74 24.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.557 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.7 p90 -133.82 160.37 37.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.375 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.65 -168.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.657 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 133.38 37.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.85 19.07 58.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.011 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -84.35 128.11 34.38 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.66 120.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 70.3 mt -120.71 113.96 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.0 111.309 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.4 m -70.15 108.65 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.411 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 29.6 tp -56.74 124.7 19.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.436 HG13 ' HA2' ' A' ' 194' ' ' GLY . 22.8 mt -89.37 -32.25 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.269 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 8.5 p30 -175.16 -171.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.685 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 27.3 mtmt -151.39 51.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.726 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.55 -39.86 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -121.77 130.32 24.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.009 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.26 -17.34 25.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.214 1.943 . . . . 0.0 111.89 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -94.45 -46.37 7.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.845 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.62 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 14.5 m95 -110.29 122.5 47.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 111.188 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.5 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 46.2 m0 -114.05 141.14 47.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.844 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.439 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 1.1 tt0 -89.97 140.85 29.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.812 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.436 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -151.06 162.05 29.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.911 -1.137 . . . . 0.0 113.16 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 169.33 161.02 18.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.061 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.8 pt -107.26 148.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.507 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.9 p90 -170.39 164.0 5.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.53 117.88 4.82 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.355 2.036 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.5 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.3 p -63.09 -17.01 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.82 -13.98 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.75 15.7 10.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 2.7 m -148.18 -171.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.17 122.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.78 128.0 8.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.733 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 85.6 t80 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.852 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 4.1 m-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.807 0.337 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.81 155.51 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.245 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.67 110.02 19.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.04 158.19 23.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.27 19.07 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.743 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.581 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.4 140.2 58.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -128.06 106.48 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -109.92 78.43 1.28 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 124.12 7.82 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.526 2.151 . . . . 0.0 112.419 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -93.75 17.44 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -131.42 173.97 10.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.845 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 29.7 p -90.04 146.26 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.41 -34.11 5.7 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -93.24 132.49 37.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.303 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -78.8 143.59 35.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.79 111.18 22.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.7 p90 -137.19 166.8 22.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -168.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.732 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -76.22 136.96 39.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.87 18.19 52.92 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.601 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -76.97 114.73 16.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.59 93.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.752 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 4.4 mt -95.82 132.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -78.72 103.16 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 37.7 tp -49.48 125.3 10.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.545 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 mt -89.65 -55.17 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -153.59 166.15 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.806 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.417 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 49.2 mtmt -128.05 47.62 2.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.543 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.302 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -118.17 115.35 36.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.911 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -44.12 -28.19 2.19 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.654 2.236 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -101.62 -44.97 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.443 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 17.9 m95 -95.61 113.44 25.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.249 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -109.58 141.72 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 0.9 OUTLIER -89.85 145.24 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.152 179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -146.96 160.15 28.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.035 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 111.095 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.683 0.278 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.52 159.47 20.12 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.748 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -106.12 150.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.425 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 13.9 p90 -164.72 156.88 13.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.99 106.9 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.464 2.109 . . . . 0.0 111.298 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -52.69 -24.31 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.052 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.3 -17.9 45.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.741 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.06 23.73 6.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 6.0 m -149.27 -170.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.334 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.69 110.41 2.18 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.31 124.86 11.15 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.472 2.115 . . . . 0.0 112.478 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 33.5 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 182' ' ' THR . 29.3 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.7 m -107.13 151.77 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.37 114.54 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.73 153.73 38.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.499 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 -22.42 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.26 128.92 24.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.93 146.34 42.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.448 ' CB ' ' CZ ' ' A' ' 175' ' ' PHE . 59.9 t80 -137.6 117.95 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.3 87.95 4.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 64.8 Cg_endo -75.89 121.69 6.38 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.19 20.12 9.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -136.07 171.52 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 38.4 p -90.01 146.28 24.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.47 -34.01 5.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.378 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.99 136.93 36.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.644 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.21 145.96 29.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.81 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.04 108.45 20.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.643 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.5 ' CE1' ' CD2' ' A' ' 203' ' ' PHE . 11.6 p90 -122.91 158.32 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.333 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -117.91 -175.53 2.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.11 132.08 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.96 18.02 53.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.61 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -79.98 117.95 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.68 96.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.756 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 mt -95.55 122.29 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.432 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 158' ' ' PHE . 1.3 m -72.83 103.23 3.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.5 tp -51.04 125.69 14.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.311 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 193' ' ' GLU . 28.5 mt -89.37 -55.42 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -155.47 165.7 35.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.725 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 34.9 mtmt -126.28 50.28 1.91 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.581 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -56.18 -25.74 47.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.374 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.53 127.01 25.34 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 -22.01 20.65 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.523 2.149 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -108.57 -36.35 6.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 111.214 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.45 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 13.5 m95 -103.23 110.95 23.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.504 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 45.5 m0 -106.55 141.85 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.4 ' HG2' ' CD1' ' A' ' 184' ' ' ILE . 3.3 tt0 -89.59 138.57 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.87 159.48 27.36 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.181 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.12 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.235 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.644 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . -179.27 159.24 23.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.257 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.45 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 3.8 pt -112.83 149.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.5 ' CD2' ' CE1' ' A' ' 175' ' ' PHE . 2.1 p90 -170.35 162.75 6.2 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.82 108.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.362 2.041 . . . . 0.0 111.339 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.504 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.0 OUTLIER -57.04 -20.86 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.143 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -62.15 -13.71 29.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -90.98 19.35 5.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 4.4 m -147.0 -171.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.4 112.4 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.52 118.43 2.56 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.534 2.156 . . . . 0.0 112.636 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 28.0 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.898 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.52 156.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.55 114.81 26.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.639 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.63 157.26 34.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.508 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.45 19.73 6.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.28 140.24 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.91 142.34 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.45 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.8 t80 -132.68 112.48 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.31 84.72 3.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.16 115.43 3.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.491 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -79.73 -26.3 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -96.85 175.14 6.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 80.4 p -90.1 151.77 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.65 -36.05 4.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.84 133.76 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.292 . . . . 0.0 110.737 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.634 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -76.65 144.88 39.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.906 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.87 111.82 23.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.536 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.7 p90 -134.97 -179.83 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.42 . . . . 0.0 111.357 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -131.17 -170.81 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.754 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -75.46 139.76 42.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.038 0.447 . . . . 0.0 111.463 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 55.85 21.26 29.39 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.17 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.56 122.33 28.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.75 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.3 103.59 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.7 mt -102.72 127.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.394 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 m -79.33 100.3 7.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.354 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.403 ' CD2' ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -49.1 127.68 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.607 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 193' ' ' GLU . 31.9 mt -89.55 -36.42 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.461 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.1 p30 -176.55 154.85 1.3 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.46 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.4 mtmt -115.18 44.02 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.34 -31.09 5.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.633 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.21 127.14 23.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.036 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.89 -14.84 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.275 1.984 . . . . 0.0 112.185 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.63 -44.26 6.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.633 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 19.6 m95 -115.24 112.41 22.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 111.508 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.465 ' CG ' ' HB3' ' A' ' 205' ' ' SER . 46.6 m0 -101.01 136.82 40.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.547 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 184' ' ' ILE . 1.9 tt0 -88.79 146.13 25.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.4 161.96 28.58 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 119.951 -1.118 . . . . 0.0 113.463 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.634 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.03 156.6 12.43 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.932 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.1 pt -102.94 149.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.804 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.426 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 19.0 p90 -162.61 157.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.57 113.36 1.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.251 1.967 . . . . 0.0 110.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.465 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.7 p -59.4 -19.61 48.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 111.35 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -65.53 -14.49 61.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.399 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 20.47 9.22 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.183 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.2 m -150.02 -167.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.49 114.65 1.25 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.03 125.19 11.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.611 2.207 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 25.4 t80 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.26 150.9 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.55 114.53 27.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.39 157.71 31.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.552 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.51 24.51 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.18 178.67 3.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -100.16 138.0 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 2.0 t80 -125.84 105.37 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -109.67 78.59 1.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.93 115.76 4.24 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.84 -26.58 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.38 172.97 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.1 m -90.11 150.89 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.63 -36.3 4.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.347 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -93.35 136.14 33.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.755 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.667 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -80.66 147.03 30.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.704 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.43 113.84 25.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.715 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.8 p90 -141.15 163.37 33.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.408 . . . . 0.0 111.087 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 -176.56 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.807 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 139.48 57.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.27 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.02 21.01 44.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.625 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -78.32 109.66 12.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.7 94.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.404 HD12 ' CG ' ' A' ' 175' ' ' PHE . 10.5 mt -95.53 135.01 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.433 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 m -81.43 102.99 10.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 31.1 tp -51.03 122.42 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mt -89.49 -36.31 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.75 174.65 0.82 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 21.3 mttt -123.16 66.14 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.59 -19.44 38.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.61 132.94 8.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.685 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.13 -25.68 4.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.861 2.374 . . . . 0.0 112.76 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -102.44 -44.64 5.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 0.0 111.358 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.422 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 32.5 m95 -94.19 110.57 22.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.325 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.437 ' CD1' ' HG2' ' A' ' 186' ' ' LYS . 44.5 m0 -108.5 141.33 40.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.76 144.87 25.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.11 158.25 27.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.766 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.887 0.375 . . . . 0.0 111.201 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.667 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.88 162.31 24.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.02 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.415 HD11 ' CZ3' ' A' ' 191' ' ' TRP . 1.4 pt -107.66 154.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.743 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.422 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 13.6 p90 -170.09 149.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.065 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 107.09 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.22 1.947 . . . . 0.0 110.906 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.41 ' OG ' ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -52.26 -22.54 4.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.313 -179.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -53.01 -19.85 3.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.765 0.317 . . . . 0.0 110.47 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.24 21.95 7.34 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.3 m -147.2 -167.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.724 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.24 111.98 1.02 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.48 115.11 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.504 2.136 . . . . 0.0 112.683 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.835 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.928 0.394 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.83 153.6 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.23 115.28 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.31 154.05 39.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.391 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.48 13.92 22.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -170.05 -164.23 0.4 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -114.94 145.9 41.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.434 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 20.8 t80 -135.75 115.13 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -111.88 85.83 6.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.684 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 113.79 3.74 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.651 2.234 . . . . 0.0 112.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.87 -27.4 55.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.884 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -96.07 174.15 7.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 74.5 m -90.08 151.51 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.23 -36.84 3.87 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.318 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.01 132.45 39.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 0.0 110.739 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.636 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -75.72 143.42 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.66 113.65 25.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.439 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.3 p90 -134.14 177.38 7.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.413 . . . . 0.0 111.497 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.423 ' O ' ' HB1' ' A' ' 161' ' ' ALA . 8.6 mttt -128.77 -175.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.811 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.66 140.56 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.683 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 51.57 25.06 13.17 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.872 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.29 123.27 30.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 36.3 t -72.62 102.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.8 mt -96.89 142.48 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.434 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.5 m -90.17 99.21 12.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 31.4 tp -50.3 123.18 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.4 mt -89.71 -54.06 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.42 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -153.93 166.35 33.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.412 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 50.3 mtmt -128.88 48.79 2.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.73 -27.3 66.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.38 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.31 115.77 34.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.926 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -44.32 -28.08 2.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.563 2.176 . . . . 0.0 112.859 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.01 -44.5 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.234 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 19.4 m95 -95.57 112.11 23.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.231 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.484 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.7 m0 -108.29 142.53 38.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.82 144.16 25.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.087 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.04 27.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.969 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 111.253 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.608 0.242 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.636 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.14 161.42 20.61 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.937 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.411 HD11 ' CZ3' ' A' ' 191' ' ' TRP . 1.6 pt -103.98 152.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.826 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.416 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 19.2 p90 -167.71 154.99 7.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.97 107.85 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.3 2.0 . . . . 0.0 111.337 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.2 p -53.18 -24.55 11.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -16.2 43.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -93.88 21.56 6.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.215 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 4.2 m -148.6 -167.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.52 111.95 1.85 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.49 121.9 7.02 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.547 2.165 . . . . 0.0 112.44 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.644 0.259 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 0.2 OUTLIER -166.8 123.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.477 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -102.26 123.83 46.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.252 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -73.99 148.33 42.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.721 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.16 14.5 14.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.812 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' HB3' ' CE2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.25 140.16 1.85 Allowed 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 145.21 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -133.66 112.51 11.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.77 87.21 5.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.7 116.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.562 2.175 . . . . 0.0 112.46 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.94 -26.06 36.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.26 172.69 7.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -90.05 150.56 22.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.5 -35.44 4.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.409 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.47 133.42 36.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.641 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -75.68 140.79 42.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.837 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.406 ' N ' HD11 ' A' ' 173' ' ' LEU . . . -96.97 114.49 26.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.165 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.7 p90 -133.29 -178.22 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 111.607 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -126.05 -174.19 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.83 140.08 42.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.264 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 161' ' ' ALA . . . 56.03 21.85 32.96 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.804 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 124.95 31.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.0 t -74.89 119.56 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.81 155.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.601 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.0 m -103.36 104.45 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.359 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 31.6 tp -50.11 124.63 10.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.583 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.3 mt -89.5 -38.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.537 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.67 174.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.802 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.421 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.9 mtmt -126.16 59.77 1.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -19.75 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -137.05 122.12 12.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.42 -28.02 2.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.715 2.277 . . . . 0.0 112.902 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -102.78 -44.14 5.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.438 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 15.8 m95 -94.8 110.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.458 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 43.1 m0 -105.82 141.96 36.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.063 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.79 143.47 26.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.081 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.86 158.43 27.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.129 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.588 0.232 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.641 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.57 162.84 24.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.822 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.438 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.8 pt -104.96 151.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' A' ' 208' ' ' VAL . 14.8 p90 -167.5 159.09 10.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.91 108.78 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.329 2.019 . . . . 0.0 111.148 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.3 p -53.32 -24.23 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -58.38 -19.66 37.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 163' ' ' PHE . 1.1 m-85 -90.9 14.26 14.24 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.467 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 161' ' ' ALA . 2.0 m -149.45 -166.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.263 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -177.74 125.38 0.28 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -43.25 129.43 6.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.769 2.312 . . . . 0.0 112.705 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.79 0.328 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.54 150.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.23 113.88 26.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.96 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.73 154.62 40.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.486 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.3 27.67 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.14 -169.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -127.37 129.72 48.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.811 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 36.5 t80 -131.94 128.6 38.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.41 88.47 49.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.94 119.49 5.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.525 2.15 . . . . 0.0 112.419 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -87.4 -23.36 24.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.04 158.47 16.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.788 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.8 m -78.73 122.48 26.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.19 -20.58 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.441 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.49 139.26 53.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.608 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -76.74 150.22 36.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.86 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.89 110.15 22.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.453 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.506 ' CE1' ' CD2' ' A' ' 203' ' ' PHE . 12.7 p90 -124.13 166.59 15.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -129.49 174.8 9.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.6 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.32 131.97 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.945 0.402 . . . . 0.0 110.926 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.18 19.04 44.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -81.21 117.88 22.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.42 92.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.27 124.91 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.3 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 m -69.97 99.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.369 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.478 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 32.7 tp -49.82 119.96 3.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.591 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 193' ' ' GLU . 12.8 mt -93.73 -41.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.634 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -143.49 158.94 43.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.529 ' HA ' ' CD1' ' A' ' 192' ' ' TRP . 9.8 mttt -138.36 15.59 2.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.539 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -49.58 -36.81 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.288 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.35 105.99 57.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.598 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -42.69 -28.8 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.764 2.309 . . . . 0.0 112.942 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.31 -38.5 9.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.149 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.426 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 17.2 m95 -110.5 107.8 17.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.688 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.558 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 53.9 m0 -108.51 149.45 28.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.278 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.518 ' HB3' ' HB ' ' A' ' 184' ' ' ILE . 1.3 tp10 -89.94 148.98 22.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.7 157.12 27.16 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.33 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 111.311 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.519 0.199 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.95 158.12 20.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.169 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.0 pt -111.38 151.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 0.0 110.91 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.506 ' CD2' ' CE1' ' A' ' 175' ' ' PHE . 2.1 p90 -170.07 164.87 5.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 108.07 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.517 2.144 . . . . 0.0 111.779 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.4 p -57.93 -21.29 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.122 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -62.88 -14.03 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.792 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.29 20.35 5.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.455 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.3 m -149.13 -169.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.39 111.79 1.37 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.735 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.6 114.45 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.521 2.147 . . . . 0.0 112.529 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.825 -179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.789 0.328 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 m -143.34 157.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.11 117.83 29.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.75 147.57 52.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.85 -20.04 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.884 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -133.94 -175.29 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.636 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.1 148.78 26.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.455 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 6.8 t80 -133.12 110.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.955 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -112.42 79.81 3.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -81.11 120.93 3.83 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.644 2.229 . . . . 0.0 112.481 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -81.42 -23.53 37.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.83 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.01 169.98 11.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.18 148.5 22.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.59 -35.13 4.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.322 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.26 126.86 35.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.837 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.614 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -69.66 144.44 52.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -96.86 107.95 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.494 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -136.67 159.8 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.336 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -117.71 -167.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 138.77 54.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.45 17.03 56.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.501 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -73.1 109.67 6.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.303 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.41 101.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.369 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.435 HD11 ' CE2' ' A' ' 203' ' ' PHE . 3.4 mt -100.79 140.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.474 . . . . 0.0 111.738 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.7 m -92.62 99.79 12.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.7 tp -46.31 119.1 2.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.115 0.483 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 194' ' ' GLY . 19.7 mt -89.64 -37.77 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.7 p30 -177.91 171.2 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.778 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.433 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 32.5 mtmt -122.75 57.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -56.65 -21.64 28.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 37.2 t70 -137.05 129.48 17.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.99 -23.35 16.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.574 2.183 . . . . 0.0 112.724 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -106.6 -38.24 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.196 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.414 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 15.3 m95 -100.94 111.67 23.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.045 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.457 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.1 m0 -107.07 144.61 33.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 0.8 OUTLIER -93.49 145.41 24.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.061 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -155.05 157.14 27.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.052 -1.071 . . . . 0.0 113.021 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.625 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.598 0.237 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.614 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.07 162.16 21.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.81 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.7 pt -99.3 152.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.549 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.45 ' HB2' ' HD2' ' A' ' 204' ' ' PRO . 24.8 p90 -167.66 159.45 9.93 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.992 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 203' ' ' PHE . 45.2 Cg_endo -68.53 110.99 2.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.166 1.911 . . . . 0.0 111.299 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.457 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -55.3 -23.18 22.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.3 -16.94 50.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.68 17.93 10.99 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.261 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 2.6 m -149.59 -168.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 111.526 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.47 122.75 1.07 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.56 128.58 12.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.164 . . . . 0.0 112.569 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.816 0.341 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.04 154.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.165 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.6 113.01 23.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.792 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.66 157.61 29.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.473 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 20.77 7.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.727 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.21 139.37 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.42 138.33 57.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 3.4 t80 -125.45 105.6 9.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.54 78.04 1.09 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 124.4 8.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -93.76 17.2 12.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.68 173.52 11.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.08 146.66 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.08 -34.52 5.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.86 135.4 35.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 0.0 110.768 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.665 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.14 144.63 31.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.894 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.7 109.9 21.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.559 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -135.88 161.64 35.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.54 -166.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -78.59 136.13 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.29 16.81 54.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.75 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.49 118.25 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.55 100.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.97 124.48 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.375 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.8 m -72.91 105.14 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 32.5 tp -51.04 123.63 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.374 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.421 HG13 ' HA2' ' A' ' 194' ' ' GLY . 25.8 mt -89.64 -53.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.507 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -156.2 166.29 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.434 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 25.8 mtmt -126.91 50.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.579 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.39 -26.81 43.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 17.3 t70 -124.54 124.89 25.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.703 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.05 -23.91 10.05 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.183 . . . . 0.0 112.726 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -106.56 -40.0 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.433 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 19.3 m95 -98.16 109.7 22.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.273 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 186' ' ' LYS . 45.8 m0 -107.46 142.73 36.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.026 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -89.99 147.0 23.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.877 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.421 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -153.38 159.67 28.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.054 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 110.969 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.665 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 176.89 159.61 22.53 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.24 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.433 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -108.0 151.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.421 ' CE1' HG13 ' A' ' 208' ' ' VAL . 13.2 p90 -165.12 155.55 12.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.59 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.364 2.042 . . . . 0.0 110.991 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -51.29 -24.51 4.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -52.38 -21.32 3.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.895 0.379 . . . . 0.0 110.466 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -93.8 22.31 5.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.909 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.4 m -146.71 -169.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 111.747 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.18 111.53 1.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.797 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.0 124.6 8.98 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 24.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.451 ' CZ ' ' CG2' ' A' ' 182' ' ' THR . 7.6 m-85 . . . . . 0 CA--C 1.525 0.013 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 210' ' ' PRO . 27.8 m -158.02 157.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.44 117.21 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.14 152.19 46.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.507 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 -22.1 12.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.874 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.12 145.35 39.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.686 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.94 147.36 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.436 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 28.0 t80 -136.11 116.14 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -108.78 88.64 5.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.767 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.09 119.42 5.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.626 2.218 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -96.24 22.14 8.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -135.19 171.67 14.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.826 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 78.1 p -90.08 142.68 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.98 -32.21 7.61 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.16 134.15 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 0.0 110.786 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.63 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.33 148.36 29.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.002 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -101.05 112.41 24.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.5 p90 -127.82 162.0 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.272 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -117.99 -167.56 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.73 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.73 36.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.56 17.62 54.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.41 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -79.77 115.42 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.63 103.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -98.61 144.8 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 158' ' ' PHE . 3.3 m -93.74 95.95 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.3 tp -47.13 124.34 6.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.637 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.31 -39.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.94 172.68 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.428 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 44.3 mtmt -124.77 58.46 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.776 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -59.93 -20.49 57.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.27 119.52 13.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.658 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.17 -28.98 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.724 2.283 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -101.42 -46.48 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.29 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 203' ' ' PHE . 13.6 m95 -92.7 110.42 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.323 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.509 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.5 m0 -105.35 142.38 35.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.788 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.78 143.16 27.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.907 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -144.77 158.12 27.49 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.232 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.401 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.259 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.401 ' HG3' ' CG ' ' A' ' 195' ' ' GLN . 1.4 mpt_? . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.631 0.253 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.63 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.34 163.17 25.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.136 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.1 pt -111.38 148.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 3.6 p90 -170.18 163.52 6.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.24 111.41 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 111.525 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.509 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -56.2 -21.15 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.233 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.11 -15.85 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 21.15 4.55 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 4.2 m -149.99 -171.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 111.718 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.84 115.04 1.83 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.499 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.456 ' HA ' HG11 ' A' ' 159' ' ' VAL . 68.5 Cg_exo -43.16 129.66 6.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.669 2.246 . . . . 0.0 112.899 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.688 -179.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.72 156.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.61 118.85 34.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -72.39 150.22 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.417 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.83 -18.21 13.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.052 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.55 129.88 19.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.702 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.95 152.81 22.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 53.0 t80 -139.8 120.32 14.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -108.76 87.45 4.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 63.2 Cg_endo -75.95 121.15 6.06 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.376 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -95.79 20.74 9.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.074 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -139.51 172.72 12.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 146.47 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.022 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.65 5.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.366 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.67 134.65 38.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 110.778 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.618 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -79.0 145.28 34.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.931 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -96.83 113.94 25.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.348 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.6 p90 -133.0 175.28 9.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.431 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -128.52 -169.86 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -76.32 139.59 41.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.47 20.18 36.76 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.82 121.57 27.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 0.0 110.809 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.68 104.04 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.1 mt -99.96 137.77 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.394 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.92 96.49 10.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.447 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.76 125.67 7.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.57 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.29 -44.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.552 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.5 150.35 5.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.435 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 31.1 mtmt -110.35 49.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.1 -22.03 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -127.36 127.85 24.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.708 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.72 -19.68 25.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.554 2.169 . . . . 0.0 112.731 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -112.42 -32.74 6.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 23.9 m95 -105.84 108.7 20.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.479 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -107.19 138.66 42.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 0.9 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.84 158.07 27.52 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.126 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.683 0.277 . . . . 0.0 111.283 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.541 0.21 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.618 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 167.88 162.0 18.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.021 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.42 HD12 ' CZ3' ' A' ' 191' ' ' TRP . 1.4 pt -106.74 149.96 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.428 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 19.7 p90 -164.07 150.34 9.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.141 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 110.14 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.216 1.944 . . . . 0.0 111.041 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.8 p -56.08 -20.54 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.461 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -61.24 -17.08 51.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 110.62 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -92.92 16.6 12.22 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 2.8 m -149.17 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.55 119.54 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.72 126.33 12.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.445 2.097 . . . . 0.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.78 139.14 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.78 129.03 49.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.786 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.26 144.88 40.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 0.66 56.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.508 ' CE1' ' CG ' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -158.44 -163.14 1.22 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.784 0.326 . . . . 0.0 110.805 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.71 145.39 42.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 10.3 t80 -130.68 113.93 14.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -114.49 76.21 3.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.23 123.48 6.13 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.601 2.201 . . . . 0.0 112.471 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -120.64 170.54 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.752 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 p -89.96 142.79 27.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.26 -32.23 7.55 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.54 133.71 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 0.0 110.792 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.668 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.0 OUTLIER -80.49 157.43 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.751 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -106.66 113.45 26.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.932 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 1.8 p90 -134.39 154.62 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -110.88 -169.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 134.65 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.344 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.89 20.51 41.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.666 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -80.62 110.53 16.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.51 105.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 2.6 mt -103.22 125.21 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.361 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 79.0 m -73.57 105.83 5.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.428 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.61 127.88 21.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.603 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 194' ' ' GLY . 25.4 mt -89.64 -40.69 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.476 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 2.6 p30 -177.94 155.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 35.4 mtmt -107.64 54.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -58.43 -18.71 30.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.088 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -132.8 118.47 15.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.693 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -42.07 -28.95 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.745 2.297 . . . . 0.0 113.135 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -106.36 -42.76 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CE3' ' HA ' ' A' ' 203' ' ' PHE . 12.6 m95 -94.88 106.83 18.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.257 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.522 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 43.9 m0 -101.54 142.48 32.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -89.29 145.87 25.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.429 ' N ' HD12 ' A' ' 184' ' ' ILE . . . -152.39 162.37 29.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.2 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.716 0.293 . . . . 0.0 110.904 179.685 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . 0.412 ' HG2' ' CD1' ' A' ' 184' ' ' ILE . 5.5 mtm-85 . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.74 158.92 22.21 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.392 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.7 pt -108.27 150.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.1 p90 -170.1 162.67 6.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.71 110.28 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.458 2.105 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.522 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.2 p -57.59 -19.63 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.79 -12.74 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.627 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . 0.508 ' CG ' ' CE1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -89.83 13.94 13.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.54 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 205' ' ' SER . 2.9 m -144.89 -169.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 111.55 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.28 113.85 2.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.875 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.14 109.84 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.609 2.206 . . . . 0.0 112.574 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 22.5 t80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.819 0.342 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.35 154.84 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.08 114.4 27.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -70.09 154.23 42.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.21 20.74 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.74 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.68 1.82 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.629 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.12 138.33 55.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 5.1 t80 -127.15 109.42 11.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.002 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -109.68 84.18 3.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.01 116.4 4.2 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.69 2.26 . . . . 0.0 112.48 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -80.83 -26.48 37.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.686 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.48 174.76 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.97 151.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.87 -36.55 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -95.17 138.77 32.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.677 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.59 147.26 28.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.757 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.77 110.47 22.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.767 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.2 p90 -135.81 157.98 45.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.422 . . . . 0.0 111.16 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -109.32 -169.74 1.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.54 136.2 39.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.89 58.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.688 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -79.5 118.13 21.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.77 97.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.7 138.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.27 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -86.2 99.11 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.607 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.0 tp -49.5 123.57 7.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.396 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.44 -39.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -177.55 173.24 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.814 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.419 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 35.1 mtmt -123.28 55.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.39 -22.96 22.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -135.74 130.32 18.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.717 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.69 -21.81 20.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.643 2.229 . . . . 0.0 112.624 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -108.38 -36.38 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.429 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 20.6 m95 -103.02 110.55 22.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.459 ' CG ' ' HB3' ' A' ' 205' ' ' SER . 44.0 m0 -106.38 140.82 38.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.944 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.83 149.59 22.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -153.79 159.28 28.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.74 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 111.181 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.677 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 174.36 159.67 21.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.015 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.421 HD13 ' CZ3' ' A' ' 191' ' ' TRP . 1.4 pt -106.3 151.8 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.747 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.432 ' CE2' HD23 ' A' ' 173' ' ' LEU . 13.8 p90 -165.55 151.2 8.31 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.65 111.47 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.264 1.976 . . . . 0.0 111.174 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.459 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.1 p -55.84 -21.54 20.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 111.197 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -17.75 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.494 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.29 17.87 12.04 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.292 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.2 m -148.7 -168.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 111.356 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.1 114.57 1.3 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -47.2 124.39 8.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.463 2.109 . . . . 0.0 112.589 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 13.9 t80 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.07 153.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.14 113.13 24.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.458 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.425 ' HA ' HG11 ' A' ' 208' ' ' VAL . . . -65.72 157.19 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.557 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.22 19.55 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.929 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -170.23 140.26 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.68 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.99 137.17 53.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.443 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.2 t80 -129.06 109.78 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.944 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -110.87 79.2 1.79 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.09 115.99 3.86 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.54 2.16 . . . . 0.0 112.509 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -80.06 -26.45 39.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.91 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.33 170.69 12.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.5 m -89.93 148.83 22.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.75 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.414 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.4 130.97 39.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.745 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.652 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -77.84 147.88 34.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.805 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.58 112.25 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.5 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.6 p90 -131.3 155.57 46.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -112.31 172.12 7.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.467 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 135.83 57.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.226 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.52 23.7 55.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.885 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.44 123.24 30.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.345 . . . . 0.0 110.863 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 37.1 t -73.12 94.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.7 mt -89.98 143.04 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.347 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.4 m -90.82 98.63 11.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.502 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.8 tp -50.03 124.4 10.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.1 mt -89.7 -39.51 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.594 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -177.76 172.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.419 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 46.9 mtmt -121.99 56.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.679 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -57.16 -21.72 34.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.139 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.09 121.61 12.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.667 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.79 -28.16 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.716 2.278 . . . . 0.0 112.949 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -102.78 -44.71 5.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.23 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.429 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 24.1 m95 -94.03 108.75 20.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.473 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 43.4 m0 -104.32 141.8 35.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 146.35 24.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.205 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.86 158.36 27.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.915 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.561 0.219 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.652 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.95 161.94 23.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.869 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.429 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -106.24 153.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.41 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 16.1 p90 -169.36 148.72 3.58 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.126 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.45 109.82 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.276 1.984 . . . . 0.0 111.384 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.0 p -54.35 -23.11 14.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.316 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -61.04 -16.13 40.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.29 22.19 6.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.425 HG11 ' HA ' ' A' ' 161' ' ' ALA . 4.1 m -149.87 -168.7 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.737 0.304 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.41 111.52 1.86 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.86 121.73 6.21 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.4 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.961 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.8 m -106.64 152.02 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.067 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.46 112.84 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.97 155.71 33.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.536 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.86 -12.41 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.52 132.0 19.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.04 143.6 31.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.446 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 9.8 t80 -127.74 109.48 11.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.59 78.9 1.6 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.17 123.91 6.94 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.608 2.205 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -94.48 18.22 11.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -129.71 173.1 10.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 m -90.15 145.88 24.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.54 -34.45 5.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.391 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -93.64 134.35 36.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.673 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.61 147.94 29.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.654 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.77 110.34 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.8 p90 -133.52 152.96 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 111.209 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -103.22 -168.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -79.1 134.74 36.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.88 18.61 54.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -80.85 119.2 23.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.8 t -69.71 99.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 4.9 mt -93.99 140.6 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.326 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -87.41 100.87 13.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.517 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.8 tp -51.21 123.77 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.421 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.2 mt -89.58 -39.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.625 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.35 172.18 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.43 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 33.0 mtmt -127.07 57.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.75 -22.02 61.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.78 117.22 15.05 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.17 -29.94 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.922 2.415 . . . . 0.0 113.168 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.49 -48.99 4.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' TRP . . . . . 0.446 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 28.0 m95 -89.82 108.11 19.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.117 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.43 ' CD2' ' HG2' ' A' ' 186' ' ' LYS . 45.0 m0 -104.68 142.46 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.966 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.87 145.52 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.248 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.95 158.92 27.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.874 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.729 0.3 . . . . 0.0 111.235 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.502 0.191 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.673 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.78 161.25 23.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.91 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.446 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.5 pt -108.39 153.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.409 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 15.5 p90 -170.03 151.91 4.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.37 106.89 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.188 1.925 . . . . 0.0 110.984 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.404 ' OG ' ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -51.35 -23.46 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.037 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -51.74 -21.74 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 110.508 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.38 23.1 4.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.711 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.7 m -147.11 -167.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 111.625 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.21 110.02 1.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.98 113.17 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.505 2.137 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 20.5 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.0 mtt -131.95 169.65 16.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.5 -177.0 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 t -68.94 144.64 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -134.37 121.82 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.64 131.29 34.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.1 m -126.09 157.64 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.82 122.66 47.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.669 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -70.08 157.85 36.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.583 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.53 17.89 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.829 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.12 140.2 1.92 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.69 142.23 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.996 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.451 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 19.5 t80 -135.13 110.82 9.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -110.22 82.15 2.51 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.24 113.49 3.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.582 2.188 . . . . 0.0 112.327 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -76.49 -27.35 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.915 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.07 168.27 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.9 p -90.05 148.8 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.0 -35.05 4.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.406 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.15 137.35 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.308 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -79.45 149.44 31.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.39 112.74 24.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.557 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.507 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.7 p90 -133.82 160.37 37.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.375 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.65 -168.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.657 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 133.38 37.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.85 19.07 58.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.011 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -84.35 128.11 34.38 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.66 120.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.453 HG12 HD21 ' A' ' 196' ' ' LEU . 70.3 mt -120.71 113.96 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.0 111.309 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.4 m -70.15 108.65 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.411 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 29.6 tp -56.74 124.7 19.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.436 HG13 ' HA2' ' A' ' 194' ' ' GLY . 22.8 mt -89.37 -32.25 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.269 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.439 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 8.5 p30 -175.16 -171.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.685 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 27.3 mtmt -151.39 51.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.726 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.55 -39.86 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -121.77 130.32 24.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.009 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.26 -17.34 25.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.214 1.943 . . . . 0.0 111.89 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -94.45 -46.37 7.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.845 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.62 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 14.5 m95 -110.29 122.5 47.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 111.188 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.5 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 46.2 m0 -114.05 141.14 47.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.844 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.439 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 1.1 tt0 -89.97 140.85 29.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.812 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.436 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -151.06 162.05 29.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.911 -1.137 . . . . 0.0 113.16 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.35 113.0 20.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 0.0 110.942 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.453 HD21 HG12 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -72.73 63.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.088 0.47 . . . . 0.0 110.696 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 14.2 t30 63.99 14.72 8.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.468 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.94 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.943 0.401 . . . . 0.0 111.154 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 130.85 42.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.485 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -97.67 165.8 11.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.457 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 169.33 161.02 18.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.061 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 3.8 pt -107.26 148.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.507 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.9 p90 -170.39 164.0 5.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.53 117.88 4.82 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.355 2.036 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.5 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.3 p -63.09 -17.01 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.82 -13.98 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.75 15.7 10.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 2.7 m -148.18 -171.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.17 122.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -44.78 128.0 8.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.733 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -106.26 -62.59 1.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.852 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -20.63 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.9 p -54.96 178.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.971 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 29.3 mtp -133.48 -77.51 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.28 135.75 51.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.9 t -89.77 121.73 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -131.85 131.76 43.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 4.1 m-85 -107.08 137.46 45.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 31.1 m -114.81 155.51 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.245 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.67 110.02 19.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.04 158.19 23.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.27 19.07 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.743 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.581 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.4 140.2 58.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -128.06 106.48 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -109.92 78.43 1.28 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 124.12 7.82 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.526 2.151 . . . . 0.0 112.419 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -93.75 17.44 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -131.42 173.97 10.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.845 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 29.7 p -90.04 146.26 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.41 -34.11 5.7 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -93.24 132.49 37.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.303 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.649 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -78.8 143.59 35.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.79 111.18 22.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.7 p90 -137.19 166.8 22.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -168.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.732 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -76.22 136.96 39.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.87 18.19 52.92 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.601 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -76.97 114.73 16.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.59 93.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.752 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 4.4 mt -95.82 132.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -78.72 103.16 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.403 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 37.7 tp -49.48 125.3 10.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.545 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 33.6 mt -89.65 -55.17 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -153.59 166.15 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.806 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.417 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 49.2 mtmt -128.05 47.62 2.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.543 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.302 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -118.17 115.35 36.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.911 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -44.12 -28.19 2.19 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.654 2.236 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -101.62 -44.97 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.443 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 17.9 m95 -95.61 113.44 25.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.249 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.474 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -109.58 141.72 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 0.9 OUTLIER -89.85 145.24 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.152 179.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -146.96 160.15 28.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.035 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.31 143.33 46.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 111.095 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.3 mt -134.51 62.39 1.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.391 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.1 m-80 66.03 64.86 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 24.8 t30 82.69 11.81 0.54 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -114.01 90.59 3.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.032 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.07 149.89 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.649 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.52 159.47 20.12 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.748 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.443 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -106.12 150.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.425 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 13.9 p90 -164.72 156.88 13.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.99 106.9 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.464 2.109 . . . . 0.0 111.298 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.474 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -52.69 -24.31 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.052 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.3 -17.9 45.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.741 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.06 23.73 6.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 6.0 m -149.27 -170.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.334 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.69 110.41 2.18 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -48.31 124.86 11.15 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.472 2.115 . . . . 0.0 112.478 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 213' ' ' SER . 33.5 t80 -101.45 -68.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 58.65 50.01 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.417 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 0.3 OUTLIER 59.53 31.56 21.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.018 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.895 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.734 0.302 . . . . 0.0 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 62.6 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.76 117.13 27.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.983 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 153' ' ' HIS . 8.7 t -86.43 131.75 34.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.87 158.08 42.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.42 ' CE1' HG22 ' A' ' 182' ' ' THR . 29.3 m-85 -142.19 111.4 6.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.7 m -107.13 151.77 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.37 114.54 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.73 153.73 38.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.499 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.36 -22.42 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.26 128.92 24.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.93 146.34 42.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.448 ' CB ' ' CZ ' ' A' ' 175' ' ' PHE . 59.9 t80 -137.6 117.95 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.3 87.95 4.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 64.8 Cg_endo -75.89 121.69 6.38 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.19 20.12 9.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -136.07 171.52 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 38.4 p -90.01 146.28 24.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.47 -34.01 5.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.378 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.99 136.93 36.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.644 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.21 145.96 29.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.81 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.04 108.45 20.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.643 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.5 ' CE1' ' CD2' ' A' ' 203' ' ' PHE . 11.6 p90 -122.91 158.32 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.333 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -117.91 -175.53 2.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.513 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.11 132.08 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.96 18.02 53.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.61 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -79.98 117.95 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.68 96.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.756 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 4.8 mt -95.55 122.29 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.432 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.42 HG22 ' CE1' ' A' ' 158' ' ' PHE . 1.3 m -72.83 103.23 3.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.5 tp -51.04 125.69 14.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.311 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 193' ' ' GLU . 28.5 mt -89.37 -55.42 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -155.47 165.7 35.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.725 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.427 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 34.9 mtmt -126.28 50.28 1.91 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.581 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -56.18 -25.74 47.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.374 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -124.53 127.01 25.34 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 -22.01 20.65 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.523 2.149 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -108.57 -36.35 6.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 111.214 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.45 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 13.5 m95 -103.23 110.95 23.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.504 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 45.5 m0 -106.55 141.85 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.4 ' HG2' ' CD1' ' A' ' 184' ' ' ILE . 3.3 tt0 -89.59 138.57 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -142.87 159.48 27.36 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.181 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 20.5 tt0 -114.54 149.38 36.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.12 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.32 96.54 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.771 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 76.23 -62.6 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -164.61 29.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.37 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.9 OUTLIER -125.94 162.15 25.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.852 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.11 150.09 50.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.644 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . -179.27 159.24 23.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.257 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.45 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 3.8 pt -112.83 149.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.5 ' CD2' ' CE1' ' A' ' 175' ' ' PHE . 2.1 p90 -170.35 162.75 6.2 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.82 108.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.362 2.041 . . . . 0.0 111.339 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.504 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.0 OUTLIER -57.04 -20.86 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.143 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -62.15 -13.71 29.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -90.98 19.35 5.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 4.4 m -147.0 -171.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.4 112.4 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -46.52 118.43 2.56 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.534 2.156 . . . . 0.0 112.636 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -98.88 -65.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 61.77 74.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.637 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.8 p -58.27 137.3 57.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.031 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.933 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.8 p80 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.783 0.325 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.24 117.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.008 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -161.15 129.67 4.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.38 107.67 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -139.86 40.0 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.993 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -80.66 137.7 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.52 156.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.55 114.81 26.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.639 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.63 157.26 34.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.508 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.45 19.73 6.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.28 140.24 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.91 142.34 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.45 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.8 t80 -132.68 112.48 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.31 84.72 3.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.16 115.43 3.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.491 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -79.73 -26.3 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -96.85 175.14 6.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 80.4 p -90.1 151.77 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.65 -36.05 4.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.84 133.76 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.292 . . . . 0.0 110.737 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.634 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -76.65 144.88 39.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.906 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.87 111.82 23.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.536 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.7 p90 -134.97 -179.83 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.42 . . . . 0.0 111.357 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -131.17 -170.81 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.754 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -75.46 139.76 42.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.038 0.447 . . . . 0.0 111.463 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 55.85 21.26 29.39 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.17 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.56 122.33 28.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.75 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.3 103.59 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.7 mt -102.72 127.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.394 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.2 m -79.33 100.3 7.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.354 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.403 ' CD2' ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -49.1 127.68 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.607 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 193' ' ' GLU . 31.9 mt -89.55 -36.42 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.461 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.1 p30 -176.55 154.85 1.3 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.46 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.4 mtmt -115.18 44.02 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.34 -31.09 5.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.633 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.21 127.14 23.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.036 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.89 -14.84 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.275 1.984 . . . . 0.0 112.185 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.63 -44.26 6.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.633 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 19.6 m95 -115.24 112.41 22.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 111.508 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.465 ' CG ' ' HB3' ' A' ' 205' ' ' SER . 46.6 m0 -101.01 136.82 40.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.547 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 184' ' ' ILE . 1.9 tt0 -88.79 146.13 25.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.4 161.96 28.58 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 119.951 -1.118 . . . . 0.0 113.463 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.77 128.7 53.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.96 59.53 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.536 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.4 t-20 67.93 65.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.342 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 10.6 t-20 83.3 10.85 0.5 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.956 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -113.3 90.42 3.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -89.61 147.4 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.659 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.634 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.03 156.6 12.43 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.932 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.1 pt -102.94 149.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.804 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.426 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 19.0 p90 -162.61 157.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.57 113.36 1.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.251 1.967 . . . . 0.0 110.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.465 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.7 p -59.4 -19.61 48.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 111.35 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -65.53 -14.49 61.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.399 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 20.47 9.22 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.183 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.2 m -150.02 -167.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.49 114.65 1.25 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -48.03 125.19 11.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.611 2.207 . . . . 0.0 112.459 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -99.94 -68.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 61.75 74.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.629 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -31.52 67.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.884 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 153' ' ' HIS . 8.9 p-80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.876 0.37 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.2 mtm -85.38 -77.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -106.84 102.99 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.5 103.01 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.004 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -147.48 105.0 3.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.948 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -110.63 125.95 53.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.26 150.9 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.55 114.53 27.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.39 157.71 31.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.552 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.51 24.51 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.18 178.67 3.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -100.16 138.0 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 2.0 t80 -125.84 105.37 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -109.67 78.59 1.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.93 115.76 4.24 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.84 -26.58 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.38 172.97 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.1 m -90.11 150.89 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.63 -36.3 4.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.347 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -93.35 136.14 33.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.755 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.667 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -80.66 147.03 30.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.704 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.43 113.84 25.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.715 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.456 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.8 p90 -141.15 163.37 33.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.408 . . . . 0.0 111.087 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 -176.56 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.807 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 139.48 57.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.27 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.02 21.01 44.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.625 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -78.32 109.66 12.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.7 94.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.404 HD12 ' CG ' ' A' ' 175' ' ' PHE . 10.5 mt -95.53 135.01 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.433 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 m -81.43 102.99 10.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 31.1 tp -51.03 122.42 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 28.4 mt -89.49 -36.31 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.75 174.65 0.82 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 21.3 mttt -123.16 66.14 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.59 -19.44 38.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -150.61 132.94 8.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.685 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.13 -25.68 4.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.861 2.374 . . . . 0.0 112.76 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -102.44 -44.64 5.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 0.0 111.358 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.422 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 32.5 m95 -94.19 110.57 22.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.325 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.437 ' CD1' ' HG2' ' A' ' 186' ' ' LYS . 44.5 m0 -108.5 141.33 40.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.76 144.87 25.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.11 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -150.11 158.25 27.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.766 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -120.63 110.02 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.887 0.375 . . . . 0.0 111.201 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.42 87.08 7.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.527 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 14.7 t30 76.59 -60.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -143.08 -40.38 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.503 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ptm85 -69.81 140.52 53.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.262 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -109.58 161.03 15.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.568 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.667 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.88 162.31 24.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.02 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.415 HD11 ' CZ3' ' A' ' 191' ' ' TRP . 1.4 pt -107.66 154.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.743 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.422 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 13.6 p90 -170.09 149.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.065 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.76 107.09 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.22 1.947 . . . . 0.0 110.906 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.41 ' OG ' ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -52.26 -22.54 4.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.313 -179.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -53.01 -19.85 3.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.765 0.317 . . . . 0.0 110.47 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.24 21.95 7.34 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.3 m -147.2 -167.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.724 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.24 111.98 1.02 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.48 115.11 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.504 2.136 . . . . 0.0 112.683 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -93.25 -66.15 0.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.835 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -84.2 -31.66 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 80.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.913 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.9 p80 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.7 mtm -144.2 -170.09 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.76 119.19 21.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 t -78.87 139.75 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -138.03 168.77 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -146.65 134.53 21.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 6.0 m -129.83 153.6 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.23 115.28 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.31 154.05 39.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.391 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.48 13.92 22.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -170.05 -164.23 0.4 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -114.94 145.9 41.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.434 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 20.8 t80 -135.75 115.13 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -111.88 85.83 6.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.684 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 113.79 3.74 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.651 2.234 . . . . 0.0 112.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.87 -27.4 55.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.884 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -96.07 174.15 7.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 74.5 m -90.08 151.51 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.23 -36.84 3.87 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.318 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.01 132.45 39.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 0.0 110.739 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.636 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -75.72 143.42 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.66 113.65 25.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.439 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.3 p90 -134.14 177.38 7.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.413 . . . . 0.0 111.497 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.423 ' O ' ' HB1' ' A' ' 161' ' ' ALA . 8.6 mttt -128.77 -175.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.811 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.66 140.56 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.683 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 51.57 25.06 13.17 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.872 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.29 123.27 30.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 36.3 t -72.62 102.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.8 mt -96.89 142.48 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.434 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.5 m -90.17 99.21 12.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.406 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 31.4 tp -50.3 123.18 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.4 mt -89.71 -54.06 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.42 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -153.93 166.35 33.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.412 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 50.3 mtmt -128.88 48.79 2.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.73 -27.3 66.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.38 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.31 115.77 34.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.926 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -44.32 -28.08 2.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.563 2.176 . . . . 0.0 112.859 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.01 -44.5 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.234 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 19.4 m95 -95.57 112.11 23.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.231 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.484 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.7 m0 -108.29 142.53 38.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.82 144.16 25.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.087 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.04 27.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.969 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -120.1 100.8 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 111.253 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.0 94.58 6.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 4.3 m120 76.61 -59.87 0.49 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.29 -38.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.477 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -69.43 136.08 51.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 111.292 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -106.54 162.47 13.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.523 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.636 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.14 161.42 20.61 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.937 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.411 HD11 ' CZ3' ' A' ' 191' ' ' TRP . 1.6 pt -103.98 152.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.826 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.416 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 19.2 p90 -167.71 154.99 7.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.97 107.85 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.3 2.0 . . . . 0.0 111.337 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.484 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.2 p -53.18 -24.55 11.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -16.2 43.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -93.88 21.56 6.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.215 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 4.2 m -148.6 -167.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.52 111.95 1.85 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.49 121.9 7.02 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.547 2.165 . . . . 0.0 112.44 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -96.35 -68.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 61.73 74.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 140.69 53.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.067 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.914 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 8.1 mtp -106.28 178.6 4.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -166.08 112.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 t -69.25 108.41 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.407 ' CB ' ' HB3' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -94.18 153.46 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.435 ' CD2' ' HA ' ' A' ' 212' ' ' ASN . 0.1 OUTLIER -127.71 163.54 24.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.689 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 0.2 OUTLIER -166.8 123.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.477 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -102.26 123.83 46.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.252 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -73.99 148.33 42.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.721 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.16 14.5 14.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.812 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' HB3' ' CE2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.25 140.16 1.85 Allowed 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 145.21 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -133.66 112.51 11.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.77 87.21 5.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.7 116.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.562 2.175 . . . . 0.0 112.46 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.94 -26.06 36.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.26 172.69 7.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -90.05 150.56 22.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.5 -35.44 4.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.409 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.47 133.42 36.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.641 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -75.68 140.79 42.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.837 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.406 ' N ' HD11 ' A' ' 173' ' ' LEU . . . -96.97 114.49 26.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.165 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.7 p90 -133.29 -178.22 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 111.607 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -126.05 -174.19 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.83 140.08 42.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.264 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 161' ' ' ALA . . . 56.03 21.85 32.96 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.804 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 124.95 31.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.0 t -74.89 119.56 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.81 155.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.601 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.0 m -103.36 104.45 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.359 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.407 ' HB3' ' CB ' ' A' ' 157' ' ' LYS . 31.6 tp -50.11 124.63 10.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.3 mt -89.5 -38.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.537 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.67 174.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.802 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.421 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.9 mtmt -126.16 59.77 1.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -19.75 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -137.05 122.12 12.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.42 -28.02 2.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.715 2.277 . . . . 0.0 112.902 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -102.78 -44.14 5.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.438 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 15.8 m95 -94.8 110.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.458 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 43.1 m0 -105.82 141.96 36.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.063 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.79 143.47 26.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.081 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -147.86 158.43 27.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.129 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.42 90.06 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.99 86.04 0.53 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.608 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 77.68 -59.73 0.45 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.149 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -146.33 -39.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.549 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -69.57 134.86 49.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.323 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.2 158.12 17.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.598 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.641 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.57 162.84 24.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.822 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.438 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.8 pt -104.96 151.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.428 ' CE1' HG13 ' A' ' 208' ' ' VAL . 14.8 p90 -167.5 159.09 10.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.91 108.78 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.329 2.019 . . . . 0.0 111.148 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.3 p -53.32 -24.23 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -58.38 -19.66 37.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 163' ' ' PHE . 1.1 m-85 -90.9 14.26 14.24 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.467 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 161' ' ' ALA . 2.0 m -149.45 -166.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.263 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -177.74 125.38 0.28 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -43.25 129.43 6.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.769 2.312 . . . . 0.0 112.705 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' A' ' 212' ' ' ASN . 1.0 OUTLIER -131.0 -83.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 211' ' ' TYR . 1.0 OUTLIER 176.3 104.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.843 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.2 m -95.3 -31.71 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.798 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.737 0.303 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.32 -177.6 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 133.5 8.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 164.29 15.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -90.06 139.59 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -108.32 123.55 48.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.54 150.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.23 113.88 26.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.96 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.73 154.62 40.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.486 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.3 27.67 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.14 -169.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -127.37 129.72 48.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.811 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 36.5 t80 -131.94 128.6 38.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.41 88.47 49.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.94 119.49 5.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.525 2.15 . . . . 0.0 112.419 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -87.4 -23.36 24.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.04 158.47 16.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.788 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.8 m -78.73 122.48 26.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.19 -20.58 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.441 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.49 139.26 53.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.608 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -76.74 150.22 36.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.86 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.89 110.15 22.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.453 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.506 ' CE1' ' CD2' ' A' ' 203' ' ' PHE . 12.7 p90 -124.13 166.59 15.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -129.49 174.8 9.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.6 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.32 131.97 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.945 0.402 . . . . 0.0 110.926 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.18 19.04 44.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -81.21 117.88 22.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.42 92.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.27 124.91 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.3 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 m -69.97 99.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.369 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.478 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 32.7 tp -49.82 119.96 3.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.591 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 193' ' ' GLU . 12.8 mt -93.73 -41.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.634 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -143.49 158.94 43.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.529 ' HA ' ' CD1' ' A' ' 192' ' ' TRP . 9.8 mttt -138.36 15.59 2.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.539 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -49.58 -36.81 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.288 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.35 105.99 57.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.598 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -42.69 -28.8 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.764 2.309 . . . . 0.0 112.942 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.31 -38.5 9.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.149 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.426 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 17.2 m95 -110.5 107.8 17.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.688 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.558 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 53.9 m0 -108.51 149.45 28.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.278 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.518 ' HB3' ' HB ' ' A' ' 184' ' ' ILE . 1.3 tp10 -89.94 148.98 22.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.7 157.12 27.16 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.33 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -110.12 149.15 30.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.31 101.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.514 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.9 t-20 78.41 31.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 13.2 m-20 82.01 5.44 1.16 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.382 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 168.37 10.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.763 0.316 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -131.4 151.56 51.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.624 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.95 158.12 20.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.169 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 8.0 pt -111.38 151.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 0.0 110.91 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.506 ' CD2' ' CE1' ' A' ' 175' ' ' PHE . 2.1 p90 -170.07 164.87 5.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.57 108.07 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.517 2.144 . . . . 0.0 111.779 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.558 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.4 p -57.93 -21.29 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.122 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -62.88 -14.03 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.792 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.29 20.35 5.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.455 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.3 m -149.13 -169.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.39 111.79 1.37 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.735 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.6 114.45 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.521 2.147 . . . . 0.0 112.529 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.413 ' CE2' ' HA ' ' A' ' 213' ' ' SER . 18.3 t80 -92.86 -66.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.825 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 47.4 t30 55.39 39.34 31.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.413 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 0.7 OUTLIER 58.89 31.34 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.906 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.767 0.318 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.44 178.76 5.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.977 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.75 137.5 16.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.77 134.17 34.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.43 111.9 5.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.09 152.52 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.814 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 m -143.34 157.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.11 117.83 29.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.75 147.57 52.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.85 -20.04 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.884 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -133.94 -175.29 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.636 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.1 148.78 26.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.455 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 6.8 t80 -133.12 110.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.955 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -112.42 79.81 3.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -81.11 120.93 3.83 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.644 2.229 . . . . 0.0 112.481 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -81.42 -23.53 37.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.83 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.01 169.98 11.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.18 148.5 22.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.59 -35.13 4.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.322 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.26 126.86 35.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.837 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.614 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -69.66 144.44 52.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -96.86 107.95 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.494 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -136.67 159.8 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.336 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -117.71 -167.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 138.77 54.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.45 17.03 56.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.501 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -73.1 109.67 6.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.303 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.41 101.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.369 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' A' ' 196' ' ' LEU . 3.4 mt -100.79 140.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.474 . . . . 0.0 111.738 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.7 m -92.62 99.79 12.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.7 tp -46.31 119.1 2.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.115 0.483 . . . . 0.0 111.467 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.423 HG13 ' HA2' ' A' ' 194' ' ' GLY . 19.7 mt -89.64 -37.77 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.7 p30 -177.91 171.2 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.778 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.433 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 32.5 mtmt -122.75 57.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -56.65 -21.64 28.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 37.2 t70 -137.05 129.48 17.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.99 -23.35 16.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.574 2.183 . . . . 0.0 112.724 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -106.6 -38.24 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.196 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.414 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 15.3 m95 -100.94 111.67 23.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.045 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.457 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.1 m0 -107.07 144.61 33.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 0.8 OUTLIER -93.49 145.41 24.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.061 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -155.05 157.14 27.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.052 -1.071 . . . . 0.0 113.021 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -120.51 135.6 55.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' A' ' 181' ' ' ILE . 14.0 mt -92.66 -157.4 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -47.1 -27.87 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -178.41 35.93 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.838 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.83 119.04 16.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.979 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.99 155.68 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.694 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.614 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.07 162.16 21.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.81 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 1.7 pt -99.3 152.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.549 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.45 ' HB2' ' HD2' ' A' ' 204' ' ' PRO . 24.8 p90 -167.66 159.45 9.93 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.992 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 203' ' ' PHE . 45.2 Cg_endo -68.53 110.99 2.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.166 1.911 . . . . 0.0 111.299 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.457 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -55.3 -23.18 22.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.3 -16.94 50.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.68 17.93 10.99 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.261 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 2.6 m -149.59 -168.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 111.526 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.47 122.75 1.07 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -46.56 128.58 12.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.164 . . . . 0.0 112.569 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.39 -67.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -59.01 -31.6 68.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.9 p 58.72 176.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.964 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.973 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.782 0.325 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.5 mmm 62.26 118.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -161.94 108.71 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.26 105.6 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.7 tptt -134.64 110.03 9.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.9 134.96 39.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.5 m -120.04 154.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.165 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.6 113.01 23.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.792 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.66 157.61 29.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.473 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 20.77 7.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.727 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.415 ' HB3' ' CD2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.21 139.37 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.42 138.33 57.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 3.4 t80 -125.45 105.6 9.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.54 78.04 1.09 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 124.4 8.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -93.76 17.2 12.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.68 173.52 11.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.08 146.66 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.08 -34.52 5.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.86 135.4 35.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 0.0 110.768 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.665 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.14 144.63 31.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.894 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.7 109.9 21.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.559 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -135.88 161.64 35.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.54 -166.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -78.59 136.13 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.29 16.81 54.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.75 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.49 118.25 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.55 100.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.43 ' CG1' ' CD2' ' A' ' 196' ' ' LEU . 3.6 mt -99.97 124.48 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.375 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.8 m -72.91 105.14 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 192' ' ' TRP . 32.5 tp -51.04 123.63 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.374 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.421 HG13 ' HA2' ' A' ' 194' ' ' GLY . 25.8 mt -89.64 -53.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.507 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -156.2 166.29 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.434 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 25.8 mtmt -126.91 50.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.579 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.39 -26.81 43.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 17.3 t70 -124.54 124.89 25.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.703 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -50.05 -23.91 10.05 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.183 . . . . 0.0 112.726 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -106.56 -40.0 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.433 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 19.3 m95 -98.16 109.7 22.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.273 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 186' ' ' LYS . 45.8 m0 -107.46 142.73 36.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.026 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 1.0 OUTLIER -89.99 147.0 23.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.877 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.421 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -153.38 159.67 28.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.054 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 2.5 tt0 -112.01 134.45 53.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 110.969 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.457 ' O ' ' CB ' ' A' ' 197' ' ' ASN . 0.2 OUTLIER -112.66 72.1 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.812 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 196' ' ' LEU . 1.8 t-20 86.86 -28.13 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.637 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -177.55 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.325 . . . . 0.0 111.271 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -69.64 151.2 46.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.163 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.41 ' HG2' ' CD1' ' A' ' 184' ' ' ILE . 0.0 OUTLIER -117.09 152.82 33.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.366 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.665 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 176.89 159.61 22.53 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.24 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.433 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -108.0 151.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.421 ' CE1' HG13 ' A' ' 208' ' ' VAL . 13.2 p90 -165.12 155.55 12.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.59 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.364 2.042 . . . . 0.0 110.991 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.423 ' OG ' ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -51.29 -24.51 4.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -52.38 -21.32 3.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.895 0.379 . . . . 0.0 110.466 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . 0.415 ' CD2' ' HB3' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -93.8 22.31 5.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.909 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.4 m -146.71 -169.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 111.747 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.18 111.53 1.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.797 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -47.0 124.6 8.98 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -103.52 -63.51 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -73.4 -20.01 60.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.0 p -54.51 -31.34 55.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.895 0.378 . . . . 0.0 111.057 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.9 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.817 0.342 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtm -147.58 -77.35 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -121.23 99.78 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 t -83.14 153.32 24.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -150.03 130.66 14.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.451 ' CZ ' ' CG2' ' A' ' 182' ' ' THR . 7.6 m-85 -118.8 -176.87 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.456 HG11 ' HA ' ' A' ' 210' ' ' PRO . 27.8 m -158.02 157.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.44 117.21 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.14 152.19 46.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.507 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.56 -22.1 12.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.874 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.12 145.35 39.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.686 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.94 147.36 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.436 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 28.0 t80 -136.11 116.14 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -108.78 88.64 5.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.767 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.09 119.42 5.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.626 2.218 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -96.24 22.14 8.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -135.19 171.67 14.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.826 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 78.1 p -90.08 142.68 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.98 -32.21 7.61 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.16 134.15 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 0.0 110.786 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.63 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.33 148.36 29.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.002 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -101.05 112.41 24.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.5 p90 -127.82 162.0 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.272 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -117.99 -167.56 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.73 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.73 36.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.56 17.62 54.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.41 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -79.77 115.42 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.63 103.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 15.3 mt -98.61 144.8 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 158' ' ' PHE . 3.3 m -93.74 95.95 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 33.3 tp -47.13 124.34 6.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.637 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.31 -39.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.94 172.68 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.428 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 44.3 mtmt -124.77 58.46 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.776 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -59.93 -20.49 57.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.27 119.52 13.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.658 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.17 -28.98 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.724 2.283 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -101.42 -46.48 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.29 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 203' ' ' PHE . 13.6 m95 -92.7 110.42 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.323 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.509 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.5 m0 -105.35 142.38 35.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.788 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.78 143.16 27.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.907 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -144.77 158.12 27.49 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.232 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.401 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.7 OUTLIER -128.49 109.05 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.259 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 12.5 mt -88.89 75.57 8.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.257 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.5 m120 73.78 -62.02 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.491 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -146.06 29.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.618 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.91 97.97 4.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.401 ' HG3' ' CG ' ' A' ' 195' ' ' GLN . 1.4 mpt_? -89.72 149.92 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.432 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.63 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.34 163.17 25.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.136 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.1 pt -111.38 148.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 3.6 p90 -170.18 163.52 6.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.24 111.41 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 111.525 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.509 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -56.2 -21.15 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.233 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.11 -15.85 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 21.15 4.55 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 4.2 m -149.99 -171.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 111.718 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.84 115.04 1.83 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.499 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.456 ' HA ' HG11 ' A' ' 159' ' ' VAL . 68.5 Cg_exo -43.16 129.66 6.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.669 2.246 . . . . 0.0 112.899 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -93.76 -78.92 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.688 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' ASN . 63.8 t30 178.91 35.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.324 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 158' ' ' PHE . 0.4 OUTLIER 64.94 -74.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 0.0 111.089 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' ASN . 34.8 t30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t60 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.9 mtm 60.37 19.66 9.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.46 97.72 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.6 t -74.1 131.18 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.834 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -106.96 124.85 50.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -89.12 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.72 156.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.61 118.85 34.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -72.39 150.22 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.417 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.83 -18.21 13.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.052 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.55 129.88 19.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.702 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.95 152.81 22.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.43 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 53.0 t80 -139.8 120.32 14.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -108.76 87.45 4.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 63.2 Cg_endo -75.95 121.15 6.06 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.376 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -95.79 20.74 9.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.074 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -139.51 172.72 12.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 146.47 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.022 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.65 5.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.366 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.67 134.65 38.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 110.778 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.618 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -79.0 145.28 34.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.931 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -96.83 113.94 25.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.348 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.6 p90 -133.0 175.28 9.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.431 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -128.52 -169.86 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -76.32 139.59 41.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.47 20.18 36.76 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.82 121.57 27.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 0.0 110.809 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.68 104.04 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.1 mt -99.96 137.77 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.394 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.92 96.49 10.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.447 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.76 125.67 7.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.57 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.29 -44.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.552 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.5 150.35 5.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.435 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 31.1 mtmt -110.35 49.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.1 -22.03 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -127.36 127.85 24.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.708 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.72 -19.68 25.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.554 2.169 . . . . 0.0 112.731 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -112.42 -32.74 6.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 23.9 m95 -105.84 108.7 20.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.479 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -107.19 138.66 42.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 202' ' ' ILE . 0.9 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.84 158.07 27.52 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.126 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.85 95.97 4.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.683 0.277 . . . . 0.0 111.283 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.9 mt -74.16 72.9 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.254 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 4.3 m120 72.61 -63.13 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.1 28.54 1.53 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -129.49 103.72 7.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.618 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 167.88 162.0 18.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.021 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.42 HD12 ' CZ3' ' A' ' 191' ' ' TRP . 1.4 pt -106.74 149.96 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.428 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 19.7 p90 -164.07 150.34 9.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.141 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 110.14 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.216 1.944 . . . . 0.0 111.041 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.479 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.8 p -56.08 -20.54 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.461 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -61.24 -17.08 51.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 110.62 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -92.92 16.6 12.22 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 2.8 m -149.17 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.55 119.54 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.72 126.33 12.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.445 2.097 . . . . 0.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -101.05 -70.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 54.58 40.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 p 49.95 76.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.857 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.59 173.09 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -170.25 133.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.919 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.07 176.25 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.07 103.07 12.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.68 120.29 41.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.78 139.14 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.78 129.03 49.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.786 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.26 144.88 40.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 0.66 56.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.508 ' CE1' ' CG ' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -158.44 -163.14 1.22 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.784 0.326 . . . . 0.0 110.805 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.71 145.39 42.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 10.3 t80 -130.68 113.93 14.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -114.49 76.21 3.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.23 123.48 6.13 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.601 2.201 . . . . 0.0 112.471 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -120.64 170.54 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.752 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 p -89.96 142.79 27.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.26 -32.23 7.55 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.54 133.71 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 0.0 110.792 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.668 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.0 OUTLIER -80.49 157.43 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.751 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -106.66 113.45 26.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.932 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.505 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 1.8 p90 -134.39 154.62 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -110.88 -169.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 134.65 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.344 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.89 20.51 41.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.666 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -80.62 110.53 16.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.51 105.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.439 ' CG1' ' CD2' ' A' ' 196' ' ' LEU . 2.6 mt -103.22 125.21 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.361 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 79.0 m -73.57 105.83 5.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.428 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.61 127.88 21.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.603 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 194' ' ' GLY . 25.4 mt -89.64 -40.69 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.476 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.4 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 2.6 p30 -177.94 155.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 35.4 mtmt -107.64 54.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -58.43 -18.71 30.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.088 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -132.8 118.47 15.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.693 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -42.07 -28.95 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.745 2.297 . . . . 0.0 113.135 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -106.36 -42.76 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.428 ' CE3' ' HA ' ' A' ' 203' ' ' PHE . 12.6 m95 -94.88 106.83 18.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.257 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.522 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 43.9 m0 -101.54 142.48 32.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.4 ' HB3' ' ND2' ' A' ' 185' ' ' ASN . 1.0 OUTLIER -89.29 145.87 25.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.429 ' N ' HD12 ' A' ' 184' ' ' ILE . . . -152.39 162.37 29.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.2 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 2.4 tt0 -112.67 140.98 46.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.716 0.293 . . . . 0.0 110.904 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.448 ' O ' ' CB ' ' A' ' 197' ' ' ASN . 0.2 OUTLIER -120.44 71.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.887 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 196' ' ' LEU . 1.9 t-20 86.09 -23.2 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.725 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 177.54 -36.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.655 0.264 . . . . 0.0 111.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 2.5 ptt-85 -69.85 153.28 43.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.178 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.412 ' HG2' ' CD1' ' A' ' 184' ' ' ILE . 5.5 mtm-85 -119.89 152.38 37.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.74 158.92 22.21 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.392 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 2.7 pt -108.27 150.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.1 p90 -170.1 162.67 6.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.71 110.28 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.458 2.105 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.522 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.2 p -57.59 -19.63 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.79 -12.74 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.627 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . 0.508 ' CG ' ' CE1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -89.83 13.94 13.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.54 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 205' ' ' SER . 2.9 m -144.89 -169.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 111.55 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.28 113.85 2.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.875 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.14 109.84 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.609 2.206 . . . . 0.0 112.574 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.95 -67.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 61.66 74.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -170.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.956 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.0 m170 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.822 0.344 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 4.7 mmt -92.57 -174.97 3.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -133.72 103.11 5.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.23 134.4 33.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.989 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -149.97 128.23 12.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -133.27 142.84 48.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.35 154.84 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.08 114.4 27.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -70.09 154.23 42.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.21 20.74 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.74 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.68 1.82 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.629 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.12 138.33 55.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 5.1 t80 -127.15 109.42 11.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.002 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -109.68 84.18 3.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.01 116.4 4.2 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.69 2.26 . . . . 0.0 112.48 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -80.83 -26.48 37.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.686 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.48 174.76 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.97 151.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.87 -36.55 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -95.17 138.77 32.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.677 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.59 147.26 28.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.757 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.77 110.47 22.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.767 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.2 p90 -135.81 157.98 45.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.422 . . . . 0.0 111.16 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -109.32 -169.74 1.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.54 136.2 39.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.89 58.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.688 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -79.5 118.13 21.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.77 97.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.7 138.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.27 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -86.2 99.11 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.607 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.0 tp -49.5 123.57 7.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.396 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.44 -39.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -177.55 173.24 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.814 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.419 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 35.1 mtmt -123.28 55.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.39 -22.96 22.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -135.74 130.32 18.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.717 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.69 -21.81 20.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.643 2.229 . . . . 0.0 112.624 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -108.38 -36.38 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.429 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 20.6 m95 -103.02 110.55 22.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.459 ' CG ' ' HB3' ' A' ' 205' ' ' SER . 44.0 m0 -106.38 140.82 38.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.944 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.83 149.59 22.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -153.79 159.28 28.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.74 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -124.34 118.91 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 111.181 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 13.0 mt -102.77 97.06 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.536 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 79.65 -55.14 0.4 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -159.62 -36.33 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -69.47 141.09 54.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 111.333 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.4 160.38 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.467 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.677 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 174.36 159.67 21.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.015 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.421 HD13 ' CZ3' ' A' ' 191' ' ' TRP . 1.4 pt -106.3 151.8 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.747 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.432 ' CE2' HD23 ' A' ' 173' ' ' LEU . 13.8 p90 -165.55 151.2 8.31 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.65 111.47 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.264 1.976 . . . . 0.0 111.174 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.459 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.1 p -55.84 -21.54 20.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 111.197 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -17.75 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.494 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.29 17.87 12.04 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.292 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.2 m -148.7 -168.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 111.356 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.1 114.57 1.3 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -47.2 124.39 8.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.463 2.109 . . . . 0.0 112.589 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.21 -68.84 0.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 61.91 81.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.647 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.1 m -57.62 -77.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.899 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.8 t60 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.792 0.329 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -77.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.34 100.64 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 t -95.92 123.1 39.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 111.46 4.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -103.54 133.23 48.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.07 153.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.14 113.13 24.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.458 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.425 ' HA ' HG11 ' A' ' 208' ' ' VAL . . . -65.72 157.19 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.557 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.22 19.55 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.929 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -170.23 140.26 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.68 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.99 137.17 53.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.443 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.2 t80 -129.06 109.78 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.944 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -110.87 79.2 1.79 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.09 115.99 3.86 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.54 2.16 . . . . 0.0 112.509 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -80.06 -26.45 39.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.91 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.33 170.69 12.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.5 m -89.93 148.83 22.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.75 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.414 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.4 130.97 39.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.745 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.652 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -77.84 147.88 34.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.805 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.58 112.25 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.5 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.6 p90 -131.3 155.57 46.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -112.31 172.12 7.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.467 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 135.83 57.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.226 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.52 23.7 55.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.885 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.44 123.24 30.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.345 . . . . 0.0 110.863 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 37.1 t -73.12 94.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 27.7 mt -89.98 143.04 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.347 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.4 m -90.82 98.63 11.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.502 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.8 tp -50.03 124.4 10.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 25.1 mt -89.7 -39.51 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.594 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -177.76 172.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.419 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 46.9 mtmt -121.99 56.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.679 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -57.16 -21.72 34.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.139 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.09 121.61 12.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.667 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.79 -28.16 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.716 2.278 . . . . 0.0 112.949 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -102.78 -44.71 5.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.23 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.429 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 24.1 m95 -94.03 108.75 20.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.473 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 43.4 m0 -104.32 141.8 35.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.99 146.35 24.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.205 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.86 158.36 27.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.915 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.07 107.13 11.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.54 95.59 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.601 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 23.4 t30 77.39 -59.03 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -152.09 -38.37 0.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -69.62 138.6 53.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.221 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -107.31 162.42 13.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.573 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.652 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.95 161.94 23.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.869 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.429 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -106.24 153.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.41 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 16.1 p90 -169.36 148.72 3.58 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.126 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.45 109.82 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.276 1.984 . . . . 0.0 111.384 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.0 p -54.35 -23.11 14.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.316 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -61.04 -16.13 40.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.29 22.19 6.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.425 HG11 ' HA ' ' A' ' 161' ' ' ALA . 4.1 m -149.87 -168.7 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.737 0.304 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.41 111.52 1.86 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.86 121.73 6.21 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -98.41 -68.24 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.6 t30 61.75 74.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -58.25 -175.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.935 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.851 0.358 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 23.5 mtm -105.71 -34.01 7.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.74 137.18 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.2 t -96.25 147.26 23.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -104.68 168.02 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.969 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -144.14 111.94 6.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 25.8 m -106.64 152.02 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.067 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.46 112.84 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.97 155.71 33.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.536 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.86 -12.41 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.52 132.0 19.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.04 143.6 31.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.446 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 9.8 t80 -127.74 109.48 11.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.59 78.9 1.6 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.17 123.91 6.94 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.608 2.205 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -94.48 18.22 11.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -129.71 173.1 10.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 m -90.15 145.88 24.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.54 -34.45 5.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.391 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -93.64 134.35 36.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.673 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.61 147.94 29.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.654 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.77 110.34 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 175' ' ' PHE . 1.8 p90 -133.52 152.96 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 111.209 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -103.22 -168.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -79.1 134.74 36.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.88 18.61 54.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -80.85 119.2 23.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.8 t -69.71 99.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 4.9 mt -93.99 140.6 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.326 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -87.41 100.87 13.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.517 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 32.8 tp -51.21 123.77 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.421 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 31.2 mt -89.58 -39.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.625 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.35 172.18 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.43 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 33.0 mtmt -127.07 57.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.75 -22.02 61.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -132.78 117.22 15.05 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.17 -29.94 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.922 2.415 . . . . 0.0 113.168 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.49 -48.99 4.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.446 ' CE3' ' CD1' ' A' ' 202' ' ' ILE . 28.0 m95 -89.82 108.11 19.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.117 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.43 ' CD2' ' HG2' ' A' ' 186' ' ' LYS . 45.0 m0 -104.68 142.46 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.966 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.87 145.52 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.248 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.95 158.92 27.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.874 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -123.57 118.63 27.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.729 0.3 . . . . 0.0 111.235 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.4 mt -103.55 97.78 7.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.513 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 79.36 -55.71 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -159.25 -36.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 -69.61 141.95 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.304 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.51 162.37 14.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.673 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.78 161.25 23.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.91 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.446 ' CD1' ' CE3' ' A' ' 191' ' ' TRP . 1.5 pt -108.39 153.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.409 ' HA ' ' CZ3' ' A' ' 191' ' ' TRP . 15.5 p90 -170.03 151.91 4.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.37 106.89 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.188 1.925 . . . . 0.0 110.984 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.404 ' OG ' ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -51.35 -23.46 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.037 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -51.74 -21.74 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 110.508 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.38 23.1 4.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.711 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 161' ' ' ALA . 3.7 m -147.11 -167.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 111.625 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.21 110.02 1.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -47.98 113.17 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.505 2.137 . . . . 0.0 112.532 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.54 -66.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.2 t30 61.7 74.56 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.636 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 79.4 p -58.27 174.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.1 p30 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.916 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.1 m -126.09 157.64 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.82 122.66 47.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.669 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -70.08 157.85 36.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.583 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -126.53 17.89 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.829 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.12 140.2 1.92 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.69 142.23 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.996 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.451 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 19.5 t80 -135.13 110.82 9.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -110.22 82.15 2.51 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.24 113.49 3.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.582 2.188 . . . . 0.0 112.327 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -76.49 -27.35 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.915 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.07 168.27 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.9 p -90.05 148.8 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.0 -35.05 4.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.406 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.15 137.35 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.308 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.45 149.44 31.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.639 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -99.39 112.74 24.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.557 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.728 ' CB ' HD11 ' A' ' 181' ' ' ILE . 6.7 p90 -133.82 160.37 37.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.375 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 13.8 mtmt -115.65 -168.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.657 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 133.38 37.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.85 19.07 58.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.011 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -84.35 128.11 34.38 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.66 120.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.728 HD11 ' CB ' ' A' ' 175' ' ' PHE . 70.3 mt -120.71 113.96 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.0 111.309 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.4 m -70.15 108.65 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.411 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 186' ' ' LYS . 29.6 tp -56.74 124.7 19.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.435 HD12 ' CG ' ' A' ' 193' ' ' GLU . 22.8 mt -89.37 -32.25 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.269 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 8.5 p30 -175.16 -171.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.685 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.696 ' HG3' HD21 ' A' ' 183' ' ' LEU . 27.3 mtmt -151.39 51.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.726 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.55 -39.86 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -121.77 130.32 24.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.009 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.26 -17.34 25.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.214 1.943 . . . . 0.0 111.89 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -94.45 -46.37 7.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.845 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.654 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 14.5 m95 -110.29 122.5 47.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 111.188 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 46.2 m0 -114.05 141.14 47.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.844 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.1 tt0 -89.97 140.85 29.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.812 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -151.06 162.05 29.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.911 -1.137 . . . . 0.0 113.16 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.424 ' HG2' HD13 ' A' ' 184' ' ' ILE . 4.7 mpt_? . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 169.33 161.02 18.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.061 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.556 HG23 ' OE2' ' A' ' 193' ' ' GLU . 3.8 pt -107.26 148.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.866 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.9 p90 -170.39 164.0 5.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.53 117.88 4.82 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.355 2.036 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.517 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.3 p -63.09 -17.01 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.82 -13.98 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.75 15.7 10.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 162' ' ' LEU . 2.7 m -148.18 -171.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.17 122.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.773 ' HA ' HG12 ' A' ' 159' ' ' VAL . 96.7 Cg_exo -44.78 128.0 8.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.733 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 85.6 t80 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.852 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 4.1 m-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.807 0.337 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 210' ' ' PRO . 31.1 m -114.81 155.51 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.245 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.67 110.02 19.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -64.04 158.19 23.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -127.27 19.07 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.743 179.326 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.581 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.4 140.2 58.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -128.06 106.48 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -109.92 78.43 1.28 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 124.12 7.82 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.526 2.151 . . . . 0.0 112.419 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -93.75 17.44 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -131.42 173.97 10.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.845 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 29.7 p -90.04 146.26 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.41 -34.11 5.7 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -93.24 132.49 37.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.303 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.725 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -78.8 143.59 35.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.494 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.79 111.18 22.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -137.19 166.8 22.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -168.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.732 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -76.22 136.96 39.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.87 18.19 52.92 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.601 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -76.97 114.73 16.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.59 93.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.752 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 173' ' ' LEU . 4.4 mt -95.82 132.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.402 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -78.72 103.16 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 193' ' ' GLU . 37.7 tp -49.48 125.3 10.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.545 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.654 HG22 ' ND2' ' A' ' 185' ' ' ASN . 33.6 mt -89.65 -55.17 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.654 ' ND2' HG22 ' A' ' 184' ' ' ILE . 8.7 m-80 -153.59 166.15 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.573 ' HG3' HD21 ' A' ' 183' ' ' LEU . 49.2 mtmt -128.05 47.62 2.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.543 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.302 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -118.17 115.35 36.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.911 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -44.12 -28.19 2.19 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.654 2.236 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -101.62 -44.97 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.993 ' CE3' HD12 ' A' ' 202' ' ' ILE . 17.9 m95 -95.61 113.44 25.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.249 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.8 m0 -109.58 141.72 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.838 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.85 145.24 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.152 179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.47 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -146.96 160.15 28.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.035 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 111.095 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.601 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.683 0.278 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.643 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.52 159.47 20.12 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.748 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.993 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -106.12 150.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.725 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.9 p90 -164.72 156.88 13.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.99 106.9 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.464 2.109 . . . . 0.0 111.298 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.7 p -52.69 -24.31 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.052 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.3 -17.9 45.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.741 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.06 23.73 6.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 205' ' ' SER . 6.0 m -149.27 -170.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.334 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.69 110.41 2.18 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.3 Cg_exo -48.31 124.86 11.15 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.472 2.115 . . . . 0.0 112.478 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 33.5 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 182' ' ' THR . 29.3 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 26.7 m -107.13 151.77 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.37 114.54 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -64.73 153.73 38.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.499 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.473 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.36 -22.42 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.26 128.92 24.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.93 146.34 42.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.448 ' CB ' ' CZ ' ' A' ' 175' ' ' PHE . 59.9 t80 -137.6 117.95 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.3 87.95 4.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 64.8 Cg_endo -75.89 121.69 6.38 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.19 20.12 9.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -136.07 171.52 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 38.4 p -90.01 146.28 24.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.47 -34.01 5.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.378 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.99 136.93 36.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.847 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -82.21 145.96 29.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.81 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.04 108.45 20.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 181' ' ' ILE . 11.6 p90 -122.91 158.32 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.333 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 18.8 mttm -117.91 -175.53 2.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.513 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.11 132.08 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.96 18.02 53.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.61 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -79.98 117.95 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.68 96.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.756 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 175' ' ' PHE . 4.8 mt -95.55 122.29 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.432 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.68 HG23 ' CE1' ' A' ' 158' ' ' PHE . 1.3 m -72.83 103.23 3.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 193' ' ' GLU . 38.5 tp -51.04 125.69 14.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.311 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.687 HG22 ' ND2' ' A' ' 185' ' ' ASN . 28.5 mt -89.37 -55.42 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.687 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.5 m-80 -155.47 165.7 35.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 34.9 mtmt -126.28 50.28 1.91 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.581 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -56.18 -25.74 47.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.374 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 10.6 t70 -124.53 127.01 25.34 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 -22.01 20.65 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.523 2.149 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 10.6 m120 -108.57 -36.35 6.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 111.214 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.922 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.5 m95 -103.23 110.95 23.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.539 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.5 m0 -106.55 141.85 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 183' ' ' LEU . 3.3 tt0 -89.59 138.57 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.437 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -142.87 159.48 27.36 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.181 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.12 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.643 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.235 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . -179.27 159.24 23.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.257 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.922 HD12 ' CE3' ' A' ' 191' ' ' TRP . 3.8 pt -112.83 149.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.847 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.35 162.75 6.2 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 34.6 Cg_exo -59.82 108.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.362 2.041 . . . . 0.0 111.339 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.0 OUTLIER -57.04 -20.86 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.143 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -62.15 -13.71 29.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -90.98 19.35 5.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 205' ' ' SER . 4.4 m -147.0 -171.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.4 112.4 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 80.8 Cg_exo -46.52 118.43 2.56 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.534 2.156 . . . . 0.0 112.636 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 28.0 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.898 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 182' ' ' THR . 46.5 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 210' ' ' PRO . 5.5 m -127.52 156.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.55 114.81 26.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.639 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.63 157.26 34.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.508 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -128.45 19.73 6.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.28 140.24 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.91 142.34 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.45 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.8 t80 -132.68 112.48 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.31 84.72 3.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.16 115.43 3.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.491 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -79.73 -26.3 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -96.85 175.14 6.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 80.4 p -90.1 151.77 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.65 -36.05 4.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.84 133.76 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.292 . . . . 0.0 110.737 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.735 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.65 144.88 39.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.906 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -95.87 111.82 23.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.536 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -134.97 -179.83 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.42 . . . . 0.0 111.357 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 6.6 pttp -131.17 -170.81 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.754 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -75.46 139.76 42.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.038 0.447 . . . . 0.0 111.463 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 55.85 21.26 29.39 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.17 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 176' ' ' LYS . 0.4 OUTLIER -84.56 122.33 28.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.75 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.3 103.59 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.7 mt -102.72 127.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.394 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.2 m -79.33 100.3 7.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.354 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.81 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -49.1 127.68 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.607 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 193' ' ' GLU . 31.9 mt -89.55 -36.42 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.461 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.1 p30 -176.55 154.85 1.3 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.81 ' HG3' HD21 ' A' ' 183' ' ' LEU . 44.4 mtmt -115.18 44.02 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.34 -31.09 5.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.21 127.14 23.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.036 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.89 -14.84 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.275 1.984 . . . . 0.0 112.185 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.63 -44.26 6.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.6 m95 -115.24 112.41 22.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 111.508 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.502 ' HB3' HD11 ' A' ' 183' ' ' LEU . 46.6 m0 -101.01 136.82 40.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.547 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 184' ' ' ILE . 1.9 tt0 -88.79 146.13 25.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.5 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.4 161.96 28.58 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 119.951 -1.118 . . . . 0.0 113.463 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.0 mtp180 . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.03 156.6 12.43 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.932 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.782 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -102.94 149.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.804 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.735 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.0 p90 -162.61 157.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.57 113.36 1.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.251 1.967 . . . . 0.0 110.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 208' ' ' VAL . 3.7 p -59.4 -19.61 48.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 111.35 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -65.53 -14.49 61.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.399 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 20.47 9.22 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.183 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.539 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -150.02 -167.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.49 114.65 1.25 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.7 Cg_exo -48.03 125.19 11.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.611 2.207 . . . . 0.0 112.459 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 25.4 t80 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 23.1 m -110.26 150.9 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.55 114.53 27.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.39 157.71 31.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.552 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.452 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -125.51 24.51 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.18 178.67 3.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -100.16 138.0 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 2.0 t80 -125.84 105.37 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -109.67 78.59 1.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.408 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 70.2 Cg_endo -75.93 115.76 4.24 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 112.551 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.84 -26.58 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.38 172.97 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.1 m -90.11 150.89 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.63 -36.3 4.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.347 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 4.9 mt-10 -93.35 136.14 33.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.659 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -80.66 147.03 30.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.704 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.519 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.43 113.84 25.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.715 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -141.15 163.37 33.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.408 . . . . 0.0 111.087 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -123.25 -176.56 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.807 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 139.48 57.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.27 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.02 21.01 44.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.625 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -78.32 109.66 12.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.7 94.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.612 HG21 ' CD2' ' A' ' 173' ' ' LEU . 10.5 mt -95.53 135.01 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.433 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 m -81.43 102.99 10.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.811 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.1 tp -51.03 122.42 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.457 HD12 ' CG ' ' A' ' 193' ' ' GLU . 28.4 mt -89.49 -36.31 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.75 174.65 0.82 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' HE2' HD21 ' A' ' 183' ' ' LEU . 21.3 mttt -123.16 66.14 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.59 -19.44 38.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 14.2 t70 -150.61 132.94 8.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.685 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.13 -25.68 4.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.861 2.374 . . . . 0.0 112.76 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -102.44 -44.64 5.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 0.0 111.358 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.909 ' CE3' HD12 ' A' ' 202' ' ' ILE . 32.5 m95 -94.19 110.57 22.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.325 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.466 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -108.5 141.33 40.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.811 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.76 144.87 25.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.11 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -150.11 158.25 27.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.766 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.887 0.375 . . . . 0.0 111.201 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.445 ' HG2' HD13 ' A' ' 184' ' ' ILE . 3.9 mpt_? . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.88 162.31 24.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.02 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.909 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -107.66 154.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.743 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.6 p90 -170.09 149.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.065 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 24.3 Cg_exo -62.76 107.09 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.22 1.947 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.759 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -52.26 -22.54 4.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.313 -179.28 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -53.01 -19.85 3.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.765 0.317 . . . . 0.0 110.47 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.24 21.95 7.34 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -147.2 -167.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.724 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.24 111.98 1.02 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 85.9 Cg_exo -46.48 115.11 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.504 2.136 . . . . 0.0 112.683 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.835 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.928 0.394 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 210' ' ' PRO . 6.0 m -129.83 153.6 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.23 115.28 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.31 154.05 39.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.391 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.462 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.48 13.92 22.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 0.1 OUTLIER -170.05 -164.23 0.4 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -114.94 145.9 41.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 20.8 t80 -135.75 115.13 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -111.88 85.83 6.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.684 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 113.79 3.74 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.651 2.234 . . . . 0.0 112.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.87 -27.4 55.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.884 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -96.07 174.15 7.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 74.5 m -90.08 151.51 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.23 -36.84 3.87 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.318 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.01 132.45 39.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 0.0 110.739 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.72 143.42 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.564 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.66 113.65 25.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.439 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.3 p90 -134.14 177.38 7.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.413 . . . . 0.0 111.497 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 8.6 mttt -128.77 -175.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.811 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -69.66 140.56 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.683 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 51.57 25.06 13.17 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.872 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.29 123.27 30.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 36.3 t -72.62 102.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.8 mt -96.89 142.48 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.434 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.5 m -90.17 99.21 12.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.4 tp -50.3 123.18 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.618 HG22 ' ND2' ' A' ' 185' ' ' ASN . 22.4 mt -89.71 -54.06 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.42 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.618 ' ND2' HG22 ' A' ' 184' ' ' ILE . 7.2 m-80 -153.93 166.35 33.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.544 ' HG3' HD21 ' A' ' 183' ' ' LEU . 50.3 mtmt -128.88 48.79 2.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.73 -27.3 66.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.38 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.31 115.77 34.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.926 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -44.32 -28.08 2.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.563 2.176 . . . . 0.0 112.859 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.01 -44.5 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.234 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.954 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.4 m95 -95.57 112.11 23.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.231 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.5 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.7 m0 -108.29 142.53 38.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -90.82 144.16 25.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.087 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.04 27.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.969 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 111.253 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.468 ' HG2' HD13 ' A' ' 184' ' ' ILE . 2.3 mpt_? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.608 0.242 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.624 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.14 161.42 20.61 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.937 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.954 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -103.98 152.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.826 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.734 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.2 p90 -167.71 154.99 7.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.97 107.85 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.3 2.0 . . . . 0.0 111.337 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.2 p -53.18 -24.55 11.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -16.2 43.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' TYR . . . . . 0.411 ' HB3' ' CE1' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -93.88 21.56 6.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.215 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -148.6 -167.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.52 111.95 1.85 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' A' ' 159' ' ' VAL . 76.8 Cg_exo -48.49 121.9 7.02 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.547 2.165 . . . . 0.0 112.44 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.705 ' O ' HG13 ' A' ' 159' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.644 0.259 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -166.8 123.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.477 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -102.26 123.83 46.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.252 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -73.99 148.33 42.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.721 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -117.16 14.5 14.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.812 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.25 140.16 1.85 Allowed 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 145.21 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -133.66 112.51 11.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.77 87.21 5.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.7 116.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.562 2.175 . . . . 0.0 112.46 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.94 -26.06 36.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.26 172.69 7.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -90.05 150.56 22.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.5 -35.44 4.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.409 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.47 133.42 36.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.68 140.79 42.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.837 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.49 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.97 114.49 26.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.165 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.7 p90 -133.29 -178.22 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 111.607 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -126.05 -174.19 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.83 140.08 42.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.264 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 56.03 21.85 32.96 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 124.95 31.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.0 t -74.89 119.56 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.678 ' HB ' HG23 ' A' ' 159' ' ' VAL . 5.0 mt -119.81 155.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.601 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.464 ' N ' HG22 ' A' ' 181' ' ' ILE . 2.0 m -103.36 104.45 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.359 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.6 tp -50.11 124.63 10.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.517 HD12 ' CG ' ' A' ' 193' ' ' GLU . 27.3 mt -89.5 -38.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.537 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.67 174.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.802 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.438 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.9 mtmt -126.16 59.77 1.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -19.75 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 24.3 t0 -137.05 122.12 12.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.42 -28.02 2.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.715 2.277 . . . . 0.0 112.902 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -102.78 -44.14 5.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.8 m95 -94.8 110.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.505 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.1 m0 -105.82 141.96 36.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.063 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.79 143.47 26.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.081 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.455 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.86 158.43 27.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.129 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.588 0.232 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.635 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.57 162.84 24.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.822 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.981 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.8 pt -104.96 151.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.809 ' CD2' HD23 ' A' ' 173' ' ' LEU . 14.8 p90 -167.5 159.09 10.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.91 108.78 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.329 2.019 . . . . 0.0 111.148 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.3 p -53.32 -24.23 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -58.38 -19.66 37.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 163' ' ' PHE . 1.1 m-85 -90.9 14.26 14.24 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.467 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.0 m -149.45 -166.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.263 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.526 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -177.74 125.38 0.28 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -43.25 129.43 6.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.769 2.312 . . . . 0.0 112.705 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.574 ' CD1' HG12 ' A' ' 180' ' ' VAL . 32.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.79 0.328 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 181' ' ' ILE . 26.8 m -112.54 150.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.23 113.88 26.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.96 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -66.73 154.62 40.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.486 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.449 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -120.3 27.67 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.14 -169.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -127.37 129.72 48.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.811 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.454 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 36.5 t80 -131.94 128.6 38.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.41 88.47 49.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.94 119.49 5.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.525 2.15 . . . . 0.0 112.419 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -87.4 -23.36 24.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.04 158.47 16.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.788 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.8 m -78.73 122.48 26.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.19 -20.58 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.441 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.49 139.26 53.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.74 150.22 36.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.86 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.5 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -97.89 110.15 22.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.453 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 181' ' ' ILE . 12.7 p90 -124.13 166.59 15.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.9 mtpp -129.49 174.8 9.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.6 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.32 131.97 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.945 0.402 . . . . 0.0 110.926 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.18 19.04 44.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -81.21 117.88 22.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 158' ' ' PHE . 38.8 t -69.42 92.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 195' ' ' GLN . 3.4 mt -92.27 124.91 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.3 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 m -69.97 99.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.369 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.883 HD21 ' HG3' ' A' ' 186' ' ' LYS . 32.7 tp -49.82 119.96 3.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.591 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.579 HD13 ' CG ' ' A' ' 200' ' ' ARG . 12.8 mt -93.73 -41.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.634 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -143.49 158.94 43.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.883 ' HG3' HD21 ' A' ' 183' ' ' LEU . 9.8 mttt -138.36 15.59 2.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.539 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -49.58 -36.81 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.288 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 191' ' ' TRP . 0.4 OUTLIER -107.35 105.99 57.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.598 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -42.69 -28.8 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.764 2.309 . . . . 0.0 112.942 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 9.3 m120 -97.31 -38.5 9.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.149 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.438 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 17.2 m95 -110.5 107.8 17.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.688 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.823 ' HB3' HD11 ' A' ' 183' ' ' LEU . 53.9 m0 -108.51 149.45 28.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.278 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.753 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.3 tp10 -89.94 148.98 22.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.7 157.12 27.16 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.33 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 181' ' ' ILE . 20.5 tt0 . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.579 ' CG ' HD13 ' A' ' 184' ' ' ILE . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.519 0.199 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.95 158.12 20.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.169 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.682 HG23 ' CD ' ' A' ' 193' ' ' GLU . 8.0 pt -111.38 151.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 0.0 110.91 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.764 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.07 164.87 5.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 31.7 Cg_exo -58.57 108.07 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.517 2.144 . . . . 0.0 111.779 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.584 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.4 p -57.93 -21.29 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.122 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -62.88 -14.03 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.792 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.29 20.35 5.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.455 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -149.13 -169.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.39 111.79 1.37 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.735 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 86.7 Cg_exo -46.6 114.45 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.521 2.147 . . . . 0.0 112.529 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.825 -179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.789 0.328 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 12.9 m -143.34 157.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.11 117.83 29.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.75 147.57 52.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.85 -20.04 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.884 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -133.94 -175.29 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.636 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.1 148.78 26.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.455 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 6.8 t80 -133.12 110.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.955 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -112.42 79.81 3.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.412 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 76.3 Cg_endo -81.11 120.93 3.83 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.644 2.229 . . . . 0.0 112.481 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -81.42 -23.53 37.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.83 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.01 169.98 11.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.18 148.5 22.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.59 -35.13 4.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.322 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 2.6 mt-10 -90.26 126.86 35.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.837 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.054 HD21 HD13 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -69.66 144.44 52.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.643 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.86 107.95 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.494 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 181' ' ' ILE . 2.0 p90 -136.67 159.8 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.336 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -117.71 -167.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 138.77 54.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.45 17.03 56.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.501 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -73.1 109.67 6.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.303 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.41 101.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.369 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 1.054 HD13 HD21 ' A' ' 173' ' ' LEU . 3.4 mt -100.79 140.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.474 . . . . 0.0 111.738 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.7 m -92.62 99.79 12.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 193' ' ' GLU . 20.7 tp -46.31 119.1 2.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.115 0.483 . . . . 0.0 111.467 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.484 HD12 ' CG ' ' A' ' 193' ' ' GLU . 19.7 mt -89.64 -37.77 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.7 p30 -177.91 171.2 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.778 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 32.5 mtmt -122.75 57.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -56.65 -21.64 28.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 37.2 t70 -137.05 129.48 17.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.99 -23.35 16.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.574 2.183 . . . . 0.0 112.724 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.5 m120 -106.6 -38.24 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.196 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.78 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.3 m95 -100.94 111.67 23.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.045 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.477 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.1 m0 -107.07 144.61 33.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.806 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -93.49 145.41 24.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.061 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -155.05 157.14 27.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.052 -1.071 . . . . 0.0 113.021 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.625 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.473 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.598 0.237 . . . . 0.0 110.694 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.07 162.16 21.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.81 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.78 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -99.3 152.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.549 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.864 ' CD2' HD23 ' A' ' 173' ' ' LEU . 24.8 p90 -167.66 159.45 9.93 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.992 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 203' ' ' PHE . 45.2 Cg_endo -68.53 110.99 2.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.166 1.911 . . . . 0.0 111.299 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -55.3 -23.18 22.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.3 -16.94 50.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.68 17.93 10.99 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.261 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.495 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.6 m -149.59 -168.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 111.526 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.414 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -165.47 122.75 1.07 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.9 Cg_exo -46.56 128.58 12.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.164 . . . . 0.0 112.569 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.816 0.341 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 19.5 m -120.04 154.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -114.6 113.01 23.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.792 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.66 157.61 29.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.473 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.42 20.77 7.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.727 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.21 139.37 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.42 138.33 57.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 3.4 t80 -125.45 105.6 9.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.54 78.04 1.09 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 124.4 8.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -93.76 17.2 12.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.68 173.52 11.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.08 146.66 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.08 -34.52 5.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.86 135.4 35.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 0.0 110.768 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.14 144.63 31.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.894 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.567 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.7 109.9 21.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.559 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -135.88 161.64 35.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.54 -166.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -78.59 136.13 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.29 16.81 54.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.75 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.49 118.25 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.55 100.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 173' ' ' LEU . 3.6 mt -99.97 124.48 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.375 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.8 m -72.91 105.14 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.5 tp -51.04 123.63 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.374 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.74 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.8 mt -89.64 -53.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.507 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.718 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.1 m-80 -156.2 166.29 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 25.8 mtmt -126.91 50.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.579 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.39 -26.81 43.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 17.3 t70 -124.54 124.89 25.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.703 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 188' ' ' ASP . 8.3 Cg_endo -50.05 -23.91 10.05 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.183 . . . . 0.0 112.726 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -106.56 -40.0 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.971 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.3 m95 -98.16 109.7 22.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.273 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.551 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.8 m0 -107.46 142.73 36.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.026 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.815 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.99 147.0 23.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.877 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -153.38 159.67 28.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.054 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 110.969 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.74 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 176.89 159.61 22.53 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.24 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.971 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -108.0 151.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.632 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.2 p90 -165.12 155.55 12.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 16.9 Cg_exo -66.59 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.364 2.042 . . . . 0.0 110.991 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.794 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.29 -24.51 4.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -52.38 -21.32 3.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.895 0.379 . . . . 0.0 110.466 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -93.8 22.31 5.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.909 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 205' ' ' SER . 3.4 m -146.71 -169.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 111.747 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.18 111.53 1.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.797 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -47.0 124.6 8.98 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 24.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.854 ' CE1' HG23 ' A' ' 182' ' ' THR . 7.6 m-85 . . . . . 0 CA--C 1.525 0.013 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 27.8 m -158.02 157.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.44 117.21 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -67.14 152.19 46.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.507 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.498 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -109.56 -22.1 12.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.874 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.12 145.35 39.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.686 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.94 147.36 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 28.0 t80 -136.11 116.14 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.78 88.64 5.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.767 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.09 119.42 5.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.626 2.218 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -96.24 22.14 8.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -135.19 171.67 14.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.826 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 78.1 p -90.08 142.68 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.98 -32.21 7.61 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.16 134.15 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 0.0 110.786 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.852 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -81.33 148.36 29.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.002 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.688 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -101.05 112.41 24.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.512 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.5 p90 -127.82 162.0 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.272 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.4 mmmt -117.99 -167.56 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.73 36.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.56 17.62 54.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.41 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -79.77 115.42 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.738 HG12 ' HD2' ' A' ' 158' ' ' PHE . 3.4 t -69.63 103.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 175' ' ' PHE . 15.3 mt -98.61 144.8 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.488 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.3 m -93.74 95.95 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 193' ' ' GLU . 33.3 tp -47.13 124.34 6.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 193' ' ' GLU . 31.4 mt -89.31 -39.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.94 172.68 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.443 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 44.3 mtmt -124.77 58.46 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.776 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -59.93 -20.49 57.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.27 119.52 13.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.658 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.17 -28.98 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.724 2.283 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -101.42 -46.48 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.29 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.63 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.6 m95 -92.7 110.42 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.323 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.555 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -105.35 142.38 35.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.788 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.78 143.16 27.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.907 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.508 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -144.77 158.12 27.49 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.232 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.403 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.259 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 195' ' ' GLN . 1.4 mpt_? . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.631 0.253 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.34 163.17 25.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.136 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.63 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -111.38 148.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.852 ' CE1' HD23 ' A' ' 173' ' ' LEU . 3.6 p90 -170.18 163.52 6.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.24 111.41 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 111.525 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -56.2 -21.15 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.233 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.11 -15.85 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 21.15 4.55 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -149.99 -171.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 111.718 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.84 115.04 1.83 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.499 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 68.5 Cg_exo -43.16 129.66 6.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.669 2.246 . . . . 0.0 112.899 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.688 -179.741 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.3 m -124.72 156.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.61 118.85 34.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -72.39 150.22 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.417 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.83 -18.21 13.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.052 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.55 129.88 19.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.702 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.95 152.81 22.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 53.0 t80 -139.8 120.32 14.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -108.76 87.45 4.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 63.2 Cg_endo -75.95 121.15 6.06 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.376 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -95.79 20.74 9.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.074 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -139.51 172.72 12.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 146.47 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.022 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.65 5.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.366 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.67 134.65 38.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 110.778 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.743 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.0 145.28 34.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.931 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.83 113.94 25.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.348 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.6 p90 -133.0 175.28 9.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.431 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -128.52 -169.86 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -76.32 139.59 41.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.47 20.18 36.76 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.82 121.57 27.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 0.0 110.809 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.68 104.04 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.1 mt -99.96 137.77 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.394 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.92 96.49 10.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.447 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -46.76 125.67 7.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.57 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.63 HD12 ' CG ' ' A' ' 193' ' ' GLU . 37.3 mt -89.29 -44.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.552 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.5 150.35 5.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.793 ' HG3' HD21 ' A' ' 183' ' ' LEU . 31.1 mtmt -110.35 49.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.1 -22.03 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -127.36 127.85 24.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.708 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.72 -19.68 25.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.554 2.169 . . . . 0.0 112.731 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -112.42 -32.74 6.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 202' ' ' ILE . 23.9 m95 -105.84 108.7 20.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -107.19 138.66 42.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.63 ' CG ' HD12 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.502 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -148.84 158.07 27.52 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.126 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.406 ' HG3' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.683 0.277 . . . . 0.0 111.283 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 184' ' ' ILE . 1.9 mtt85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.541 0.21 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 167.88 162.0 18.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.021 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.884 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.74 149.96 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.743 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.7 p90 -164.07 150.34 9.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.141 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 110.14 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.216 1.944 . . . . 0.0 111.041 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.492 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.8 p -56.08 -20.54 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.461 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -61.24 -17.08 51.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 110.62 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -92.92 16.6 12.22 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.8 m -149.17 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.55 119.54 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 88.5 Cg_exo -47.72 126.33 12.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.445 2.097 . . . . 0.0 112.502 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.518 ' HD2' HG11 ' A' ' 180' ' ' VAL . 3.3 m-85 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 210' ' ' PRO . 30.6 m -122.78 139.14 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -102.78 129.03 49.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.786 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -76.26 144.88 40.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 0.66 56.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.508 ' CE1' ' CG ' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -158.44 -163.14 1.22 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.784 0.326 . . . . 0.0 110.805 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.71 145.39 42.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 10.3 t80 -130.68 113.93 14.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -114.49 76.21 3.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.23 123.48 6.13 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.601 2.201 . . . . 0.0 112.471 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -120.64 170.54 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.752 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 p -89.96 142.79 27.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.26 -32.23 7.55 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.54 133.71 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 0.0 110.792 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.0 OUTLIER -80.49 157.43 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.751 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.584 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -106.66 113.45 26.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.932 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.521 ' HB2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -134.39 154.62 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -110.88 -169.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 134.65 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.344 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.89 20.51 41.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.666 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -80.62 110.53 16.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.518 HG11 ' HD2' ' A' ' 158' ' ' PHE . 33.8 t -69.51 105.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 175' ' ' PHE . 2.6 mt -103.22 125.21 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.361 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 79.0 m -73.57 105.83 5.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.428 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.575 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.7 OUTLIER -51.61 127.88 21.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.603 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.697 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.4 mt -89.64 -40.69 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.476 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -177.94 155.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HG3' HD21 ' A' ' 183' ' ' LEU . 35.4 mtmt -107.64 54.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -58.43 -18.71 30.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.088 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -132.8 118.47 15.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.693 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -42.07 -28.95 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.745 2.297 . . . . 0.0 113.135 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -106.36 -42.76 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.904 ' CE3' HD12 ' A' ' 202' ' ' ILE . 12.6 m95 -94.88 106.83 18.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.257 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.9 m0 -101.54 142.48 32.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.609 ' CG ' HD12 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -89.29 145.87 25.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -152.39 162.37 29.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.2 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.514 ' O ' HG23 ' A' ' 181' ' ' ILE . 2.4 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.716 0.293 . . . . 0.0 110.904 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.697 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.5 mtm-85 . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.74 158.92 22.21 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.392 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.904 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.7 pt -108.27 150.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.1 p90 -170.1 162.67 6.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.71 110.28 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.458 2.105 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.53 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.2 p -57.59 -19.63 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.79 -12.74 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.627 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' TYR . . . . . 0.508 ' CG ' ' CE1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -89.83 13.94 13.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.54 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 161' ' ' ALA . 2.9 m -144.89 -169.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 111.55 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.28 113.85 2.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.875 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.4 Cg_exo -46.14 109.84 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.609 2.206 . . . . 0.0 112.574 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 22.5 t80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.939 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.452 ' HD1' HG12 ' A' ' 180' ' ' VAL . 67.1 m-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.819 0.342 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 210' ' ' PRO . 14.3 m -128.35 154.84 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.08 114.4 27.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -70.09 154.23 42.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.21 20.74 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.74 179.42 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.68 1.82 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.629 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.12 138.33 55.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 5.1 t80 -127.15 109.42 11.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.002 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -109.68 84.18 3.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 74.3 Cg_endo -77.01 116.4 4.2 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.69 2.26 . . . . 0.0 112.48 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -80.83 -26.48 37.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.686 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.48 174.76 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.97 151.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.87 -36.55 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 87.6 mt-10 -95.17 138.77 32.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.675 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.59 147.26 28.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.757 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.534 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.47 22.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.767 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.2 p90 -135.81 157.98 45.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.422 . . . . 0.0 111.16 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -109.32 -169.74 1.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.54 136.2 39.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.89 58.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.688 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -79.5 118.13 21.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' A' ' 158' ' ' PHE . 38.3 t -69.77 97.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.7 138.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.27 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -86.2 99.11 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.607 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.0 tp -49.5 123.57 7.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.396 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 200' ' ' ARG . 29.0 mt -89.44 -39.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 187' ' ' ASP . 8.5 p-10 -177.55 173.24 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.814 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.444 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 35.1 mtmt -123.28 55.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' A' ' 185' ' ' ASN . 6.5 t70 -55.39 -22.96 22.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -135.74 130.32 18.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.717 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.69 -21.81 20.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.643 2.229 . . . . 0.0 112.624 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -108.38 -36.38 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.929 ' CE3' HD12 ' A' ' 202' ' ' ILE . 20.6 m95 -103.02 110.55 22.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.486 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.0 m0 -106.38 140.82 38.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.944 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.83 149.59 22.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.416 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -153.79 159.28 28.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.74 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 111.181 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.61 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 174.36 159.67 21.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.015 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.929 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.3 151.8 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.747 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.597 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.8 p90 -165.55 151.2 8.31 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.65 111.47 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.264 1.976 . . . . 0.0 111.174 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.462 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.1 p -55.84 -21.54 20.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 111.197 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -17.75 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.494 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.29 17.87 12.04 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.292 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.597 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -148.7 -168.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 111.356 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.1 114.57 1.3 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.606 ' HA ' HG12 ' A' ' 159' ' ' VAL . 87.0 Cg_exo -47.2 124.39 8.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.463 2.109 . . . . 0.0 112.589 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 13.9 t80 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.544 ' HD2' HG12 ' A' ' 180' ' ' VAL . 84.9 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 210' ' ' PRO . 16.4 m -122.07 153.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.14 113.13 24.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.458 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.477 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -65.72 157.19 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.557 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.22 19.55 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.929 179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -170.23 140.26 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.68 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.99 137.17 53.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.443 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.2 t80 -129.06 109.78 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.944 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -110.87 79.2 1.79 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.09 115.99 3.86 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.54 2.16 . . . . 0.0 112.509 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -80.06 -26.45 39.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.91 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.33 170.69 12.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.5 m -89.93 148.83 22.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.75 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.414 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.4 130.97 39.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.745 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -77.84 147.88 34.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.805 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.597 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.58 112.25 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.5 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.528 ' CB ' HD11 ' A' ' 181' ' ' ILE . 1.6 p90 -131.3 155.57 46.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -112.31 172.12 7.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.467 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 135.83 57.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.226 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.52 23.7 55.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.885 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.44 123.24 30.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.345 . . . . 0.0 110.863 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.544 HG12 ' HD2' ' A' ' 158' ' ' PHE . 37.1 t -73.12 94.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.528 HD11 ' CB ' ' A' ' 175' ' ' PHE . 27.7 mt -89.98 143.04 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.4 m -90.82 98.63 11.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.502 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -50.03 124.4 10.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.52 HD12 ' CG ' ' A' ' 193' ' ' GLU . 25.1 mt -89.7 -39.51 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.594 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 187' ' ' ASP . 8.7 p-10 -177.76 172.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 46.9 mtmt -121.99 56.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.679 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.441 ' HB2' ' ND2' ' A' ' 185' ' ' ASN . 20.9 t0 -57.16 -21.72 34.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.139 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -137.09 121.61 12.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.667 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.79 -28.16 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.716 2.278 . . . . 0.0 112.949 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -102.78 -44.71 5.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.23 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.984 ' CE3' HD12 ' A' ' 202' ' ' ILE . 24.1 m95 -94.03 108.75 20.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.501 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.4 m0 -104.32 141.8 35.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.852 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.99 146.35 24.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.205 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.86 158.36 27.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.915 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.492 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.561 0.219 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.95 161.94 23.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.869 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.984 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -106.24 153.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.67 ' CD2' HD23 ' A' ' 173' ' ' LEU . 16.1 p90 -169.36 148.72 3.58 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.126 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.45 109.82 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.276 1.984 . . . . 0.0 111.384 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.0 p -54.35 -23.11 14.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.316 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -61.04 -16.13 40.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.29 22.19 6.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 205' ' ' SER . 4.1 m -149.87 -168.7 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.737 0.304 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.41 111.52 1.86 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.5 Cg_exo -47.86 121.73 6.21 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.4 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.961 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 25.8 m -106.64 152.02 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.067 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -113.46 112.84 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.97 155.71 33.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.536 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.478 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -114.86 -12.41 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.52 132.0 19.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.04 143.6 31.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.446 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 9.8 t80 -127.74 109.48 11.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.59 78.9 1.6 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.17 123.91 6.94 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.608 2.205 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -94.48 18.22 11.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -129.71 173.1 10.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 m -90.15 145.88 24.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.54 -34.45 5.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.391 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -93.64 134.35 36.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.668 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.61 147.94 29.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.654 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.539 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.34 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.8 p90 -133.52 152.96 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 111.209 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -103.22 -168.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -79.1 134.74 36.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.88 18.61 54.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -80.85 119.2 23.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.8 t -69.71 99.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.568 HG21 HD21 ' A' ' 173' ' ' LEU . 4.9 mt -93.99 140.6 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.326 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -87.41 100.87 13.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.517 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -51.21 123.77 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.421 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.564 HD13 ' HG2' ' A' ' 200' ' ' ARG . 31.2 mt -89.58 -39.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.625 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.35 172.18 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 33.0 mtmt -127.07 57.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.75 -22.02 61.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 1.6 t70 -132.78 117.22 15.05 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.17 -29.94 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.922 2.415 . . . . 0.0 113.168 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.49 -48.99 4.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' TRP . . . . . 0.994 ' CE3' HD12 ' A' ' 202' ' ' ILE . 28.0 m95 -89.82 108.11 19.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.117 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.534 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.0 m0 -104.68 142.46 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.966 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.831 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.87 145.52 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.248 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -149.95 158.92 27.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.729 0.3 . . . . 0.0 111.235 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.502 0.191 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.78 161.25 23.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.91 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.994 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.5 pt -108.39 153.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' PHE . . . . . 0.557 ' CE1' HG11 ' A' ' 208' ' ' VAL . 15.5 p90 -170.03 151.91 4.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.37 106.89 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.188 1.925 . . . . 0.0 110.984 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.825 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.35 -23.46 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.037 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -51.74 -21.74 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 110.508 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.38 23.1 4.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.711 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 205' ' ' SER . 3.7 m -147.11 -167.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 111.625 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.21 110.02 1.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 87.6 Cg_exo -47.98 113.17 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.505 2.137 . . . . 0.0 112.532 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 20.5 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.0 mtt -131.95 169.65 16.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.5 -177.0 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 t -68.94 144.64 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -134.37 121.82 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.64 131.29 34.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.1 m -126.09 157.64 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.82 122.66 47.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.669 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -70.08 157.85 36.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.583 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -126.53 17.89 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.829 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.12 140.2 1.92 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.69 142.23 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.996 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.451 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 19.5 t80 -135.13 110.82 9.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -110.22 82.15 2.51 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.24 113.49 3.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.582 2.188 . . . . 0.0 112.327 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -76.49 -27.35 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.915 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.07 168.27 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.9 p -90.05 148.8 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.0 -35.05 4.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.406 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.15 137.35 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.308 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.45 149.44 31.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.639 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -99.39 112.74 24.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.557 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.728 ' CB ' HD11 ' A' ' 181' ' ' ILE . 6.7 p90 -133.82 160.37 37.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.375 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 13.8 mtmt -115.65 -168.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.657 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 133.38 37.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.85 19.07 58.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.011 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.736 ' CG ' HD21 ' A' ' 196' ' ' LEU . 46.0 t0 -84.35 128.11 34.38 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.66 120.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.728 HD11 ' CB ' ' A' ' 175' ' ' PHE . 70.3 mt -120.71 113.96 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.0 111.309 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.4 m -70.15 108.65 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.411 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 186' ' ' LYS . 29.6 tp -56.74 124.7 19.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.435 HD12 ' CG ' ' A' ' 193' ' ' GLU . 22.8 mt -89.37 -32.25 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.269 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 8.5 p30 -175.16 -171.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.685 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.696 ' HG3' HD21 ' A' ' 183' ' ' LEU . 27.3 mtmt -151.39 51.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.726 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.55 -39.86 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -121.77 130.32 24.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.009 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.26 -17.34 25.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.214 1.943 . . . . 0.0 111.89 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -94.45 -46.37 7.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.845 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.654 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 14.5 m95 -110.29 122.5 47.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 111.188 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 46.2 m0 -114.05 141.14 47.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.844 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.1 tt0 -89.97 140.85 29.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.812 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -151.06 162.05 29.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.911 -1.137 . . . . 0.0 113.16 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.35 113.0 20.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 0.0 110.942 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.736 HD21 ' CG ' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -72.73 63.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.088 0.47 . . . . 0.0 110.696 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 14.2 t30 63.99 14.72 8.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.468 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.94 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.943 0.401 . . . . 0.0 111.154 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 130.85 42.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.485 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.424 ' HG2' HD13 ' A' ' 184' ' ' ILE . 4.7 mpt_? -97.67 165.8 11.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.457 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 169.33 161.02 18.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.061 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.556 HG23 ' OE2' ' A' ' 193' ' ' GLU . 3.8 pt -107.26 148.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.866 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.9 p90 -170.39 164.0 5.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.53 117.88 4.82 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.355 2.036 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.517 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.3 p -63.09 -17.01 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.82 -13.98 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.75 15.7 10.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 162' ' ' LEU . 2.7 m -148.18 -171.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.17 122.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.773 ' HA ' HG12 ' A' ' 159' ' ' VAL . 96.7 Cg_exo -44.78 128.0 8.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.733 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -106.26 -62.59 1.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.852 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -73.57 -20.63 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.134 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.9 p -54.96 178.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.971 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 23.2 p80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 29.3 mtp -133.48 -77.51 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.28 135.75 51.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.9 t -89.77 121.73 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -131.85 131.76 43.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 4.1 m-85 -107.08 137.46 45.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 210' ' ' PRO . 31.1 m -114.81 155.51 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.245 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.67 110.02 19.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -64.04 158.19 23.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -127.27 19.07 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.743 179.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.581 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.4 140.2 58.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -128.06 106.48 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -109.92 78.43 1.28 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 124.12 7.82 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.526 2.151 . . . . 0.0 112.419 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -93.75 17.44 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -131.42 173.97 10.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.845 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 29.7 p -90.04 146.26 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.41 -34.11 5.7 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -93.24 132.49 37.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.303 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.725 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -78.8 143.59 35.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.494 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.79 111.18 22.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -137.19 166.8 22.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -168.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.732 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -76.22 136.96 39.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.87 18.19 52.92 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.601 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.788 ' OD1' HD21 ' A' ' 196' ' ' LEU . 58.1 t0 -76.97 114.73 16.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.59 93.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.752 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 173' ' ' LEU . 4.4 mt -95.82 132.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.402 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -78.72 103.16 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 193' ' ' GLU . 37.7 tp -49.48 125.3 10.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.545 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.654 HG22 ' ND2' ' A' ' 185' ' ' ASN . 33.6 mt -89.65 -55.17 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.654 ' ND2' HG22 ' A' ' 184' ' ' ILE . 8.7 m-80 -153.59 166.15 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.573 ' HG3' HD21 ' A' ' 183' ' ' LEU . 49.2 mtmt -128.05 47.62 2.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.543 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.302 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -118.17 115.35 36.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.911 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -44.12 -28.19 2.19 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.654 2.236 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -101.62 -44.97 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.993 ' CE3' HD12 ' A' ' 202' ' ' ILE . 17.9 m95 -95.61 113.44 25.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.249 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.8 m0 -109.58 141.72 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.838 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.85 145.24 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.152 179.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.47 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -146.96 160.15 28.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.035 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.31 143.33 46.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 111.095 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.788 HD21 ' OD1' ' A' ' 179' ' ' ASP . 6.3 mt -134.51 62.39 1.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.391 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.1 m-80 66.03 64.86 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 24.8 t30 82.69 11.81 0.54 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 196' ' ' LEU . 9.8 mmt180 -114.01 90.59 3.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.601 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -90.07 149.89 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.643 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.52 159.47 20.12 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.748 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.993 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -106.12 150.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.725 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.9 p90 -164.72 156.88 13.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.99 106.9 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.464 2.109 . . . . 0.0 111.298 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.7 p -52.69 -24.31 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.052 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.3 -17.9 45.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.741 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.06 23.73 6.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 205' ' ' SER . 6.0 m -149.27 -170.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.334 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.69 110.41 2.18 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.3 Cg_exo -48.31 124.86 11.15 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.472 2.115 . . . . 0.0 112.478 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 213' ' ' SER . 33.5 t80 -101.45 -68.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 58.65 50.01 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.427 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 0.3 OUTLIER 59.53 31.56 21.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.018 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.895 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.734 0.302 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 62.6 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.76 117.13 27.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.983 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.7 t -86.43 131.75 34.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.87 158.08 42.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 182' ' ' THR . 29.3 m-85 -142.19 111.4 6.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 26.7 m -107.13 151.77 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.37 114.54 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -64.73 153.73 38.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.499 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.473 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.36 -22.42 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.26 128.92 24.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.93 146.34 42.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.448 ' CB ' ' CZ ' ' A' ' 175' ' ' PHE . 59.9 t80 -137.6 117.95 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.3 87.95 4.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 64.8 Cg_endo -75.89 121.69 6.38 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.19 20.12 9.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -136.07 171.52 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 38.4 p -90.01 146.28 24.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.47 -34.01 5.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.378 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.99 136.93 36.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.847 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -82.21 145.96 29.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.81 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.04 108.45 20.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 181' ' ' ILE . 11.6 p90 -122.91 158.32 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.333 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 18.8 mttm -117.91 -175.53 2.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.513 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.11 132.08 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.96 18.02 53.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.61 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -79.98 117.95 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.68 96.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.756 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 175' ' ' PHE . 4.8 mt -95.55 122.29 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.432 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.68 HG23 ' CE1' ' A' ' 158' ' ' PHE . 1.3 m -72.83 103.23 3.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 193' ' ' GLU . 38.5 tp -51.04 125.69 14.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.311 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.687 HG22 ' ND2' ' A' ' 185' ' ' ASN . 28.5 mt -89.37 -55.42 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.687 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.5 m-80 -155.47 165.7 35.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 34.9 mtmt -126.28 50.28 1.91 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.581 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -56.18 -25.74 47.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.374 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 10.6 t70 -124.53 127.01 25.34 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 -22.01 20.65 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.523 2.149 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 10.6 m120 -108.57 -36.35 6.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 111.214 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.922 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.5 m95 -103.23 110.95 23.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.539 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.5 m0 -106.55 141.85 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 183' ' ' LEU . 3.3 tt0 -89.59 138.57 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.437 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -142.87 159.48 27.36 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.181 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 20.5 tt0 -114.54 149.38 36.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.12 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.702 HD23 HG12 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -140.32 96.54 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.771 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 76.23 -62.6 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -164.61 29.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.37 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.9 OUTLIER -125.94 162.15 25.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.852 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.643 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -129.11 150.09 50.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . -179.27 159.24 23.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.257 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.922 HD12 ' CE3' ' A' ' 191' ' ' TRP . 3.8 pt -112.83 149.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.847 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.35 162.75 6.2 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 34.6 Cg_exo -59.82 108.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.362 2.041 . . . . 0.0 111.339 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.0 OUTLIER -57.04 -20.86 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.143 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -62.15 -13.71 29.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -90.98 19.35 5.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 205' ' ' SER . 4.4 m -147.0 -171.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.4 112.4 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 80.8 Cg_exo -46.52 118.43 2.56 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.534 2.156 . . . . 0.0 112.636 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -98.88 -65.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 61.77 74.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.637 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.8 p -58.27 137.3 57.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.031 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.933 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.783 0.325 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.24 117.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.008 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -161.15 129.67 4.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.646 HG21 ' OD1' ' A' ' 212' ' ' ASN . 0.2 OUTLIER -88.38 107.67 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -139.86 40.0 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.993 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 182' ' ' THR . 46.5 m-85 -80.66 137.7 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 210' ' ' PRO . 5.5 m -127.52 156.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.55 114.81 26.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.639 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.63 157.26 34.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.508 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -128.45 19.73 6.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.28 140.24 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.91 142.34 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.45 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.8 t80 -132.68 112.48 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.31 84.72 3.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.16 115.43 3.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.491 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -79.73 -26.3 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -96.85 175.14 6.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 80.4 p -90.1 151.77 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.65 -36.05 4.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.84 133.76 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.292 . . . . 0.0 110.737 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.735 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.65 144.88 39.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.906 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -95.87 111.82 23.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.536 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -134.97 -179.83 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.42 . . . . 0.0 111.357 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 6.6 pttp -131.17 -170.81 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.754 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -75.46 139.76 42.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.038 0.447 . . . . 0.0 111.463 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 55.85 21.26 29.39 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.17 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' OD2' HD11 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -84.56 122.33 28.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.75 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.3 103.59 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.7 mt -102.72 127.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.394 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.2 m -79.33 100.3 7.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.354 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.81 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -49.1 127.68 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.607 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 193' ' ' GLU . 31.9 mt -89.55 -36.42 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.461 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.1 p30 -176.55 154.85 1.3 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.81 ' HG3' HD21 ' A' ' 183' ' ' LEU . 44.4 mtmt -115.18 44.02 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.34 -31.09 5.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.21 127.14 23.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.036 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.89 -14.84 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.275 1.984 . . . . 0.0 112.185 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.63 -44.26 6.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.6 m95 -115.24 112.41 22.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 111.508 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.502 ' HB3' HD11 ' A' ' 183' ' ' LEU . 46.6 m0 -101.01 136.82 40.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.547 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 184' ' ' ILE . 1.9 tt0 -88.79 146.13 25.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.5 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.4 161.96 28.58 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 119.951 -1.118 . . . . 0.0 113.463 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -120.77 128.7 53.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 110.869 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.483 HD11 ' OD2' ' A' ' 179' ' ' ASP . 0.5 OUTLIER -116.96 59.53 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.536 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.4 t-20 67.93 65.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.342 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 10.6 t-20 83.3 10.85 0.5 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.956 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -113.3 90.42 3.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.0 mtp180 -89.61 147.4 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.659 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.03 156.6 12.43 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.932 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.782 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -102.94 149.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.804 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.735 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.0 p90 -162.61 157.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.57 113.36 1.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.251 1.967 . . . . 0.0 110.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 208' ' ' VAL . 3.7 p -59.4 -19.61 48.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 111.35 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -65.53 -14.49 61.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.399 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 20.47 9.22 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.183 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.539 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -150.02 -167.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.49 114.65 1.25 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.7 Cg_exo -48.03 125.19 11.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.611 2.207 . . . . 0.0 112.459 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -99.94 -68.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.646 ' OD1' HG21 ' A' ' 156' ' ' THR . 49.9 t-20 61.75 74.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.629 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -31.52 67.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.421 ' OXT' ' ND2' ' A' ' 214' ' ' ASN . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.7 p80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.876 0.37 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.2 mtm -85.38 -77.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -106.84 102.99 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.5 103.01 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.004 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.695 ' HE3' HD23 ' A' ' 183' ' ' LEU . 39.1 mtmt -147.48 105.0 3.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -110.63 125.95 53.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 23.1 m -110.26 150.9 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.55 114.53 27.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.39 157.71 31.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.552 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.452 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -125.51 24.51 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.18 178.67 3.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -100.16 138.0 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 2.0 t80 -125.84 105.37 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -109.67 78.59 1.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.408 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 70.2 Cg_endo -75.93 115.76 4.24 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 112.551 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.84 -26.58 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.38 172.97 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.1 m -90.11 150.89 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.63 -36.3 4.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.347 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 4.9 mt-10 -93.35 136.14 33.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.659 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -80.66 147.03 30.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.704 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.519 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.43 113.84 25.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.715 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -141.15 163.37 33.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.408 . . . . 0.0 111.087 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -123.25 -176.56 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.807 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 139.48 57.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.27 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.02 21.01 44.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.625 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.829 ' OD2' HD11 ' A' ' 196' ' ' LEU . 8.3 t70 -78.32 109.66 12.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.022 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.7 94.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.612 HG21 ' CD2' ' A' ' 173' ' ' LEU . 10.5 mt -95.53 135.01 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.433 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 m -81.43 102.99 10.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.811 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.1 tp -51.03 122.42 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.457 HD12 ' CG ' ' A' ' 193' ' ' GLU . 28.4 mt -89.49 -36.31 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.75 174.65 0.82 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' HE2' HD21 ' A' ' 183' ' ' LEU . 21.3 mttt -123.16 66.14 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.59 -19.44 38.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 14.2 t70 -150.61 132.94 8.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.685 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.13 -25.68 4.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.861 2.374 . . . . 0.0 112.76 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -102.44 -44.64 5.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 0.0 111.358 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.909 ' CE3' HD12 ' A' ' 202' ' ' ILE . 32.5 m95 -94.19 110.57 22.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.325 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.466 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -108.5 141.33 40.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.811 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.76 144.87 25.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.11 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -150.11 158.25 27.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.766 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -120.63 110.02 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.887 0.375 . . . . 0.0 111.201 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.829 HD11 ' OD2' ' A' ' 179' ' ' ASP . 0.7 OUTLIER -84.42 87.08 7.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.527 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 14.7 t30 76.59 -60.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -143.08 -40.38 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.503 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ptm85 -69.81 140.52 53.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.262 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.445 ' HG2' HD13 ' A' ' 184' ' ' ILE . 3.9 mpt_? -109.58 161.03 15.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.568 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.88 162.31 24.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.02 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.909 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -107.66 154.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.743 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.6 p90 -170.09 149.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.065 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 24.3 Cg_exo -62.76 107.09 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.22 1.947 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.759 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -52.26 -22.54 4.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.313 -179.28 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -53.01 -19.85 3.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.765 0.317 . . . . 0.0 110.47 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.24 21.95 7.34 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -147.2 -167.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.724 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.24 111.98 1.02 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 85.9 Cg_exo -46.48 115.11 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.504 2.136 . . . . 0.0 112.683 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -93.25 -66.15 0.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.835 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -84.2 -31.66 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 80.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.913 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.9 p80 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.7 mtm -144.2 -170.09 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.76 119.19 21.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 t -78.87 139.75 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -138.03 168.77 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -146.65 134.53 21.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 210' ' ' PRO . 6.0 m -129.83 153.6 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.23 115.28 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.31 154.05 39.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.391 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.462 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.48 13.92 22.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 0.1 OUTLIER -170.05 -164.23 0.4 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -114.94 145.9 41.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 20.8 t80 -135.75 115.13 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -111.88 85.83 6.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.684 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 113.79 3.74 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.651 2.234 . . . . 0.0 112.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.87 -27.4 55.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.884 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -96.07 174.15 7.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 74.5 m -90.08 151.51 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.23 -36.84 3.87 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.318 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.01 132.45 39.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 0.0 110.739 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.72 143.42 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.564 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.66 113.65 25.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.439 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.3 p90 -134.14 177.38 7.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.413 . . . . 0.0 111.497 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 8.6 mttt -128.77 -175.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.811 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -69.66 140.56 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.683 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 51.57 25.06 13.17 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.872 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.29 123.27 30.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 36.3 t -72.62 102.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.8 mt -96.89 142.48 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.434 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.5 m -90.17 99.21 12.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.4 tp -50.3 123.18 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.618 HG22 ' ND2' ' A' ' 185' ' ' ASN . 22.4 mt -89.71 -54.06 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.42 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.618 ' ND2' HG22 ' A' ' 184' ' ' ILE . 7.2 m-80 -153.93 166.35 33.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.544 ' HG3' HD21 ' A' ' 183' ' ' LEU . 50.3 mtmt -128.88 48.79 2.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.73 -27.3 66.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.38 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.31 115.77 34.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.926 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -44.32 -28.08 2.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.563 2.176 . . . . 0.0 112.859 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.01 -44.5 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.234 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.954 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.4 m95 -95.57 112.11 23.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.231 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.5 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.7 m0 -108.29 142.53 38.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -90.82 144.16 25.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.087 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.04 27.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.969 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -120.1 100.8 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 111.253 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.448 HD22 ' OD1' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -81.0 94.58 6.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.448 ' OD1' HD22 ' A' ' 196' ' ' LEU . 4.3 m120 76.61 -59.87 0.49 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.29 -38.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.477 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -69.43 136.08 51.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 111.292 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.468 ' HG2' HD13 ' A' ' 184' ' ' ILE . 2.3 mpt_? -106.54 162.47 13.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.523 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.624 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.14 161.42 20.61 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.937 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.954 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -103.98 152.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.826 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.734 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.2 p90 -167.71 154.99 7.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.97 107.85 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.3 2.0 . . . . 0.0 111.337 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.2 p -53.18 -24.55 11.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -16.2 43.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' TYR . . . . . 0.411 ' HB3' ' CE1' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -93.88 21.56 6.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.215 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -148.6 -167.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.52 111.95 1.85 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' A' ' 159' ' ' VAL . 76.8 Cg_exo -48.49 121.9 7.02 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.547 2.165 . . . . 0.0 112.44 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -96.35 -68.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 61.73 74.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 140.69 53.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.067 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.914 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 8.1 mtp -106.28 178.6 4.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -166.08 112.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 t -69.25 108.41 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -94.18 153.46 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.705 ' O ' HG13 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -127.71 163.54 24.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.689 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -166.8 123.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.477 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -102.26 123.83 46.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.252 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -73.99 148.33 42.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.721 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -117.16 14.5 14.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.812 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.25 140.16 1.85 Allowed 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 145.21 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -133.66 112.51 11.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.77 87.21 5.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.7 116.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.562 2.175 . . . . 0.0 112.46 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.94 -26.06 36.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.26 172.69 7.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -90.05 150.56 22.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.5 -35.44 4.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.409 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.47 133.42 36.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.68 140.79 42.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.837 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.49 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.97 114.49 26.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.165 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.7 p90 -133.29 -178.22 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 111.607 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -126.05 -174.19 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.83 140.08 42.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.264 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 56.03 21.85 32.96 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 124.95 31.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.684 HG11 ' HA ' ' A' ' 213' ' ' SER . 10.0 t -74.89 119.56 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.678 ' HB ' HG23 ' A' ' 159' ' ' VAL . 5.0 mt -119.81 155.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.601 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.464 ' N ' HG22 ' A' ' 181' ' ' ILE . 2.0 m -103.36 104.45 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.359 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.6 tp -50.11 124.63 10.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.517 HD12 ' CG ' ' A' ' 193' ' ' GLU . 27.3 mt -89.5 -38.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.537 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.67 174.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.802 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.438 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.9 mtmt -126.16 59.77 1.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -19.75 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 24.3 t0 -137.05 122.12 12.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.42 -28.02 2.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.715 2.277 . . . . 0.0 112.902 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -102.78 -44.14 5.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.8 m95 -94.8 110.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.505 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.1 m0 -105.82 141.96 36.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.063 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.79 143.47 26.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.081 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.455 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.86 158.43 27.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.129 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -117.42 90.06 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.99 86.04 0.53 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.608 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 77.68 -59.73 0.45 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.149 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -146.33 -39.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.549 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -69.57 134.86 49.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.323 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -107.2 158.12 17.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.598 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.635 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.57 162.84 24.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.822 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.981 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.8 pt -104.96 151.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.809 ' CD2' HD23 ' A' ' 173' ' ' LEU . 14.8 p90 -167.5 159.09 10.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.91 108.78 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.329 2.019 . . . . 0.0 111.148 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.3 p -53.32 -24.23 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -58.38 -19.66 37.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 163' ' ' PHE . 1.1 m-85 -90.9 14.26 14.24 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.467 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.0 m -149.45 -166.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.263 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.526 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -177.74 125.38 0.28 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -43.25 129.43 6.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.769 2.312 . . . . 0.0 112.705 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' A' ' 212' ' ' ASN . 1.0 OUTLIER -131.0 -83.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 211' ' ' TYR . 1.0 OUTLIER 176.3 104.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.843 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.684 ' HA ' HG11 ' A' ' 180' ' ' VAL . 4.2 m -95.3 -31.71 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.798 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.737 0.303 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -60.32 -177.6 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 133.5 8.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 164.29 15.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -90.06 139.59 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.574 ' CD1' HG12 ' A' ' 180' ' ' VAL . 32.4 m-85 -108.32 123.55 48.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 181' ' ' ILE . 26.8 m -112.54 150.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.23 113.88 26.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.96 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -66.73 154.62 40.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.486 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.449 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -120.3 27.67 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.14 -169.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -127.37 129.72 48.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.811 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.454 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 36.5 t80 -131.94 128.6 38.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.41 88.47 49.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.94 119.49 5.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.525 2.15 . . . . 0.0 112.419 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -87.4 -23.36 24.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.04 158.47 16.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.788 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.8 m -78.73 122.48 26.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.19 -20.58 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.441 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.49 139.26 53.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.74 150.22 36.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.86 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.749 ' HB3' ' NH1' ' A' ' 199' ' ' ARG . . . -97.89 110.15 22.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.453 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 181' ' ' ILE . 12.7 p90 -124.13 166.59 15.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.9 mtpp -129.49 174.8 9.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.6 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.32 131.97 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.945 0.402 . . . . 0.0 110.926 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.18 19.04 44.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.513 ' OD2' HD11 ' A' ' 196' ' ' LEU . 60.4 t0 -81.21 117.88 22.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 158' ' ' PHE . 38.8 t -69.42 92.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 195' ' ' GLN . 3.4 mt -92.27 124.91 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.3 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 m -69.97 99.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.369 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.883 HD21 ' HG3' ' A' ' 186' ' ' LYS . 32.7 tp -49.82 119.96 3.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.591 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.579 HD13 ' CG ' ' A' ' 200' ' ' ARG . 12.8 mt -93.73 -41.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.634 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -143.49 158.94 43.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.883 ' HG3' HD21 ' A' ' 183' ' ' LEU . 9.8 mttt -138.36 15.59 2.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.539 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -49.58 -36.81 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.288 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 191' ' ' TRP . 0.4 OUTLIER -107.35 105.99 57.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.598 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -42.69 -28.8 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.764 2.309 . . . . 0.0 112.942 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 9.3 m120 -97.31 -38.5 9.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.149 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.438 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 17.2 m95 -110.5 107.8 17.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.688 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.823 ' HB3' HD11 ' A' ' 183' ' ' LEU . 53.9 m0 -108.51 149.45 28.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.278 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.753 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.3 tp10 -89.94 148.98 22.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.7 157.12 27.16 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.33 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 181' ' ' ILE . 20.5 tt0 -110.12 149.15 30.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 111.311 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -160.31 101.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.514 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.9 t-20 78.41 31.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 13.2 m-20 82.01 5.44 1.16 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.382 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.749 ' NH1' ' HB3' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -95.76 168.37 10.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.763 0.316 . . . . 0.0 111.027 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.579 ' CG ' HD13 ' A' ' 184' ' ' ILE . 4.3 mpt_? -131.4 151.56 51.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.624 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.95 158.12 20.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.169 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.682 HG23 ' CD ' ' A' ' 193' ' ' GLU . 8.0 pt -111.38 151.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 0.0 110.91 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.764 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.07 164.87 5.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 31.7 Cg_exo -58.57 108.07 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.517 2.144 . . . . 0.0 111.779 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.584 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.4 p -57.93 -21.29 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.122 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -62.88 -14.03 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.792 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.29 20.35 5.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.455 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -149.13 -169.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.39 111.79 1.37 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.735 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 86.7 Cg_exo -46.6 114.45 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.521 2.147 . . . . 0.0 112.529 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 213' ' ' SER . 18.3 t80 -92.86 -66.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.825 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 47.4 t30 55.39 39.34 31.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.42 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 0.7 OUTLIER 58.89 31.34 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.906 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.767 0.318 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.44 178.76 5.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.977 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.75 137.5 16.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.77 134.17 34.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.43 111.9 5.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.09 152.52 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.814 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 12.9 m -143.34 157.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.11 117.83 29.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.75 147.57 52.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.85 -20.04 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.884 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -133.94 -175.29 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.636 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.1 148.78 26.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.455 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 6.8 t80 -133.12 110.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.955 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -112.42 79.81 3.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.412 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 76.3 Cg_endo -81.11 120.93 3.83 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.644 2.229 . . . . 0.0 112.481 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -81.42 -23.53 37.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.83 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.01 169.98 11.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.18 148.5 22.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.59 -35.13 4.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.322 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 2.6 mt-10 -90.26 126.86 35.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.837 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.054 HD21 HD13 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -69.66 144.44 52.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.643 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.86 107.95 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.494 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 181' ' ' ILE . 2.0 p90 -136.67 159.8 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.336 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -117.71 -167.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 138.77 54.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.45 17.03 56.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.501 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -73.1 109.67 6.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.303 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.41 101.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.369 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 1.054 HD13 HD21 ' A' ' 173' ' ' LEU . 3.4 mt -100.79 140.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.474 . . . . 0.0 111.738 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.7 m -92.62 99.79 12.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 193' ' ' GLU . 20.7 tp -46.31 119.1 2.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.115 0.483 . . . . 0.0 111.467 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.484 HD12 ' CG ' ' A' ' 193' ' ' GLU . 19.7 mt -89.64 -37.77 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.7 p30 -177.91 171.2 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.778 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 32.5 mtmt -122.75 57.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -56.65 -21.64 28.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 37.2 t70 -137.05 129.48 17.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.99 -23.35 16.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.574 2.183 . . . . 0.0 112.724 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.5 m120 -106.6 -38.24 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.196 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.78 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.3 m95 -100.94 111.67 23.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.045 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.477 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.1 m0 -107.07 144.61 33.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.806 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -93.49 145.41 24.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.061 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -155.05 157.14 27.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.052 -1.071 . . . . 0.0 113.021 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 49.6 tt0 -120.51 135.6 55.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.649 HD23 HG23 ' A' ' 181' ' ' ILE . 14.0 mt -92.66 -157.4 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -47.1 -27.87 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -178.41 35.93 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.838 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -135.83 119.04 16.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.979 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.473 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -100.99 155.68 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.694 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.07 162.16 21.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.81 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.78 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -99.3 152.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.549 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.864 ' CD2' HD23 ' A' ' 173' ' ' LEU . 24.8 p90 -167.66 159.45 9.93 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.992 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 203' ' ' PHE . 45.2 Cg_endo -68.53 110.99 2.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.166 1.911 . . . . 0.0 111.299 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -55.3 -23.18 22.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.3 -16.94 50.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.68 17.93 10.99 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.261 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.495 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.6 m -149.59 -168.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 111.526 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.414 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -165.47 122.75 1.07 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.9 Cg_exo -46.56 128.58 12.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.164 . . . . 0.0 112.569 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.39 -67.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -59.01 -31.6 68.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.9 p 58.72 176.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.964 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.782 0.325 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.5 mmm 62.26 118.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -161.94 108.71 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.26 105.6 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.631 ' HG2' HD23 ' A' ' 183' ' ' LEU . 16.7 tptt -134.64 110.03 9.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.9 134.96 39.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 19.5 m -120.04 154.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -114.6 113.01 23.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.792 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.66 157.61 29.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.473 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.42 20.77 7.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.727 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.21 139.37 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.42 138.33 57.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 3.4 t80 -125.45 105.6 9.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.54 78.04 1.09 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 124.4 8.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -93.76 17.2 12.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.68 173.52 11.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.08 146.66 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.08 -34.52 5.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.86 135.4 35.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 0.0 110.768 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.14 144.63 31.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.894 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.567 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.7 109.9 21.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.559 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -135.88 161.64 35.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.54 -166.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -78.59 136.13 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.29 16.81 54.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.75 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.839 ' CG ' HD21 ' A' ' 196' ' ' LEU . 65.6 t0 -78.49 118.25 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.55 100.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.875 HG12 HD23 ' A' ' 196' ' ' LEU . 3.6 mt -99.97 124.48 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.375 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.8 m -72.91 105.14 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.5 tp -51.04 123.63 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.374 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.74 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.8 mt -89.64 -53.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.507 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.718 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.1 m-80 -156.2 166.29 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 25.8 mtmt -126.91 50.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.579 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.39 -26.81 43.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 17.3 t70 -124.54 124.89 25.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.703 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 188' ' ' ASP . 8.3 Cg_endo -50.05 -23.91 10.05 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.183 . . . . 0.0 112.726 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -106.56 -40.0 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.971 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.3 m95 -98.16 109.7 22.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.273 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.551 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.8 m0 -107.46 142.73 36.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.026 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.815 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.99 147.0 23.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.877 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -153.38 159.67 28.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.054 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 2.5 tt0 -112.01 134.45 53.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 110.969 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.875 HD23 HG12 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -112.66 72.1 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.812 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 196' ' ' LEU . 1.8 t-20 86.86 -28.13 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.637 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -177.55 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.325 . . . . 0.0 111.271 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -69.64 151.2 46.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.163 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.74 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -117.09 152.82 33.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.366 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 176.89 159.61 22.53 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.24 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.971 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -108.0 151.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.632 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.2 p90 -165.12 155.55 12.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 16.9 Cg_exo -66.59 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.364 2.042 . . . . 0.0 110.991 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.794 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.29 -24.51 4.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -52.38 -21.32 3.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.895 0.379 . . . . 0.0 110.466 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -93.8 22.31 5.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.909 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 205' ' ' SER . 3.4 m -146.71 -169.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 111.747 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.18 111.53 1.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.797 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -47.0 124.6 8.98 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -103.52 -63.51 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -73.4 -20.01 60.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.0 p -54.51 -31.34 55.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.895 0.378 . . . . 0.0 111.057 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.9 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.817 0.342 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtm -147.58 -77.35 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -121.23 99.78 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 t -83.14 153.32 24.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -150.03 130.66 14.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.854 ' CE1' HG23 ' A' ' 182' ' ' THR . 7.6 m-85 -118.8 -176.87 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 27.8 m -158.02 157.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.44 117.21 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -67.14 152.19 46.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.507 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.498 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -109.56 -22.1 12.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.874 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.12 145.35 39.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.686 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.94 147.36 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 28.0 t80 -136.11 116.14 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.78 88.64 5.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.767 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.09 119.42 5.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.626 2.218 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -96.24 22.14 8.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -135.19 171.67 14.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.826 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 78.1 p -90.08 142.68 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.98 -32.21 7.61 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.16 134.15 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 0.0 110.786 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.852 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -81.33 148.36 29.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.002 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.688 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -101.05 112.41 24.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.512 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.5 p90 -127.82 162.0 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.272 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.4 mmmt -117.99 -167.56 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.73 36.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.56 17.62 54.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.41 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -79.77 115.42 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.738 HG12 ' HD2' ' A' ' 158' ' ' PHE . 3.4 t -69.63 103.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.404 HG23 ' HG ' ' A' ' 196' ' ' LEU . 15.3 mt -98.61 144.8 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.488 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.3 m -93.74 95.95 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 193' ' ' GLU . 33.3 tp -47.13 124.34 6.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 193' ' ' GLU . 31.4 mt -89.31 -39.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.94 172.68 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.443 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 44.3 mtmt -124.77 58.46 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.776 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -59.93 -20.49 57.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.27 119.52 13.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.658 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.17 -28.98 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.724 2.283 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -101.42 -46.48 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.29 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.63 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.6 m95 -92.7 110.42 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.323 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.555 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -105.35 142.38 35.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.788 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.78 143.16 27.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.907 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.508 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -144.77 158.12 27.49 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.232 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.403 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.7 OUTLIER -128.49 109.05 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.259 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 181' ' ' ILE . 12.5 mt -88.89 75.57 8.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.257 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.5 m120 73.78 -62.02 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.491 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -146.06 29.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.618 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.91 97.97 4.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 195' ' ' GLN . 1.4 mpt_? -89.72 149.92 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.432 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.34 163.17 25.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.136 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.63 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -111.38 148.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.852 ' CE1' HD23 ' A' ' 173' ' ' LEU . 3.6 p90 -170.18 163.52 6.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.24 111.41 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 111.525 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -56.2 -21.15 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.233 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.11 -15.85 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 21.15 4.55 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -149.99 -171.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 111.718 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.84 115.04 1.83 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.499 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 68.5 Cg_exo -43.16 129.66 6.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.669 2.246 . . . . 0.0 112.899 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 212' ' ' ASN . 35.1 t80 -93.76 -78.92 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.688 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' ASN . 63.8 t30 178.91 35.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.324 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 158' ' ' PHE . 0.4 OUTLIER 64.94 -74.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 0.0 111.089 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' ASN . 34.8 t30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t60 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.9 mtm 60.37 19.66 9.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.46 97.72 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.585 ' OG1' HG22 ' A' ' 182' ' ' THR . 9.6 t -74.1 131.18 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.834 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -106.96 124.85 50.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -89.12 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.3 m -124.72 156.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.61 118.85 34.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -72.39 150.22 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.417 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.83 -18.21 13.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.052 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.55 129.88 19.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.702 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.95 152.81 22.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 53.0 t80 -139.8 120.32 14.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -108.76 87.45 4.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 63.2 Cg_endo -75.95 121.15 6.06 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.376 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -95.79 20.74 9.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.074 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -139.51 172.72 12.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 146.47 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.022 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.65 5.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.366 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.67 134.65 38.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 110.778 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.743 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.0 145.28 34.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.931 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.83 113.94 25.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.348 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.6 p90 -133.0 175.28 9.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.431 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -128.52 -169.86 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -76.32 139.59 41.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.47 20.18 36.76 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.819 ' OD2' HD11 ' A' ' 196' ' ' LEU . 0.6 OUTLIER -83.82 121.57 27.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 0.0 110.809 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.68 104.04 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.1 mt -99.96 137.77 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.394 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.585 HG22 ' OG1' ' A' ' 156' ' ' THR . 1.0 OUTLIER -90.92 96.49 10.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.447 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -46.76 125.67 7.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.57 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.63 HD12 ' CG ' ' A' ' 193' ' ' GLU . 37.3 mt -89.29 -44.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.552 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.5 150.35 5.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.793 ' HG3' HD21 ' A' ' 183' ' ' LEU . 31.1 mtmt -110.35 49.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.1 -22.03 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -127.36 127.85 24.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.708 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.72 -19.68 25.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.554 2.169 . . . . 0.0 112.731 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -112.42 -32.74 6.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 202' ' ' ILE . 23.9 m95 -105.84 108.7 20.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -107.19 138.66 42.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.63 ' CG ' HD12 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.502 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -148.84 158.07 27.52 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.126 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.406 ' HG3' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -123.85 95.97 4.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.683 0.277 . . . . 0.0 111.283 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.819 HD11 ' OD2' ' A' ' 179' ' ' ASP . 5.9 mt -74.16 72.9 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.254 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 4.3 m120 72.61 -63.13 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.1 28.54 1.53 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -129.49 103.72 7.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 184' ' ' ILE . 1.9 mtt85 -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 167.88 162.0 18.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.021 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.884 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.74 149.96 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.743 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.7 p90 -164.07 150.34 9.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.141 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 110.14 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.216 1.944 . . . . 0.0 111.041 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.492 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.8 p -56.08 -20.54 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.461 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -61.24 -17.08 51.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 110.62 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -92.92 16.6 12.22 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.8 m -149.17 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.55 119.54 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 88.5 Cg_exo -47.72 126.33 12.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.445 2.097 . . . . 0.0 112.502 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -101.05 -70.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 54.58 40.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 p 49.95 76.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.857 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.59 173.09 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -170.25 133.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.919 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.07 176.25 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.528 ' HD2' HD22 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -105.07 103.07 12.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.518 ' HD2' HG11 ' A' ' 180' ' ' VAL . 3.3 m-85 -104.68 120.29 41.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 210' ' ' PRO . 30.6 m -122.78 139.14 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -102.78 129.03 49.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.786 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -76.26 144.88 40.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 0.66 56.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.508 ' CE1' ' CG ' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -158.44 -163.14 1.22 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.784 0.326 . . . . 0.0 110.805 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.71 145.39 42.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 10.3 t80 -130.68 113.93 14.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -114.49 76.21 3.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.23 123.48 6.13 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.601 2.201 . . . . 0.0 112.471 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -120.64 170.54 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.752 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 p -89.96 142.79 27.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.26 -32.23 7.55 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.54 133.71 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 0.0 110.792 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.0 OUTLIER -80.49 157.43 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.751 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.584 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -106.66 113.45 26.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.932 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.521 ' HB2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -134.39 154.62 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -110.88 -169.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 134.65 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.344 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.89 20.51 41.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.666 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.819 ' CG ' HD21 ' A' ' 196' ' ' LEU . 67.9 t0 -80.62 110.53 16.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.518 HG11 ' HD2' ' A' ' 158' ' ' PHE . 33.8 t -69.51 105.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.887 HG12 HD23 ' A' ' 196' ' ' LEU . 2.6 mt -103.22 125.21 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.361 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 79.0 m -73.57 105.83 5.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.428 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.575 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.7 OUTLIER -51.61 127.88 21.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.603 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.697 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.4 mt -89.64 -40.69 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.476 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -177.94 155.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HG3' HD21 ' A' ' 183' ' ' LEU . 35.4 mtmt -107.64 54.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -58.43 -18.71 30.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.088 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -132.8 118.47 15.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.693 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -42.07 -28.95 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.745 2.297 . . . . 0.0 113.135 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -106.36 -42.76 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.904 ' CE3' HD12 ' A' ' 202' ' ' ILE . 12.6 m95 -94.88 106.83 18.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.257 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.9 m0 -101.54 142.48 32.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.609 ' CG ' HD12 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -89.29 145.87 25.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -152.39 162.37 29.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.2 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.514 ' O ' HG23 ' A' ' 181' ' ' ILE . 0.8 OUTLIER -112.67 140.98 46.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.716 0.293 . . . . 0.0 110.904 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -120.44 71.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.887 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 196' ' ' LEU . 1.9 t-20 86.09 -23.2 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.725 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 177.54 -36.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.655 0.264 . . . . 0.0 111.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 2.5 ptt-85 -69.85 153.28 43.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.178 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.697 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.5 mtm-85 -119.89 152.38 37.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.74 158.92 22.21 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.392 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.904 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.7 pt -108.27 150.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.1 p90 -170.1 162.67 6.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.71 110.28 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.458 2.105 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.53 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.2 p -57.59 -19.63 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.79 -12.74 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.627 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' TYR . . . . . 0.508 ' CG ' ' CE1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -89.83 13.94 13.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.54 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 161' ' ' ALA . 2.9 m -144.89 -169.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 111.55 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.28 113.85 2.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.875 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.4 Cg_exo -46.14 109.84 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.609 2.206 . . . . 0.0 112.574 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.95 -67.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 61.66 74.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -170.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.956 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.0 m170 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.822 0.344 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 4.7 mmt -92.57 -174.97 3.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -133.72 103.11 5.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.23 134.4 33.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.989 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -149.97 128.23 12.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.452 ' HD1' HG12 ' A' ' 180' ' ' VAL . 67.1 m-85 -133.27 142.84 48.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 210' ' ' PRO . 14.3 m -128.35 154.84 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.08 114.4 27.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -70.09 154.23 42.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.21 20.74 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.74 179.42 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.68 1.82 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.629 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.12 138.33 55.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 5.1 t80 -127.15 109.42 11.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.002 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -109.68 84.18 3.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 74.3 Cg_endo -77.01 116.4 4.2 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.69 2.26 . . . . 0.0 112.48 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -80.83 -26.48 37.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.686 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.48 174.76 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.97 151.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.87 -36.55 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 87.6 mt-10 -95.17 138.77 32.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.675 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.59 147.26 28.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.757 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.534 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.47 22.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.767 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.2 p90 -135.81 157.98 45.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.422 . . . . 0.0 111.16 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -109.32 -169.74 1.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.54 136.2 39.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.89 58.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.688 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.44 ' OD2' HD13 ' A' ' 196' ' ' LEU . 62.8 t0 -79.5 118.13 21.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' A' ' 158' ' ' PHE . 38.3 t -69.77 97.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.7 138.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.27 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -86.2 99.11 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.607 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.0 tp -49.5 123.57 7.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.396 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 200' ' ' ARG . 29.0 mt -89.44 -39.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 187' ' ' ASP . 8.5 p-10 -177.55 173.24 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.814 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.444 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 35.1 mtmt -123.28 55.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.416 ' HB2' ' ND2' ' A' ' 185' ' ' ASN . 6.5 t70 -55.39 -22.96 22.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -135.74 130.32 18.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.717 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.69 -21.81 20.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.643 2.229 . . . . 0.0 112.624 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -108.38 -36.38 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.929 ' CE3' HD12 ' A' ' 202' ' ' ILE . 20.6 m95 -103.02 110.55 22.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.486 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.0 m0 -106.38 140.82 38.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.944 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.83 149.59 22.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.416 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -153.79 159.28 28.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.74 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -124.34 118.91 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 111.181 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 173' ' ' LEU . 13.0 mt -102.77 97.06 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.536 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 79.65 -55.14 0.4 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -159.62 -36.33 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -69.47 141.09 54.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 111.333 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.61 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -109.4 160.38 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.467 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 174.36 159.67 21.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.015 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.929 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.3 151.8 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.747 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.597 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.8 p90 -165.55 151.2 8.31 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.65 111.47 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.264 1.976 . . . . 0.0 111.174 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.462 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.1 p -55.84 -21.54 20.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 111.197 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -17.75 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.494 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.29 17.87 12.04 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.292 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.597 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -148.7 -168.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 111.356 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.1 114.57 1.3 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.606 ' HA ' HG12 ' A' ' 159' ' ' VAL . 87.0 Cg_exo -47.2 124.39 8.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.463 2.109 . . . . 0.0 112.589 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.21 -68.84 0.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 212' ' ' ASN . 0.6 OUTLIER 61.91 81.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.647 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.1 m -57.62 -77.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.899 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.8 t60 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.792 0.329 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -77.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.34 100.64 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 t -95.92 123.1 39.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 111.46 4.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.544 ' HD2' HG12 ' A' ' 180' ' ' VAL . 84.9 m-85 -103.54 133.23 48.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 210' ' ' PRO . 16.4 m -122.07 153.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.14 113.13 24.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.458 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.477 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -65.72 157.19 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.557 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.22 19.55 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.929 179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -170.23 140.26 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.68 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.99 137.17 53.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.443 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.2 t80 -129.06 109.78 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.944 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -110.87 79.2 1.79 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.09 115.99 3.86 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.54 2.16 . . . . 0.0 112.509 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -80.06 -26.45 39.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.91 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.33 170.69 12.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.5 m -89.93 148.83 22.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.75 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.414 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.4 130.97 39.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.745 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -77.84 147.88 34.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.805 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.597 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.58 112.25 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.5 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.528 ' CB ' HD11 ' A' ' 181' ' ' ILE . 1.6 p90 -131.3 155.57 46.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -112.31 172.12 7.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.467 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 135.83 57.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.226 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.52 23.7 55.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.885 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.44 123.24 30.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.345 . . . . 0.0 110.863 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.544 HG12 ' HD2' ' A' ' 158' ' ' PHE . 37.1 t -73.12 94.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.528 HD11 ' CB ' ' A' ' 175' ' ' PHE . 27.7 mt -89.98 143.04 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.4 m -90.82 98.63 11.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.502 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -50.03 124.4 10.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.52 HD12 ' CG ' ' A' ' 193' ' ' GLU . 25.1 mt -89.7 -39.51 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.594 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 187' ' ' ASP . 8.7 p-10 -177.76 172.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 46.9 mtmt -121.99 56.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.679 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.441 ' HB2' ' ND2' ' A' ' 185' ' ' ASN . 20.9 t0 -57.16 -21.72 34.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.139 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -137.09 121.61 12.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.667 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.79 -28.16 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.716 2.278 . . . . 0.0 112.949 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -102.78 -44.71 5.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.23 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.984 ' CE3' HD12 ' A' ' 202' ' ' ILE . 24.1 m95 -94.03 108.75 20.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.501 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.4 m0 -104.32 141.8 35.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.852 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.99 146.35 24.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.205 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.86 158.36 27.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.915 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.07 107.13 11.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 175' ' ' PHE . 0.7 OUTLIER -87.54 95.59 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.601 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 23.4 t30 77.39 -59.03 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -152.09 -38.37 0.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -69.62 138.6 53.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.221 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.492 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -107.31 162.42 13.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.573 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.95 161.94 23.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.869 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.984 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -106.24 153.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.67 ' CD2' HD23 ' A' ' 173' ' ' LEU . 16.1 p90 -169.36 148.72 3.58 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.126 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.45 109.82 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.276 1.984 . . . . 0.0 111.384 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.0 p -54.35 -23.11 14.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.316 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -61.04 -16.13 40.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.29 22.19 6.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 205' ' ' SER . 4.1 m -149.87 -168.7 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.737 0.304 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.41 111.52 1.86 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.5 Cg_exo -47.86 121.73 6.21 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -98.41 -68.24 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.6 t30 61.75 74.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -58.25 -175.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.935 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.851 0.358 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 23.5 mtm -105.71 -34.01 7.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.74 137.18 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.2 t -96.25 147.26 23.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -104.68 168.02 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.969 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -144.14 111.94 6.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 25.8 m -106.64 152.02 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.067 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -113.46 112.84 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.97 155.71 33.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.536 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.478 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -114.86 -12.41 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.52 132.0 19.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.04 143.6 31.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.446 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 9.8 t80 -127.74 109.48 11.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.59 78.9 1.6 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.17 123.91 6.94 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.608 2.205 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -94.48 18.22 11.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -129.71 173.1 10.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 m -90.15 145.88 24.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.54 -34.45 5.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.391 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -93.64 134.35 36.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.668 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.61 147.94 29.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.654 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.539 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.34 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.8 p90 -133.52 152.96 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 111.209 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -103.22 -168.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -79.1 134.74 36.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.88 18.61 54.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.738 ' OD1' HD21 ' A' ' 196' ' ' LEU . 62.7 t0 -80.85 119.2 23.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.8 t -69.71 99.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.568 HG21 HD21 ' A' ' 173' ' ' LEU . 4.9 mt -93.99 140.6 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.326 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -87.41 100.87 13.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.517 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -51.21 123.77 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.421 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.564 HD13 ' HG2' ' A' ' 200' ' ' ARG . 31.2 mt -89.58 -39.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.625 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.35 172.18 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 33.0 mtmt -127.07 57.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.75 -22.02 61.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 1.6 t70 -132.78 117.22 15.05 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.17 -29.94 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.922 2.415 . . . . 0.0 113.168 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.49 -48.99 4.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.994 ' CE3' HD12 ' A' ' 202' ' ' ILE . 28.0 m95 -89.82 108.11 19.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.117 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.534 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.0 m0 -104.68 142.46 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.966 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.831 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.87 145.52 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.248 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -149.95 158.92 27.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -123.57 118.63 27.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.729 0.3 . . . . 0.0 111.235 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.738 HD21 ' OD1' ' A' ' 179' ' ' ASP . 4.4 mt -103.55 97.78 7.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.513 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 79.36 -55.71 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -159.25 -36.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 -69.61 141.95 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.304 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -109.51 162.37 14.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.78 161.25 23.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.91 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.994 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.5 pt -108.39 153.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PHE . . . . . 0.557 ' CE1' HG11 ' A' ' 208' ' ' VAL . 15.5 p90 -170.03 151.91 4.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.37 106.89 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.188 1.925 . . . . 0.0 110.984 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.825 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.35 -23.46 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.037 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -51.74 -21.74 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 110.508 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.38 23.1 4.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.711 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 205' ' ' SER . 3.7 m -147.11 -167.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 111.625 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.21 110.02 1.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 87.6 Cg_exo -47.98 113.17 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.505 2.137 . . . . 0.0 112.532 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.54 -66.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.2 t30 61.7 74.56 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.636 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 79.4 p -58.27 174.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.1 p30 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.916 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.1 m -126.09 157.64 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.82 122.66 47.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.669 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -70.08 157.85 36.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.583 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -126.53 17.89 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.829 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.12 140.2 1.92 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.69 142.23 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.996 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.451 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 19.5 t80 -135.13 110.82 9.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -110.22 82.15 2.51 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.24 113.49 3.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.582 2.188 . . . . 0.0 112.327 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -76.49 -27.35 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.915 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.07 168.27 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.9 p -90.05 148.8 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.0 -35.05 4.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.406 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.15 137.35 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.308 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.45 149.44 31.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.639 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -99.39 112.74 24.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.557 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.728 ' CB ' HD11 ' A' ' 181' ' ' ILE . 6.7 p90 -133.82 160.37 37.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.375 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 13.8 mtmt -115.65 -168.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.657 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 133.38 37.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.85 19.07 58.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.011 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -84.35 128.11 34.38 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.66 120.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.728 HD11 ' CB ' ' A' ' 175' ' ' PHE . 70.3 mt -120.71 113.96 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.0 111.309 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.4 m -70.15 108.65 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.411 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 186' ' ' LYS . 29.6 tp -56.74 124.7 19.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.435 HD12 ' CG ' ' A' ' 193' ' ' GLU . 22.8 mt -89.37 -32.25 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.269 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 8.5 p30 -175.16 -171.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.685 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.696 ' HG3' HD21 ' A' ' 183' ' ' LEU . 27.3 mtmt -151.39 51.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.726 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.55 -39.86 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -121.77 130.32 24.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.009 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.26 -17.34 25.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.214 1.943 . . . . 0.0 111.89 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -94.45 -46.37 7.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.845 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.654 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 14.5 m95 -110.29 122.5 47.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 111.188 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 46.2 m0 -114.05 141.14 47.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.844 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.1 tt0 -89.97 140.85 29.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.812 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -151.06 162.05 29.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.911 -1.137 . . . . 0.0 113.16 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.424 ' HG2' HD13 ' A' ' 184' ' ' ILE . 4.7 mpt_? . . . . . 0 C--O 1.231 0.131 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 169.33 161.02 18.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.061 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.556 HG23 ' OE2' ' A' ' 193' ' ' GLU . 3.8 pt -107.26 148.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.866 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.9 p90 -170.39 164.0 5.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.53 117.88 4.82 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.355 2.036 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.517 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.3 p -63.09 -17.01 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.82 -13.98 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.75 15.7 10.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 162' ' ' LEU . 2.7 m -148.18 -171.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.17 122.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.773 ' HA ' HG12 ' A' ' 159' ' ' VAL . 96.7 Cg_exo -44.78 128.0 8.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.733 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 85.6 t80 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.852 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 4.1 m-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.807 0.337 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 210' ' ' PRO . 31.1 m -114.81 155.51 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.245 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.67 110.02 19.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -64.04 158.19 23.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -127.27 19.07 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.743 179.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.581 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.4 140.2 58.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -128.06 106.48 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -109.92 78.43 1.28 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 124.12 7.82 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.526 2.151 . . . . 0.0 112.419 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -93.75 17.44 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -131.42 173.97 10.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.845 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 29.7 p -90.04 146.26 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.41 -34.11 5.7 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -93.24 132.49 37.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.303 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.725 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -78.8 143.59 35.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.494 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.79 111.18 22.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -137.19 166.8 22.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -168.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.732 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -76.22 136.96 39.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.87 18.19 52.92 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.601 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -76.97 114.73 16.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.59 93.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.752 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 173' ' ' LEU . 4.4 mt -95.82 132.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.402 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -78.72 103.16 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 193' ' ' GLU . 37.7 tp -49.48 125.3 10.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.545 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.654 HG22 ' ND2' ' A' ' 185' ' ' ASN . 33.6 mt -89.65 -55.17 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.654 ' ND2' HG22 ' A' ' 184' ' ' ILE . 8.7 m-80 -153.59 166.15 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.573 ' HG3' HD21 ' A' ' 183' ' ' LEU . 49.2 mtmt -128.05 47.62 2.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.543 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.302 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -118.17 115.35 36.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.911 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -44.12 -28.19 2.19 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.654 2.236 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -101.62 -44.97 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.993 ' CE3' HD12 ' A' ' 202' ' ' ILE . 17.9 m95 -95.61 113.44 25.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.249 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.8 m0 -109.58 141.72 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.838 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.85 145.24 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.152 179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.47 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -146.96 160.15 28.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.035 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 111.095 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.601 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.683 0.278 . . . . 0.0 110.612 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.643 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.52 159.47 20.12 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.748 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.993 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -106.12 150.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.725 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.9 p90 -164.72 156.88 13.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.99 106.9 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.464 2.109 . . . . 0.0 111.298 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.7 p -52.69 -24.31 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.052 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.3 -17.9 45.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.741 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.06 23.73 6.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 205' ' ' SER . 6.0 m -149.27 -170.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.334 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.69 110.41 2.18 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.3 Cg_exo -48.31 124.86 11.15 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.472 2.115 . . . . 0.0 112.478 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 33.5 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 182' ' ' THR . 29.3 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.891 0.377 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 26.7 m -107.13 151.77 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.37 114.54 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -64.73 153.73 38.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.499 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.473 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.36 -22.42 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.26 128.92 24.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.93 146.34 42.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.448 ' CB ' ' CZ ' ' A' ' 175' ' ' PHE . 59.9 t80 -137.6 117.95 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.3 87.95 4.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 64.8 Cg_endo -75.89 121.69 6.38 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.19 20.12 9.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -136.07 171.52 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 38.4 p -90.01 146.28 24.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.47 -34.01 5.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.378 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.99 136.93 36.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.847 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -82.21 145.96 29.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.81 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.04 108.45 20.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 181' ' ' ILE . 11.6 p90 -122.91 158.32 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.333 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 18.8 mttm -117.91 -175.53 2.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.513 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.11 132.08 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.96 18.02 53.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.61 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -79.98 117.95 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.68 96.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.756 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 175' ' ' PHE . 4.8 mt -95.55 122.29 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.432 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.68 HG23 ' CE1' ' A' ' 158' ' ' PHE . 1.3 m -72.83 103.23 3.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 193' ' ' GLU . 38.5 tp -51.04 125.69 14.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.311 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.687 HG22 ' ND2' ' A' ' 185' ' ' ASN . 28.5 mt -89.37 -55.42 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.687 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.5 m-80 -155.47 165.7 35.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 34.9 mtmt -126.28 50.28 1.91 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.581 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -56.18 -25.74 47.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.374 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 10.6 t70 -124.53 127.01 25.34 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 -22.01 20.65 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.523 2.149 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 10.6 m120 -108.57 -36.35 6.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 111.214 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.922 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.5 m95 -103.23 110.95 23.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.539 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.5 m0 -106.55 141.85 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 183' ' ' LEU . 3.3 tt0 -89.59 138.57 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.437 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -142.87 159.48 27.36 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.181 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.12 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.643 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.235 0 N-CA-C 110.364 -0.235 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . -179.27 159.24 23.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.257 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.922 HD12 ' CE3' ' A' ' 191' ' ' TRP . 3.8 pt -112.83 149.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.847 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.35 162.75 6.2 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 34.6 Cg_exo -59.82 108.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.362 2.041 . . . . 0.0 111.339 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.0 OUTLIER -57.04 -20.86 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.143 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -62.15 -13.71 29.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -90.98 19.35 5.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 205' ' ' SER . 4.4 m -147.0 -171.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.4 112.4 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 80.8 Cg_exo -46.52 118.43 2.56 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.534 2.156 . . . . 0.0 112.636 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 28.0 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.898 -179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 182' ' ' THR . 46.5 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 210' ' ' PRO . 5.5 m -127.52 156.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.55 114.81 26.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.639 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.63 157.26 34.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.508 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -128.45 19.73 6.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.28 140.24 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.91 142.34 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.45 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.8 t80 -132.68 112.48 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.31 84.72 3.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.16 115.43 3.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.491 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -79.73 -26.3 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -96.85 175.14 6.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 80.4 p -90.1 151.77 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.65 -36.05 4.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.84 133.76 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.292 . . . . 0.0 110.737 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.735 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.65 144.88 39.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.906 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -95.87 111.82 23.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.536 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -134.97 -179.83 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.42 . . . . 0.0 111.357 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 6.6 pttp -131.17 -170.81 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.754 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -75.46 139.76 42.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.038 0.447 . . . . 0.0 111.463 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 55.85 21.26 29.39 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.17 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 176' ' ' LYS . 0.4 OUTLIER -84.56 122.33 28.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.75 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.3 103.59 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.7 mt -102.72 127.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.394 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.2 m -79.33 100.3 7.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.354 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.81 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -49.1 127.68 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.607 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 193' ' ' GLU . 31.9 mt -89.55 -36.42 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.461 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.1 p30 -176.55 154.85 1.3 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.81 ' HG3' HD21 ' A' ' 183' ' ' LEU . 44.4 mtmt -115.18 44.02 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.34 -31.09 5.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.21 127.14 23.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.036 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.89 -14.84 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.275 1.984 . . . . 0.0 112.185 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.63 -44.26 6.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.6 m95 -115.24 112.41 22.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 111.508 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.502 ' HB3' HD11 ' A' ' 183' ' ' LEU . 46.6 m0 -101.01 136.82 40.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.547 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 184' ' ' ILE . 1.9 tt0 -88.79 146.13 25.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.5 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.4 161.96 28.58 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 119.951 -1.118 . . . . 0.0 113.463 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.0 mtp180 . . . . . 0 CA--C 1.521 -0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.03 156.6 12.43 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.932 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.782 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -102.94 149.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.804 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.735 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.0 p90 -162.61 157.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.57 113.36 1.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.251 1.967 . . . . 0.0 110.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 208' ' ' VAL . 3.7 p -59.4 -19.61 48.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 111.35 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -65.53 -14.49 61.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.399 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 20.47 9.22 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.183 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.539 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -150.02 -167.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.49 114.65 1.25 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.7 Cg_exo -48.03 125.19 11.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.611 2.207 . . . . 0.0 112.459 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 25.4 t80 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.748 0.309 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 23.1 m -110.26 150.9 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.55 114.53 27.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.39 157.71 31.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.552 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.452 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -125.51 24.51 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.18 178.67 3.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -100.16 138.0 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 2.0 t80 -125.84 105.37 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -109.67 78.59 1.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.408 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 70.2 Cg_endo -75.93 115.76 4.24 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 112.551 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.84 -26.58 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.38 172.97 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.1 m -90.11 150.89 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.63 -36.3 4.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.347 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 4.9 mt-10 -93.35 136.14 33.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.659 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -80.66 147.03 30.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.704 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.519 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.43 113.84 25.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.715 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -141.15 163.37 33.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.408 . . . . 0.0 111.087 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -123.25 -176.56 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.807 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 139.48 57.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.27 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.02 21.01 44.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.625 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -78.32 109.66 12.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.022 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.7 94.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.612 HG21 ' CD2' ' A' ' 173' ' ' LEU . 10.5 mt -95.53 135.01 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.433 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 m -81.43 102.99 10.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.811 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.1 tp -51.03 122.42 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.457 HD12 ' CG ' ' A' ' 193' ' ' GLU . 28.4 mt -89.49 -36.31 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.75 174.65 0.82 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.551 ' HE2' HD21 ' A' ' 183' ' ' LEU . 21.3 mttt -123.16 66.14 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.59 -19.44 38.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 14.2 t70 -150.61 132.94 8.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.685 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.13 -25.68 4.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.861 2.374 . . . . 0.0 112.76 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -102.44 -44.64 5.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 0.0 111.358 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.909 ' CE3' HD12 ' A' ' 202' ' ' ILE . 32.5 m95 -94.19 110.57 22.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.325 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.466 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -108.5 141.33 40.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.811 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.76 144.87 25.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.11 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -150.11 158.25 27.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.766 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.887 0.375 . . . . 0.0 111.201 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.445 ' HG2' HD13 ' A' ' 184' ' ' ILE . 3.9 mpt_? . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 110.568 -0.16 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.88 162.31 24.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.02 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.909 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -107.66 154.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.743 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.6 p90 -170.09 149.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.065 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 24.3 Cg_exo -62.76 107.09 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.22 1.947 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.759 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -52.26 -22.54 4.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.313 -179.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -53.01 -19.85 3.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.765 0.317 . . . . 0.0 110.47 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.24 21.95 7.34 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -147.2 -167.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.724 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.24 111.98 1.02 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 85.9 Cg_exo -46.48 115.11 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.504 2.136 . . . . 0.0 112.683 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.0 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.835 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.928 0.394 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 210' ' ' PRO . 6.0 m -129.83 153.6 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.23 115.28 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.31 154.05 39.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.391 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.462 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.48 13.92 22.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 0.1 OUTLIER -170.05 -164.23 0.4 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -114.94 145.9 41.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 20.8 t80 -135.75 115.13 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -111.88 85.83 6.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.684 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 113.79 3.74 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.651 2.234 . . . . 0.0 112.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.87 -27.4 55.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.884 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -96.07 174.15 7.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 74.5 m -90.08 151.51 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.23 -36.84 3.87 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.318 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.01 132.45 39.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 0.0 110.739 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.72 143.42 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.564 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.66 113.65 25.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.439 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.3 p90 -134.14 177.38 7.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.413 . . . . 0.0 111.497 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 8.6 mttt -128.77 -175.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.811 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -69.66 140.56 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.683 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 51.57 25.06 13.17 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.872 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.29 123.27 30.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 36.3 t -72.62 102.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.8 mt -96.89 142.48 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.434 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.5 m -90.17 99.21 12.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.4 tp -50.3 123.18 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.618 HG22 ' ND2' ' A' ' 185' ' ' ASN . 22.4 mt -89.71 -54.06 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.42 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.618 ' ND2' HG22 ' A' ' 184' ' ' ILE . 7.2 m-80 -153.93 166.35 33.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.544 ' HG3' HD21 ' A' ' 183' ' ' LEU . 50.3 mtmt -128.88 48.79 2.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.73 -27.3 66.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.38 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.31 115.77 34.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.926 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -44.32 -28.08 2.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.563 2.176 . . . . 0.0 112.859 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.01 -44.5 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.234 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.954 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.4 m95 -95.57 112.11 23.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.231 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.5 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.7 m0 -108.29 142.53 38.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -90.82 144.16 25.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.087 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.04 27.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.969 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 111.253 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.468 ' HG2' HD13 ' A' ' 184' ' ' ILE . 2.3 mpt_? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.608 0.242 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.624 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.14 161.42 20.61 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.937 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.954 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -103.98 152.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.826 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.734 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.2 p90 -167.71 154.99 7.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.97 107.85 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.3 2.0 . . . . 0.0 111.337 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.2 p -53.18 -24.55 11.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -16.2 43.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . 0.411 ' HB3' ' CE1' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -93.88 21.56 6.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.215 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -148.6 -167.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.52 111.95 1.85 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' A' ' 159' ' ' VAL . 76.8 Cg_exo -48.49 121.9 7.02 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.547 2.165 . . . . 0.0 112.44 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.705 ' O ' HG13 ' A' ' 159' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.644 0.259 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -166.8 123.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.477 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -102.26 123.83 46.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.252 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -73.99 148.33 42.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.721 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -117.16 14.5 14.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.812 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.25 140.16 1.85 Allowed 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 145.21 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -133.66 112.51 11.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.77 87.21 5.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.7 116.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.562 2.175 . . . . 0.0 112.46 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.94 -26.06 36.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.26 172.69 7.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -90.05 150.56 22.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.5 -35.44 4.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.409 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.47 133.42 36.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.68 140.79 42.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.837 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.49 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.97 114.49 26.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.165 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.7 p90 -133.29 -178.22 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 111.607 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -126.05 -174.19 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.83 140.08 42.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.264 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 56.03 21.85 32.96 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 124.95 31.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.0 t -74.89 119.56 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.678 ' HB ' HG23 ' A' ' 159' ' ' VAL . 5.0 mt -119.81 155.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.601 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.464 ' N ' HG22 ' A' ' 181' ' ' ILE . 2.0 m -103.36 104.45 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.359 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.6 tp -50.11 124.63 10.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.517 HD12 ' CG ' ' A' ' 193' ' ' GLU . 27.3 mt -89.5 -38.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.537 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.67 174.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.802 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.438 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.9 mtmt -126.16 59.77 1.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -19.75 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 24.3 t0 -137.05 122.12 12.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.42 -28.02 2.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.715 2.277 . . . . 0.0 112.902 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -102.78 -44.14 5.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.8 m95 -94.8 110.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.505 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.1 m0 -105.82 141.96 36.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.063 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.79 143.47 26.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.081 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.455 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.86 158.43 27.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.129 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.588 0.232 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.635 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.57 162.84 24.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.822 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.981 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.8 pt -104.96 151.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.809 ' CD2' HD23 ' A' ' 173' ' ' LEU . 14.8 p90 -167.5 159.09 10.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.91 108.78 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.329 2.019 . . . . 0.0 111.148 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.3 p -53.32 -24.23 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -58.38 -19.66 37.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 163' ' ' PHE . 1.1 m-85 -90.9 14.26 14.24 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.467 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.0 m -149.45 -166.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.263 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.526 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -177.74 125.38 0.28 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -43.25 129.43 6.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.769 2.312 . . . . 0.0 112.705 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.574 ' CD1' HG12 ' A' ' 180' ' ' VAL . 32.4 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.79 0.328 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 181' ' ' ILE . 26.8 m -112.54 150.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.23 113.88 26.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.96 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -66.73 154.62 40.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.486 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.449 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -120.3 27.67 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.14 -169.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -127.37 129.72 48.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.811 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.454 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 36.5 t80 -131.94 128.6 38.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.41 88.47 49.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.94 119.49 5.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.525 2.15 . . . . 0.0 112.419 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -87.4 -23.36 24.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.04 158.47 16.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.788 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.8 m -78.73 122.48 26.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.19 -20.58 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.441 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.49 139.26 53.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.74 150.22 36.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.86 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.5 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -97.89 110.15 22.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.453 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 181' ' ' ILE . 12.7 p90 -124.13 166.59 15.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.9 mtpp -129.49 174.8 9.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.6 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.32 131.97 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.945 0.402 . . . . 0.0 110.926 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.18 19.04 44.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -81.21 117.88 22.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 158' ' ' PHE . 38.8 t -69.42 92.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 195' ' ' GLN . 3.4 mt -92.27 124.91 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.3 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 m -69.97 99.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.369 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.883 HD21 ' HG3' ' A' ' 186' ' ' LYS . 32.7 tp -49.82 119.96 3.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.591 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.579 HD13 ' CG ' ' A' ' 200' ' ' ARG . 12.8 mt -93.73 -41.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.634 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -143.49 158.94 43.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.883 ' HG3' HD21 ' A' ' 183' ' ' LEU . 9.8 mttt -138.36 15.59 2.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.539 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -49.58 -36.81 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.288 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 191' ' ' TRP . 0.4 OUTLIER -107.35 105.99 57.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.598 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -42.69 -28.8 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.764 2.309 . . . . 0.0 112.942 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 9.3 m120 -97.31 -38.5 9.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.149 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.438 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 17.2 m95 -110.5 107.8 17.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.688 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.823 ' HB3' HD11 ' A' ' 183' ' ' LEU . 53.9 m0 -108.51 149.45 28.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.278 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.753 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.3 tp10 -89.94 148.98 22.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.7 157.12 27.16 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.33 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 181' ' ' ILE . 20.5 tt0 . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.579 ' CG ' HD13 ' A' ' 184' ' ' ILE . 4.3 mpt_? . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.519 0.199 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.95 158.12 20.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.169 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.682 HG23 ' CD ' ' A' ' 193' ' ' GLU . 8.0 pt -111.38 151.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 0.0 110.91 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.764 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.07 164.87 5.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 31.7 Cg_exo -58.57 108.07 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.517 2.144 . . . . 0.0 111.779 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.584 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.4 p -57.93 -21.29 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.122 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -62.88 -14.03 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.792 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.29 20.35 5.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.455 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -149.13 -169.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.39 111.79 1.37 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.735 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 86.7 Cg_exo -46.6 114.45 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.521 2.147 . . . . 0.0 112.529 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 18.3 t80 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.825 -179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.789 0.328 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 12.9 m -143.34 157.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.11 117.83 29.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.75 147.57 52.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.85 -20.04 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.884 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -133.94 -175.29 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.636 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.1 148.78 26.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.455 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 6.8 t80 -133.12 110.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.955 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -112.42 79.81 3.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.412 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 76.3 Cg_endo -81.11 120.93 3.83 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.644 2.229 . . . . 0.0 112.481 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -81.42 -23.53 37.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.83 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.01 169.98 11.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.18 148.5 22.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.59 -35.13 4.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.322 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 2.6 mt-10 -90.26 126.86 35.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.837 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.054 HD21 HD13 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -69.66 144.44 52.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.643 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.86 107.95 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.494 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 181' ' ' ILE . 2.0 p90 -136.67 159.8 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.336 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -117.71 -167.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 138.77 54.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.45 17.03 56.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.501 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -73.1 109.67 6.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.303 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.41 101.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.369 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 1.054 HD13 HD21 ' A' ' 173' ' ' LEU . 3.4 mt -100.79 140.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.474 . . . . 0.0 111.738 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.7 m -92.62 99.79 12.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 193' ' ' GLU . 20.7 tp -46.31 119.1 2.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.115 0.483 . . . . 0.0 111.467 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.484 HD12 ' CG ' ' A' ' 193' ' ' GLU . 19.7 mt -89.64 -37.77 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.7 p30 -177.91 171.2 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.778 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 32.5 mtmt -122.75 57.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -56.65 -21.64 28.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 37.2 t70 -137.05 129.48 17.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.99 -23.35 16.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.574 2.183 . . . . 0.0 112.724 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.5 m120 -106.6 -38.24 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.196 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.78 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.3 m95 -100.94 111.67 23.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.045 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.477 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.1 m0 -107.07 144.61 33.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.806 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -93.49 145.41 24.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.061 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -155.05 157.14 27.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.052 -1.071 . . . . 0.0 113.021 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.625 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.473 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.598 0.237 . . . . 0.0 110.694 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.07 162.16 21.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.81 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.78 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -99.3 152.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.549 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.864 ' CD2' HD23 ' A' ' 173' ' ' LEU . 24.8 p90 -167.66 159.45 9.93 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.992 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 203' ' ' PHE . 45.2 Cg_endo -68.53 110.99 2.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.166 1.911 . . . . 0.0 111.299 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -55.3 -23.18 22.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.3 -16.94 50.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.68 17.93 10.99 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.261 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.495 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.6 m -149.59 -168.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 111.526 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.414 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -165.47 122.75 1.07 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.9 Cg_exo -46.56 128.58 12.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.164 . . . . 0.0 112.569 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.816 0.341 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 19.5 m -120.04 154.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.6 113.01 23.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.792 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.66 157.61 29.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.473 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.42 20.77 7.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.727 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.21 139.37 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.42 138.33 57.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 3.4 t80 -125.45 105.6 9.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.54 78.04 1.09 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 124.4 8.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -93.76 17.2 12.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.68 173.52 11.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.08 146.66 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.08 -34.52 5.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.86 135.4 35.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 0.0 110.768 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.14 144.63 31.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.894 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.567 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.7 109.9 21.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.559 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -135.88 161.64 35.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.54 -166.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -78.59 136.13 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.29 16.81 54.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.75 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -78.49 118.25 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.55 100.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 173' ' ' LEU . 3.6 mt -99.97 124.48 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.375 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.8 m -72.91 105.14 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.5 tp -51.04 123.63 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.374 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.74 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.8 mt -89.64 -53.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.507 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.718 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.1 m-80 -156.2 166.29 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 25.8 mtmt -126.91 50.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.579 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.39 -26.81 43.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 17.3 t70 -124.54 124.89 25.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.703 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 188' ' ' ASP . 8.3 Cg_endo -50.05 -23.91 10.05 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.183 . . . . 0.0 112.726 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -106.56 -40.0 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.971 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.3 m95 -98.16 109.7 22.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.273 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.551 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.8 m0 -107.46 142.73 36.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.026 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.815 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.99 147.0 23.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.877 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -153.38 159.67 28.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.054 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 110.969 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.74 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.067 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 176.89 159.61 22.53 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.24 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.971 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -108.0 151.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.632 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.2 p90 -165.12 155.55 12.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 16.9 Cg_exo -66.59 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.364 2.042 . . . . 0.0 110.991 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.794 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.29 -24.51 4.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -52.38 -21.32 3.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.895 0.379 . . . . 0.0 110.466 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -93.8 22.31 5.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.909 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 205' ' ' SER . 3.4 m -146.71 -169.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 111.747 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.18 111.53 1.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.797 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -47.0 124.6 8.98 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 24.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.819 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.854 ' CE1' HG23 ' A' ' 182' ' ' THR . 7.6 m-85 . . . . . 0 CA--C 1.525 0.013 0 CA-C-O 120.788 0.328 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 27.8 m -158.02 157.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.44 117.21 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -67.14 152.19 46.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.507 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.498 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -109.56 -22.1 12.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.874 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.12 145.35 39.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.686 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.94 147.36 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 28.0 t80 -136.11 116.14 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -108.78 88.64 5.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.767 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.09 119.42 5.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.626 2.218 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -96.24 22.14 8.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -135.19 171.67 14.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.826 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 78.1 p -90.08 142.68 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.98 -32.21 7.61 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.16 134.15 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 0.0 110.786 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.852 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -81.33 148.36 29.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.002 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.688 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -101.05 112.41 24.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.512 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.5 p90 -127.82 162.0 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.272 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.4 mmmt -117.99 -167.56 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.73 36.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.56 17.62 54.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.41 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -79.77 115.42 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.738 HG12 ' HD2' ' A' ' 158' ' ' PHE . 3.4 t -69.63 103.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 175' ' ' PHE . 15.3 mt -98.61 144.8 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.488 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.3 m -93.74 95.95 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 193' ' ' GLU . 33.3 tp -47.13 124.34 6.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 193' ' ' GLU . 31.4 mt -89.31 -39.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.94 172.68 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.443 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 44.3 mtmt -124.77 58.46 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.776 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -59.93 -20.49 57.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.27 119.52 13.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.658 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.17 -28.98 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.724 2.283 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -101.42 -46.48 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.29 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.63 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.6 m95 -92.7 110.42 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.323 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.555 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -105.35 142.38 35.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.788 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.78 143.16 27.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.907 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.508 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -144.77 158.12 27.49 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.232 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.403 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.259 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 195' ' ' GLN . 1.4 mpt_? . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.631 0.253 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.34 163.17 25.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.136 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.63 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -111.38 148.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.852 ' CE1' HD23 ' A' ' 173' ' ' LEU . 3.6 p90 -170.18 163.52 6.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.24 111.41 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 111.525 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -56.2 -21.15 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.233 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.11 -15.85 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 21.15 4.55 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -149.99 -171.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 111.718 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.84 115.04 1.83 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.499 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 68.5 Cg_exo -43.16 129.66 6.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.669 2.246 . . . . 0.0 112.899 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.688 -179.741 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.3 m -124.72 156.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.61 118.85 34.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -72.39 150.22 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.417 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.83 -18.21 13.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.052 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.55 129.88 19.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.702 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.95 152.81 22.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 53.0 t80 -139.8 120.32 14.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -108.76 87.45 4.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 63.2 Cg_endo -75.95 121.15 6.06 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.376 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -95.79 20.74 9.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.074 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -139.51 172.72 12.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 146.47 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.022 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.65 5.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.366 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.67 134.65 38.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 110.778 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.743 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.0 145.28 34.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.931 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.83 113.94 25.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.348 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.6 p90 -133.0 175.28 9.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.431 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -128.52 -169.86 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -76.32 139.59 41.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.47 20.18 36.76 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.82 121.57 27.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 0.0 110.809 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.68 104.04 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.1 mt -99.96 137.77 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.394 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.92 96.49 10.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.447 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -46.76 125.67 7.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.57 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.63 HD12 ' CG ' ' A' ' 193' ' ' GLU . 37.3 mt -89.29 -44.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.552 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.5 150.35 5.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.793 ' HG3' HD21 ' A' ' 183' ' ' LEU . 31.1 mtmt -110.35 49.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.1 -22.03 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -127.36 127.85 24.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.708 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.72 -19.68 25.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.554 2.169 . . . . 0.0 112.731 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -112.42 -32.74 6.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 202' ' ' ILE . 23.9 m95 -105.84 108.7 20.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -107.19 138.66 42.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.63 ' CG ' HD12 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.502 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -148.84 158.07 27.52 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.126 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.406 ' HG3' ' HG3' ' A' ' 200' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.683 0.277 . . . . 0.0 111.283 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 184' ' ' ILE . 1.9 mtt85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.541 0.21 . . . . 0.0 110.519 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 167.88 162.0 18.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.021 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.884 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.74 149.96 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.743 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.7 p90 -164.07 150.34 9.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.141 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 110.14 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.216 1.944 . . . . 0.0 111.041 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.492 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.8 p -56.08 -20.54 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.461 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -61.24 -17.08 51.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 110.62 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -92.92 16.6 12.22 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.8 m -149.17 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.55 119.54 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 88.5 Cg_exo -47.72 126.33 12.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.445 2.097 . . . . 0.0 112.502 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 23.0 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.518 ' HD2' HG11 ' A' ' 180' ' ' VAL . 3.3 m-85 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 210' ' ' PRO . 30.6 m -122.78 139.14 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -102.78 129.03 49.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.786 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -76.26 144.88 40.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 0.66 56.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.508 ' CE1' ' CG ' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -158.44 -163.14 1.22 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.784 0.326 . . . . 0.0 110.805 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.71 145.39 42.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 10.3 t80 -130.68 113.93 14.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -114.49 76.21 3.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.23 123.48 6.13 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.601 2.201 . . . . 0.0 112.471 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -120.64 170.54 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.752 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 p -89.96 142.79 27.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.26 -32.23 7.55 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.54 133.71 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 0.0 110.792 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.0 OUTLIER -80.49 157.43 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.751 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.584 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -106.66 113.45 26.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.932 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.521 ' HB2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -134.39 154.62 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -110.88 -169.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 134.65 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.344 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.89 20.51 41.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.666 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -80.62 110.53 16.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.518 HG11 ' HD2' ' A' ' 158' ' ' PHE . 33.8 t -69.51 105.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.521 HD11 ' HB2' ' A' ' 175' ' ' PHE . 2.6 mt -103.22 125.21 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.361 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 79.0 m -73.57 105.83 5.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.428 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.575 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.7 OUTLIER -51.61 127.88 21.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.603 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.697 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.4 mt -89.64 -40.69 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.476 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 2.6 p30 -177.94 155.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HG3' HD21 ' A' ' 183' ' ' LEU . 35.4 mtmt -107.64 54.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -58.43 -18.71 30.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.088 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -132.8 118.47 15.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.693 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -42.07 -28.95 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.745 2.297 . . . . 0.0 113.135 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -106.36 -42.76 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.904 ' CE3' HD12 ' A' ' 202' ' ' ILE . 12.6 m95 -94.88 106.83 18.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.257 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.9 m0 -101.54 142.48 32.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.609 ' CG ' HD12 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -89.29 145.87 25.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -152.39 162.37 29.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.2 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.514 ' O ' HG23 ' A' ' 181' ' ' ILE . 2.4 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.716 0.293 . . . . 0.0 110.904 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.697 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.5 mtm-85 . . . . . 0 C--O 1.231 0.095 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.74 158.92 22.21 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.392 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.904 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.7 pt -108.27 150.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.1 p90 -170.1 162.67 6.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.71 110.28 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.458 2.105 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.53 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.2 p -57.59 -19.63 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.79 -12.74 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.627 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . 0.508 ' CG ' ' CE1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -89.83 13.94 13.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.54 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 161' ' ' ALA . 2.9 m -144.89 -169.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 111.55 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.28 113.85 2.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.875 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.4 Cg_exo -46.14 109.84 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.609 2.206 . . . . 0.0 112.574 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 22.5 t80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.452 ' HD1' HG12 ' A' ' 180' ' ' VAL . 67.1 m-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.819 0.342 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 210' ' ' PRO . 14.3 m -128.35 154.84 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.08 114.4 27.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -70.09 154.23 42.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.21 20.74 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.74 179.42 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.68 1.82 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.629 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.12 138.33 55.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 5.1 t80 -127.15 109.42 11.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.002 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -109.68 84.18 3.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 74.3 Cg_endo -77.01 116.4 4.2 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.69 2.26 . . . . 0.0 112.48 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -80.83 -26.48 37.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.686 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.48 174.76 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.97 151.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.87 -36.55 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 87.6 mt-10 -95.17 138.77 32.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.675 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.59 147.26 28.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.757 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.534 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.47 22.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.767 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.2 p90 -135.81 157.98 45.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.422 . . . . 0.0 111.16 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -109.32 -169.74 1.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.54 136.2 39.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.89 58.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.688 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -79.5 118.13 21.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' A' ' 158' ' ' PHE . 38.3 t -69.77 97.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.7 138.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.27 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -86.2 99.11 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.607 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.0 tp -49.5 123.57 7.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.396 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 200' ' ' ARG . 29.0 mt -89.44 -39.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.3 p30 -177.55 173.24 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.814 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.444 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 35.1 mtmt -123.28 55.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.39 -22.96 22.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -135.74 130.32 18.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.717 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.69 -21.81 20.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.643 2.229 . . . . 0.0 112.624 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -108.38 -36.38 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.929 ' CE3' HD12 ' A' ' 202' ' ' ILE . 20.6 m95 -103.02 110.55 22.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.486 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.0 m0 -106.38 140.82 38.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.944 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.83 149.59 22.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.416 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -153.79 159.28 28.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.74 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 111.181 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.61 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 174.36 159.67 21.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.015 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.929 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.3 151.8 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.747 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.597 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.8 p90 -165.55 151.2 8.31 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.65 111.47 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.264 1.976 . . . . 0.0 111.174 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.462 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.1 p -55.84 -21.54 20.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 111.197 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -17.75 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.494 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.29 17.87 12.04 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.292 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.597 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -148.7 -168.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 111.356 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.1 114.57 1.3 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.606 ' HA ' HG12 ' A' ' 159' ' ' VAL . 87.0 Cg_exo -47.2 124.39 8.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.463 2.109 . . . . 0.0 112.589 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 13.9 t80 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.544 ' HD2' HG12 ' A' ' 180' ' ' VAL . 84.9 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.816 0.341 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 210' ' ' PRO . 16.4 m -122.07 153.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.14 113.13 24.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.458 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.477 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -65.72 157.19 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.557 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.22 19.55 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.929 179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -170.23 140.26 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.68 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.99 137.17 53.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.443 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.2 t80 -129.06 109.78 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.944 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -110.87 79.2 1.79 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.09 115.99 3.86 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.54 2.16 . . . . 0.0 112.509 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -80.06 -26.45 39.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.91 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.33 170.69 12.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.5 m -89.93 148.83 22.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.75 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.414 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.4 130.97 39.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.745 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -77.84 147.88 34.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.805 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.597 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.58 112.25 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.5 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.528 ' CB ' HD11 ' A' ' 181' ' ' ILE . 1.6 p90 -131.3 155.57 46.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -112.31 172.12 7.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.467 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 135.83 57.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.226 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.52 23.7 55.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.885 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.44 123.24 30.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.345 . . . . 0.0 110.863 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.544 HG12 ' HD2' ' A' ' 158' ' ' PHE . 37.1 t -73.12 94.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.528 HD11 ' CB ' ' A' ' 175' ' ' PHE . 27.7 mt -89.98 143.04 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.4 m -90.82 98.63 11.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.502 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -50.03 124.4 10.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.52 HD12 ' CG ' ' A' ' 193' ' ' GLU . 25.1 mt -89.7 -39.51 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.594 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.2 p30 -177.76 172.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 46.9 mtmt -121.99 56.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.679 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -57.16 -21.72 34.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.139 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -137.09 121.61 12.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.667 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.79 -28.16 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.716 2.278 . . . . 0.0 112.949 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -102.78 -44.71 5.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.23 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.984 ' CE3' HD12 ' A' ' 202' ' ' ILE . 24.1 m95 -94.03 108.75 20.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.501 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.4 m0 -104.32 141.8 35.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.852 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.99 146.35 24.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.205 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.86 158.36 27.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.915 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.913 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.492 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.561 0.219 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.95 161.94 23.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.869 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.984 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -106.24 153.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.67 ' CD2' HD23 ' A' ' 173' ' ' LEU . 16.1 p90 -169.36 148.72 3.58 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.126 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.45 109.82 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.276 1.984 . . . . 0.0 111.384 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.0 p -54.35 -23.11 14.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.316 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -61.04 -16.13 40.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.29 22.19 6.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 205' ' ' SER . 4.1 m -149.87 -168.7 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.737 0.304 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.41 111.52 1.86 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.5 Cg_exo -47.86 121.73 6.21 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.4 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.961 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.864 0.364 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 25.8 m -106.64 152.02 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.067 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.46 112.84 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.97 155.71 33.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.536 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.478 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -114.86 -12.41 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.52 132.0 19.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.04 143.6 31.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.446 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 9.8 t80 -127.74 109.48 11.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.59 78.9 1.6 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.17 123.91 6.94 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.608 2.205 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -94.48 18.22 11.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -129.71 173.1 10.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 m -90.15 145.88 24.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.54 -34.45 5.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.391 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -93.64 134.35 36.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.668 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.61 147.94 29.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.654 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.539 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.34 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.8 p90 -133.52 152.96 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 111.209 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -103.22 -168.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -79.1 134.74 36.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.88 18.61 54.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -80.85 119.2 23.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.8 t -69.71 99.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.568 HG21 HD21 ' A' ' 173' ' ' LEU . 4.9 mt -93.99 140.6 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.326 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -87.41 100.87 13.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.517 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -51.21 123.77 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.421 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.564 HD13 ' HG2' ' A' ' 200' ' ' ARG . 31.2 mt -89.58 -39.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.625 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.35 172.18 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 33.0 mtmt -127.07 57.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.75 -22.02 61.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 1.6 t70 -132.78 117.22 15.05 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.17 -29.94 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.922 2.415 . . . . 0.0 113.168 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.49 -48.99 4.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' TRP . . . . . 0.994 ' CE3' HD12 ' A' ' 202' ' ' ILE . 28.0 m95 -89.82 108.11 19.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.117 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.534 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.0 m0 -104.68 142.46 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.966 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.831 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.87 145.52 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.248 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -149.95 158.92 27.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.729 0.3 . . . . 0.0 111.235 179.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.502 0.191 . . . . 0.0 110.494 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.78 161.25 23.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.91 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.994 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.5 pt -108.39 153.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . 0.557 ' CE1' HG11 ' A' ' 208' ' ' VAL . 15.5 p90 -170.03 151.91 4.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.37 106.89 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.188 1.925 . . . . 0.0 110.984 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.825 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.35 -23.46 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.037 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -51.74 -21.74 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 110.508 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.38 23.1 4.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.711 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 205' ' ' SER . 3.7 m -147.11 -167.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 111.625 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.21 110.02 1.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 87.6 Cg_exo -47.98 113.17 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.505 2.137 . . . . 0.0 112.532 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 20.5 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.0 mtt -131.95 169.65 16.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.5 -177.0 5.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 t -68.94 144.64 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -134.37 121.82 21.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -85.64 131.29 34.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.1 m -126.09 157.64 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.82 122.66 47.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.669 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -70.08 157.85 36.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.583 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.509 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -126.53 17.89 7.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.829 179.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.12 140.2 1.92 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.624 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.69 142.23 53.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.996 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.451 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 19.5 t80 -135.13 110.82 9.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.006 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -110.22 82.15 2.51 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.769 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.24 113.49 3.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.582 2.188 . . . . 0.0 112.327 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -76.49 -27.35 56.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.915 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -85.07 168.27 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 28.9 p -90.05 148.8 22.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.962 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.0 -35.05 4.99 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.406 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -91.15 137.35 32.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.746 0.308 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.45 149.44 31.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.639 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -99.39 112.74 24.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.557 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.728 ' CB ' HD11 ' A' ' 181' ' ' ILE . 6.7 p90 -133.82 160.37 37.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.375 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 13.8 mtmt -115.65 -168.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.657 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.18 133.38 37.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.85 19.07 58.21 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.011 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.736 ' CG ' HD21 ' A' ' 196' ' ' LEU . 46.0 t0 -84.35 128.11 34.38 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.908 0.385 . . . . 0.0 110.981 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.5 t -69.66 120.03 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.728 HD11 ' CB ' ' A' ' 175' ' ' PHE . 70.3 mt -120.71 113.96 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.0 111.309 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.4 m -70.15 108.65 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.411 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.696 HD21 ' HG3' ' A' ' 186' ' ' LYS . 29.6 tp -56.74 124.7 19.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.499 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.435 HD12 ' CG ' ' A' ' 193' ' ' GLU . 22.8 mt -89.37 -32.25 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.269 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 8.5 p30 -175.16 -171.73 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.685 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.696 ' HG3' HD21 ' A' ' 183' ' ' LEU . 27.3 mtmt -151.39 51.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.726 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.55 -39.86 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.654 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -121.77 130.32 24.8 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.009 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.26 -17.34 25.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.214 1.943 . . . . 0.0 111.89 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -94.45 -46.37 7.04 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.845 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.654 ' HB2' ' OD2' ' A' ' 188' ' ' ASP . 14.5 m95 -110.29 122.5 47.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.478 . . . . 0.0 111.188 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 46.2 m0 -114.05 141.14 47.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.844 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.1 tt0 -89.97 140.85 29.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.812 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.423 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -151.06 162.05 29.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.911 -1.137 . . . . 0.0 113.16 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.35 113.0 20.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.768 0.318 . . . . 0.0 110.942 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.736 HD21 ' CG ' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -72.73 63.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.088 0.47 . . . . 0.0 110.696 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 14.2 t30 63.99 14.72 8.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.468 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.94 -67.7 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.943 0.401 . . . . 0.0 111.154 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 130.85 42.54 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.485 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.424 ' HG2' HD13 ' A' ' 184' ' ' ILE . 4.7 mpt_? -97.67 165.8 11.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.457 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 169.33 161.02 18.91 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.061 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.556 HG23 ' OE2' ' A' ' 193' ' ' GLU . 3.8 pt -107.26 148.11 11.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.794 0.33 . . . . 0.0 110.776 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.866 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.9 p90 -170.39 164.0 5.86 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.03 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.53 117.88 4.82 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.355 2.036 . . . . 0.0 111.134 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.517 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.3 p -63.09 -17.01 61.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.703 0.287 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.82 -13.98 49.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.75 15.7 10.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.423 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' A' ' 162' ' ' LEU . 2.7 m -148.18 -171.02 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.087 0.47 . . . . 0.0 111.802 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.17 122.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.61 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.773 ' HA ' HG12 ' A' ' 159' ' ' VAL . 96.7 Cg_exo -44.78 128.0 8.53 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.733 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -106.26 -62.59 1.36 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.852 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -20.63 60.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.9 p -54.96 178.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.05 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.971 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.812 0.339 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 29.3 mtp -133.48 -77.51 0.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -111.28 135.75 51.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 8.9 t -89.77 121.73 32.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.817 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -131.85 131.76 43.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.831 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 158' ' ' PHE . 4.1 m-85 -107.08 137.46 45.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 210' ' ' PRO . 31.1 m -114.81 155.51 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.245 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.67 110.02 19.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.516 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -64.04 158.19 23.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.677 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -127.27 19.07 6.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.743 179.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.49 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.581 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.4 140.2 58.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -128.06 106.48 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -109.92 78.43 1.28 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.94 124.12 7.82 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.526 2.151 . . . . 0.0 112.419 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -93.75 17.44 11.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.111 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -131.42 173.97 10.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.845 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 29.7 p -90.04 146.26 24.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.41 -34.11 5.7 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -93.24 132.49 37.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.735 0.303 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.725 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -78.8 143.59 35.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.86 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.494 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.79 111.18 22.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -137.19 166.8 22.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 -168.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.732 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -76.22 136.96 39.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.027 0.441 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.87 18.19 52.92 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.601 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.788 ' OD1' HD21 ' A' ' 196' ' ' LEU . 58.1 t0 -76.97 114.73 16.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.751 0.31 . . . . 0.0 110.802 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.59 93.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.752 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 173' ' ' LEU . 4.4 mt -95.82 132.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.402 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -78.72 103.16 8.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.492 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.838 HD12 ' O ' ' A' ' 193' ' ' GLU . 37.7 tp -49.48 125.3 10.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.545 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.654 HG22 ' ND2' ' A' ' 185' ' ' ASN . 33.6 mt -89.65 -55.17 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.488 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.654 ' ND2' HG22 ' A' ' 184' ' ' ILE . 8.7 m-80 -153.59 166.15 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.573 ' HG3' HD21 ' A' ' 183' ' ' LEU . 49.2 mtmt -128.05 47.62 2.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.543 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.302 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -118.17 115.35 36.35 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.911 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -44.12 -28.19 2.19 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.654 2.236 . . . . 0.0 112.939 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -101.62 -44.97 5.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.19 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.993 ' CE3' HD12 ' A' ' 202' ' ' ILE . 17.9 m95 -95.61 113.44 25.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.249 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.526 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.8 m0 -109.58 141.72 41.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.838 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.85 145.24 25.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.152 179.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.47 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -146.96 160.15 28.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.197 -1.001 . . . . 0.0 113.035 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.31 143.33 46.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 0.0 111.095 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.788 HD21 ' OD1' ' A' ' 179' ' ' ASP . 6.3 mt -134.51 62.39 1.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.391 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.428 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.1 m-80 66.03 64.86 0.53 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.589 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 24.8 t30 82.69 11.81 0.54 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 196' ' ' LEU . 9.8 mmt180 -114.01 90.59 3.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.815 0.34 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.601 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -90.07 149.89 22.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.643 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.52 159.47 20.12 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.748 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.993 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -106.12 150.8 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.921 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.725 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.9 p90 -164.72 156.88 13.97 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.064 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.99 106.9 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.464 2.109 . . . . 0.0 111.298 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.662 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.7 p -52.69 -24.31 8.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 0.0 111.052 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.3 -17.9 45.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.741 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.06 23.73 6.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.996 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 205' ' ' SER . 6.0 m -149.27 -170.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 0.0 111.334 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.69 110.41 2.18 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.957 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.3 Cg_exo -48.31 124.86 11.15 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.472 2.115 . . . . 0.0 112.478 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 213' ' ' SER . 33.5 t80 -101.45 -68.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 58.65 50.01 9.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.763 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.427 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 0.3 OUTLIER 59.53 31.56 21.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.018 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.895 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.421 ' CE1' ' HB ' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.734 0.302 . . . . 0.0 111.189 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 62.6 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.76 117.13 27.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.983 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.421 ' HB ' ' CE1' ' A' ' 153' ' ' HIS . 8.7 t -86.43 131.75 34.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.87 158.08 42.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.68 ' CE1' HG23 ' A' ' 182' ' ' THR . 29.3 m-85 -142.19 111.4 6.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.895 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 26.7 m -107.13 151.77 8.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.085 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.37 114.54 27.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -64.73 153.73 38.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.499 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.473 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.36 -22.42 11.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.26 128.92 24.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.778 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.93 146.34 42.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.018 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.448 ' CB ' ' CZ ' ' A' ' 175' ' ' PHE . 59.9 t80 -137.6 117.95 13.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.3 87.95 4.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 64.8 Cg_endo -75.89 121.69 6.38 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.19 20.12 9.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -136.07 171.52 14.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 38.4 p -90.01 146.28 24.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.927 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.47 -34.01 5.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.378 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -96.99 136.93 36.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.702 0.286 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.847 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -82.21 145.96 29.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.81 -179.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.04 108.45 20.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.643 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 181' ' ' ILE . 11.6 p90 -122.91 158.32 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.333 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.642 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 18.8 mttm -117.91 -175.53 2.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.513 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.11 132.08 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.929 0.395 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.96 18.02 53.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.61 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -79.98 117.95 21.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.712 0.291 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.3 t -69.68 96.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.756 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 175' ' ' PHE . 4.8 mt -95.55 122.29 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.432 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.68 HG23 ' CE1' ' A' ' 158' ' ' PHE . 1.3 m -72.83 103.23 3.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' O ' ' A' ' 193' ' ' GLU . 38.5 tp -51.04 125.69 14.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.311 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.687 HG22 ' ND2' ' A' ' 185' ' ' ASN . 28.5 mt -89.37 -55.42 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.687 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.5 m-80 -155.47 165.7 35.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.725 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 34.9 mtmt -126.28 50.28 1.91 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.581 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -56.18 -25.74 47.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.374 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 10.6 t70 -124.53 127.01 25.34 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.55 -22.01 20.65 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.523 2.149 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 10.6 m120 -108.57 -36.35 6.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 111.214 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.922 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.5 m95 -103.23 110.95 23.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.539 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.5 m0 -106.55 141.85 37.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.993 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.722 ' O ' HD12 ' A' ' 183' ' ' LEU . 3.3 tt0 -89.59 138.57 31.35 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.437 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -142.87 159.48 27.36 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.181 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 20.5 tt0 -114.54 149.38 36.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.12 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.702 HD23 HG12 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -140.32 96.54 3.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.771 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 76.23 -62.6 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -164.61 29.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.37 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.9 OUTLIER -125.94 162.15 25.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.826 0.346 . . . . 0.0 110.852 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.643 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -129.11 150.09 50.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.639 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . -179.27 159.24 23.85 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.257 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.922 HD12 ' CE3' ' A' ' 191' ' ' TRP . 3.8 pt -112.83 149.93 15.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.677 0.275 . . . . 0.0 110.707 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.847 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.35 162.75 6.2 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.178 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 34.6 Cg_exo -59.82 108.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.362 2.041 . . . . 0.0 111.339 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.637 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.0 OUTLIER -57.04 -20.86 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.143 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -62.15 -13.71 29.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.049 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -90.98 19.35 5.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.38 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 205' ' ' SER . 4.4 m -147.0 -171.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.4 112.4 2.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.705 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 80.8 Cg_exo -46.52 118.43 2.56 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.534 2.156 . . . . 0.0 112.636 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -98.88 -65.67 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.898 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 61.77 74.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.637 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 18.8 p -58.27 137.3 57.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.031 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.5 p30 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.933 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.8 p80 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.783 0.325 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 13.3 mtm 62.24 117.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.008 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -161.15 129.67 4.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.646 HG21 ' OD1' ' A' ' 212' ' ' ASN . 0.2 OUTLIER -88.38 107.67 18.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.98 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -139.86 40.0 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.993 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.518 ' CE1' HG23 ' A' ' 182' ' ' THR . 46.5 m-85 -80.66 137.7 36.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.888 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 210' ' ' PRO . 5.5 m -127.52 156.25 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.134 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.55 114.81 26.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.639 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.63 157.26 34.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.508 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -128.45 19.73 6.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.778 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -170.28 140.24 1.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -69.91 142.34 52.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.917 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.45 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.8 t80 -132.68 112.48 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.979 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -110.31 84.72 3.96 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.16 115.43 3.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.521 2.147 . . . . 0.0 112.491 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -79.73 -26.3 40.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -96.85 175.14 6.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 80.4 p -90.1 151.77 21.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.65 -36.05 4.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.392 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -96.84 133.76 41.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.292 . . . . 0.0 110.737 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.735 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.65 144.88 39.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.906 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -95.87 111.82 23.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.536 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.7 p90 -134.97 -179.83 5.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.42 . . . . 0.0 111.357 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 6.6 pttp -131.17 -170.81 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.754 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -75.46 139.76 42.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.038 0.447 . . . . 0.0 111.463 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 55.85 21.26 29.39 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.17 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' OD2' HD11 ' A' ' 196' ' ' LEU . 0.4 OUTLIER -84.56 122.33 28.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.956 0.408 . . . . 0.0 110.75 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 25.2 t -70.3 103.59 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 20.7 mt -102.72 127.98 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.394 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.518 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.2 m -79.33 100.3 7.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.354 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.81 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -49.1 127.68 14.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.607 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.633 HD12 ' HG2' ' A' ' 193' ' ' GLU . 31.9 mt -89.55 -36.42 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.461 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.1 p30 -176.55 154.85 1.3 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.81 ' HG3' HD21 ' A' ' 183' ' ' LEU . 44.4 mtmt -115.18 44.02 1.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.717 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -48.34 -31.09 5.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 111.068 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.664 ' OD2' ' HB2' ' A' ' 191' ' ' TRP . 0.0 OUTLIER -128.21 127.14 23.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.036 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.89 -14.84 24.24 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.275 1.984 . . . . 0.0 112.185 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -97.63 -44.26 6.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.782 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.6 m95 -115.24 112.41 22.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.228 0.537 . . . . 0.0 111.508 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.502 ' HB3' HD11 ' A' ' 183' ' ' LEU . 46.6 m0 -101.01 136.82 40.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.547 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.633 ' HG2' HD12 ' A' ' 184' ' ' ILE . 1.9 tt0 -88.79 146.13 25.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.5 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.4 161.96 28.58 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 119.951 -1.118 . . . . 0.0 113.463 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.408 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.0 OUTLIER -120.77 128.7 53.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.956 0.407 . . . . 0.0 110.869 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.483 HD11 ' OD2' ' A' ' 179' ' ' ASP . 0.5 OUTLIER -116.96 59.53 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.536 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.4 t-20 67.93 65.98 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.342 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 10.6 t-20 83.3 10.85 0.5 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.956 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -113.3 90.42 3.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.511 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.0 mtp180 -89.61 147.4 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.659 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.629 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.03 156.6 12.43 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.218 -0.991 . . . . 0.0 112.932 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.782 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -102.94 149.78 6.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.907 0.384 . . . . 0.0 110.804 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.735 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.0 p90 -162.61 157.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.042 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -61.57 113.36 1.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.251 1.967 . . . . 0.0 110.911 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 208' ' ' VAL . 3.7 p -59.4 -19.61 48.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 111.35 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -65.53 -14.49 61.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.399 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 20.47 9.22 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.183 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.539 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -150.02 -167.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.49 114.65 1.25 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.97 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.7 Cg_exo -48.03 125.19 11.26 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.611 2.207 . . . . 0.0 112.459 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -99.94 -68.71 0.8 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.646 ' OD1' HG21 ' A' ' 156' ' ' THR . 49.9 t-20 61.75 74.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.629 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.23 -31.52 67.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.884 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' 153' ' ' HIS . 8.9 p-80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.876 0.37 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 47.2 mtm -85.38 -77.26 0.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -106.84 102.99 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.5 103.01 15.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.004 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.695 ' HE3' HD23 ' A' ' 183' ' ' LEU . 39.1 mtmt -147.48 105.0 3.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.948 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -110.63 125.95 53.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 23.1 m -110.26 150.9 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.041 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.55 114.53 27.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -66.39 157.71 31.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.552 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.452 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -125.51 24.51 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.623 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -170.18 178.67 3.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.721 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -100.16 138.0 37.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.853 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 2.0 t80 -125.84 105.37 8.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -109.67 78.59 1.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.408 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 70.2 Cg_endo -75.93 115.76 4.24 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.64 2.227 . . . . 0.0 112.551 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -79.84 -26.58 40.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -92.38 172.97 8.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 70.1 m -90.11 150.89 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.98 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.63 -36.3 4.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.347 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 4.9 mt-10 -93.35 136.14 33.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.707 0.289 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.659 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -80.66 147.03 30.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.704 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.519 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.43 113.84 25.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.715 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -141.15 163.37 33.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.958 0.408 . . . . 0.0 111.087 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 0.0 OUTLIER -123.25 -176.56 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.807 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.36 139.48 57.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.27 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.02 21.01 44.21 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.625 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.829 ' OD2' HD11 ' A' ' 196' ' ' LEU . 8.3 t70 -78.32 109.66 12.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.674 0.273 . . . . 0.0 111.022 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.7 94.7 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.602 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.612 HG21 ' CD2' ' A' ' 173' ' ' LEU . 10.5 mt -95.53 135.01 30.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.433 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 m -81.43 102.99 10.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.811 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.1 tp -51.03 122.42 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.457 HD12 ' CG ' ' A' ' 193' ' ' GLU . 28.4 mt -89.49 -36.31 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.75 174.65 0.82 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.551 ' HE2' HD21 ' A' ' 183' ' ' LEU . 21.3 mttt -123.16 66.14 0.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.705 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.59 -19.44 38.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.112 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 14.2 t70 -150.61 132.94 8.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.685 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -47.13 -25.68 4.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.861 2.374 . . . . 0.0 112.76 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -102.44 -44.64 5.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.887 0.375 . . . . 0.0 111.358 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.909 ' CE3' HD12 ' A' ' 202' ' ' ILE . 32.5 m95 -94.19 110.57 22.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.325 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.466 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -108.5 141.33 40.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.811 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.76 144.87 25.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.11 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -150.11 158.25 27.58 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.766 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -120.63 110.02 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.887 0.375 . . . . 0.0 111.201 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.829 HD11 ' OD2' ' A' ' 179' ' ' ASP . 0.7 OUTLIER -84.42 87.08 7.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.527 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 14.7 t30 76.59 -60.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -143.08 -40.38 0.32 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.503 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ptm85 -69.81 140.52 53.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.262 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.445 ' HG2' HD13 ' A' ' 184' ' ' ILE . 3.9 mpt_? -109.58 161.03 15.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.568 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.88 162.31 24.76 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.02 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.909 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -107.66 154.3 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.766 0.317 . . . . 0.0 110.743 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.623 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.6 p90 -170.09 149.45 3.33 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.065 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 24.3 Cg_exo -62.76 107.09 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.22 1.947 . . . . 0.0 110.906 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.759 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -52.26 -22.54 4.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.313 -179.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -53.01 -19.85 3.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.765 0.317 . . . . 0.0 110.47 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.24 21.95 7.34 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.78 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -147.2 -167.4 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.932 0.396 . . . . 0.0 111.724 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.24 111.98 1.02 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 85.9 Cg_exo -46.48 115.11 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.504 2.136 . . . . 0.0 112.683 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -93.25 -66.15 0.94 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.835 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -84.2 -31.66 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.77 80.61 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.832 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.913 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.9 p80 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 7.7 mtm -144.2 -170.09 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.76 119.19 21.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.8 t -78.87 139.75 38.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -138.03 168.77 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -146.65 134.53 21.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 210' ' ' PRO . 6.0 m -129.83 153.6 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.23 115.28 26.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.31 154.05 39.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.391 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.462 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.48 13.92 22.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.312 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' N ' ' HG2' ' A' ' 177' ' ' ARG . 0.1 OUTLIER -170.05 -164.23 0.4 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.835 0.35 . . . . 0.0 110.882 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -114.94 145.9 41.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.444 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 20.8 t80 -135.75 115.13 12.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -111.88 85.83 6.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.684 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 113.79 3.74 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.651 2.234 . . . . 0.0 112.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.87 -27.4 55.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.884 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -96.07 174.15 7.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.836 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 74.5 m -90.08 151.51 21.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 113.23 -36.84 3.87 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.318 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.01 132.45 39.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 0.0 110.739 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.72 143.42 42.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.761 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.564 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.66 113.65 25.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.439 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.3 p90 -134.14 177.38 7.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.413 . . . . 0.0 111.497 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 8.6 mttt -128.77 -175.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.811 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -69.66 140.56 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.683 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 51.57 25.06 13.17 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.872 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.29 123.27 30.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 36.3 t -72.62 102.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 19.8 mt -96.89 142.48 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.434 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.5 m -90.17 99.21 12.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.393 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.4 tp -50.3 123.18 8.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.595 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.618 HG22 ' ND2' ' A' ' 185' ' ' ASN . 22.4 mt -89.71 -54.06 8.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.42 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.618 ' ND2' HG22 ' A' ' 184' ' ' ILE . 7.2 m-80 -153.93 166.35 33.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.669 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.544 ' HG3' HD21 ' A' ' 183' ' ' LEU . 50.3 mtmt -128.88 48.79 2.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.621 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.73 -27.3 66.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.38 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -119.31 115.77 34.09 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.926 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -44.32 -28.08 2.32 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.563 2.176 . . . . 0.0 112.859 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -102.01 -44.5 5.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.234 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.954 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.4 m95 -95.57 112.11 23.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.231 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.5 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.7 m0 -108.29 142.53 38.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.953 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -90.82 144.16 25.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.087 179.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -149.7 158.04 27.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.969 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -120.1 100.8 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.688 0.28 . . . . 0.0 111.253 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.448 HD22 ' OD1' ' A' ' 197' ' ' ASN . 0.7 OUTLIER -81.0 94.58 6.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.576 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.448 ' OD1' HD22 ' A' ' 196' ' ' LEU . 4.3 m120 76.61 -59.87 0.49 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -150.29 -38.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.477 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -69.43 136.08 51.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 111.292 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.468 ' HG2' HD13 ' A' ' 184' ' ' ILE . 2.3 mpt_? -106.54 162.47 13.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.523 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.624 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.14 161.42 20.61 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.937 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.954 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -103.98 152.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.826 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.734 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.2 p90 -167.71 154.99 7.99 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.97 107.85 0.68 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.3 2.0 . . . . 0.0 111.337 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.631 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.2 p -53.18 -24.55 11.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -16.2 43.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.646 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . 0.411 ' HB3' ' CE1' ' A' ' 163' ' ' PHE . 0.4 OUTLIER -93.88 21.56 6.48 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.215 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -148.6 -167.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.777 0.322 . . . . 0.0 111.407 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.52 111.95 1.85 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.611 ' HA ' HG12 ' A' ' 159' ' ' VAL . 76.8 Cg_exo -48.49 121.9 7.02 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.547 2.165 . . . . 0.0 112.44 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -96.35 -68.82 0.78 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 61.73 74.61 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.543 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 140.69 53.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.067 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 52.6 t30 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.914 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 8.1 mtp -106.28 178.6 4.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -166.08 112.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 t -69.25 108.41 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.8 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.424 ' CB ' ' HB3' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -94.18 153.46 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.812 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.705 ' O ' HG13 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -127.71 163.54 24.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.689 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 158' ' ' PHE . 0.2 OUTLIER -166.8 123.29 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.942 0.401 . . . . 0.0 111.477 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -102.26 123.83 46.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.252 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -73.99 148.33 42.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.721 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -117.16 14.5 14.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.812 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.25 140.16 1.85 Allowed 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.738 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 145.21 56.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.899 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.454 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 4.9 t80 -133.66 112.51 11.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.77 87.21 5.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.788 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.7 116.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.562 2.175 . . . . 0.0 112.46 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -80.94 -26.06 36.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.817 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -96.26 172.69 7.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 88.6 p -90.05 150.56 22.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 111.5 -35.44 4.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.409 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.47 133.42 36.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.792 0.329 . . . . 0.0 110.786 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.809 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -75.68 140.79 42.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.837 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.49 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.97 114.49 26.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.165 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.454 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 1.7 p90 -133.29 -178.22 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 111.607 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -126.05 -174.19 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.83 140.08 42.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.264 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 56.03 21.85 32.96 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.804 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.87 124.95 31.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.684 HG11 ' HA ' ' A' ' 213' ' ' SER . 10.0 t -74.89 119.56 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.871 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.678 ' HB ' HG23 ' A' ' 159' ' ' VAL . 5.0 mt -119.81 155.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.964 0.412 . . . . 0.0 111.601 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.464 ' N ' HG22 ' A' ' 181' ' ' ILE . 2.0 m -103.36 104.45 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.359 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.8 HD12 ' O ' ' A' ' 193' ' ' GLU . 31.6 tp -50.11 124.63 10.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.517 HD12 ' CG ' ' A' ' 193' ' ' GLU . 27.3 mt -89.5 -38.49 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.537 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.67 174.35 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.802 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.438 ' HG2' ' CG ' ' A' ' 192' ' ' TRP . 44.9 mtmt -126.16 59.77 1.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.802 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.7 -19.75 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 24.3 t0 -137.05 122.12 12.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -44.42 -28.02 2.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.715 2.277 . . . . 0.0 112.902 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -102.78 -44.14 5.37 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.286 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.981 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.8 m95 -94.8 110.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.505 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.1 m0 -105.82 141.96 36.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.063 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.8 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.79 143.47 26.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.081 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.455 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -147.86 158.43 27.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.129 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.42 90.06 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.99 86.04 0.53 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.608 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 77.68 -59.73 0.45 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.149 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -146.33 -39.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.549 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -69.57 134.86 49.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.323 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.501 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -107.2 158.12 17.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.598 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.635 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.57 162.84 24.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.822 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.981 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.8 pt -104.96 151.9 7.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 0.0 110.762 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.809 ' CD2' HD23 ' A' ' 173' ' ' LEU . 14.8 p90 -167.5 159.09 10.11 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.093 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -64.91 108.78 1.16 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.329 2.019 . . . . 0.0 111.148 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.47 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.3 p -53.32 -24.23 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -58.38 -19.66 37.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.807 0.337 . . . . 0.0 110.634 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 163' ' ' PHE . 1.1 m-85 -90.9 14.26 14.24 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.467 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.0 m -149.45 -166.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 111.263 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.526 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -177.74 125.38 0.28 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.895 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -43.25 129.43 6.15 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.769 2.312 . . . . 0.0 112.705 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.509 ' CG ' ' N ' ' A' ' 212' ' ' ASN . 1.0 OUTLIER -131.0 -83.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.943 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 211' ' ' TYR . 1.0 OUTLIER 176.3 104.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.843 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.684 ' HA ' HG11 ' A' ' 180' ' ' VAL . 4.2 m -95.3 -31.71 13.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.798 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.737 0.303 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.431 ' HE2' ' HA ' ' A' ' 154' ' ' MET . 0.0 OUTLIER -60.32 -177.6 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 133.5 8.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 164.29 15.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.99 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -90.06 139.59 30.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.574 ' CD1' HG12 ' A' ' 180' ' ' VAL . 32.4 m-85 -108.32 123.55 48.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 181' ' ' ILE . 26.8 m -112.54 150.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.23 113.88 26.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.96 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -66.73 154.62 40.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.486 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.449 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -120.3 27.67 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.546 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.14 -169.96 0.92 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.68 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -127.37 129.72 48.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.811 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.454 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 36.5 t80 -131.94 128.6 38.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -122.41 88.47 49.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.94 119.49 5.69 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.525 2.15 . . . . 0.0 112.419 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -87.4 -23.36 24.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -103.04 158.47 16.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.788 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 54.8 m -78.73 122.48 26.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.813 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 148.19 -20.58 1.39 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.441 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -126.49 139.26 53.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.734 0.302 . . . . 0.0 110.814 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.764 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -76.74 150.22 36.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.86 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.749 ' HB3' ' NH1' ' A' ' 199' ' ' ARG . . . -97.89 110.15 22.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.453 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 181' ' ' ILE . 12.7 p90 -124.13 166.59 15.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.9 mtpp -129.49 174.8 9.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.6 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.32 131.97 48.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.945 0.402 . . . . 0.0 110.926 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.18 19.04 44.37 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.513 ' OD2' HD11 ' A' ' 196' ' ' LEU . 60.4 t0 -81.21 117.88 22.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.828 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.574 HG12 ' CD1' ' A' ' 158' ' ' PHE . 38.8 t -69.42 92.46 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.557 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.73 HG23 ' O ' ' A' ' 195' ' ' GLN . 3.4 mt -92.27 124.91 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.3 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 m -69.97 99.74 1.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.369 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.883 HD21 ' HG3' ' A' ' 186' ' ' LYS . 32.7 tp -49.82 119.96 3.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.591 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.579 HD13 ' CG ' ' A' ' 200' ' ' ARG . 12.8 mt -93.73 -41.25 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.634 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 193' ' ' GLU . 0.3 OUTLIER -143.49 158.94 43.25 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.883 ' HG3' HD21 ' A' ' 183' ' ' LEU . 9.8 mttt -138.36 15.59 2.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.539 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -49.58 -36.81 25.2 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.288 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 191' ' ' TRP . 0.4 OUTLIER -107.35 105.99 57.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.598 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -42.69 -28.8 1.19 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.764 2.309 . . . . 0.0 112.942 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 9.3 m120 -97.31 -38.5 9.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.149 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.438 ' CZ3' ' HA ' ' A' ' 203' ' ' PHE . 17.2 m95 -110.5 107.8 17.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.688 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.823 ' HB3' HD11 ' A' ' 183' ' ' LEU . 53.9 m0 -108.51 149.45 28.8 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.278 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.753 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.3 tp10 -89.94 148.98 22.79 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -148.7 157.12 27.16 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.044 -1.074 . . . . 0.0 113.33 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 181' ' ' ILE . 20.5 tt0 -110.12 149.15 30.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.917 0.389 . . . . 0.0 111.311 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 181' ' ' ILE . 0.2 OUTLIER -160.31 101.6 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.514 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 1.9 t-20 78.41 31.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.936 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 197' ' ' ASN . 13.2 m-20 82.01 5.44 1.16 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.382 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.749 ' NH1' ' HB3' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -95.76 168.37 10.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.763 0.316 . . . . 0.0 111.027 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.579 ' CG ' HD13 ' A' ' 184' ' ' ILE . 4.3 mpt_? -131.4 151.56 51.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.624 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.609 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.95 158.12 20.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.169 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.682 HG23 ' CD ' ' A' ' 193' ' ' GLU . 8.0 pt -111.38 151.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.738 0.304 . . . . 0.0 110.91 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.764 ' CE1' HD23 ' A' ' 173' ' ' LEU . 2.1 p90 -170.07 164.87 5.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.12 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 31.7 Cg_exo -58.57 108.07 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.517 2.144 . . . . 0.0 111.779 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.584 ' O ' HG22 ' A' ' 208' ' ' VAL . 1.4 p -57.93 -21.29 43.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.122 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -62.88 -14.03 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.792 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -91.29 20.35 5.23 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.455 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 205' ' ' SER . 3.3 m -149.13 -169.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.39 111.79 1.37 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.735 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 86.7 Cg_exo -46.6 114.45 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.521 2.147 . . . . 0.0 112.529 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 213' ' ' SER . 18.3 t80 -92.86 -66.34 0.93 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.825 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 47.4 t30 55.39 39.34 31.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.938 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.42 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 0.7 OUTLIER 58.89 31.34 21.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.906 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.767 0.318 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.44 178.76 5.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.977 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.75 137.5 16.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.77 134.17 34.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.052 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.43 111.9 5.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.09 152.52 50.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.814 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 12.9 m -143.34 157.02 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -119.11 117.83 29.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -67.75 147.57 52.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.85 -20.04 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.884 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -133.94 -175.29 3.79 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.636 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -105.1 148.78 26.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.078 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.455 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 6.8 t80 -133.12 110.94 10.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.955 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -112.42 79.81 3.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.735 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.412 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 76.3 Cg_endo -81.11 120.93 3.83 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.644 2.229 . . . . 0.0 112.481 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -81.42 -23.53 37.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.83 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -88.01 169.98 11.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.853 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.18 148.5 22.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.59 -35.13 4.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.322 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 2.6 mt-10 -90.26 126.86 35.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.837 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.054 HD21 HD13 ' A' ' 181' ' ' ILE . 0.1 OUTLIER -69.66 144.44 52.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.85 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.643 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.86 107.95 20.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.494 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.471 ' CD2' HD11 ' A' ' 181' ' ' ILE . 2.0 p90 -136.67 159.8 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.336 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -117.71 -167.15 1.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.633 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.94 138.77 54.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 110.888 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.45 17.03 56.09 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.501 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -73.1 109.67 6.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.303 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.41 101.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.369 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 1.054 HD13 HD21 ' A' ' 173' ' ' LEU . 3.4 mt -100.79 140.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.094 0.474 . . . . 0.0 111.738 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.7 m -92.62 99.79 12.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.238 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 193' ' ' GLU . 20.7 tp -46.31 119.1 2.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.115 0.483 . . . . 0.0 111.467 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.484 HD12 ' CG ' ' A' ' 193' ' ' GLU . 19.7 mt -89.64 -37.77 10.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.7 p30 -177.91 171.2 1.81 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.778 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 192' ' ' TRP . 32.5 mtmt -122.75 57.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -56.65 -21.64 28.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 37.2 t70 -137.05 129.48 17.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.789 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.99 -23.35 16.57 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.574 2.183 . . . . 0.0 112.724 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.5 m120 -106.6 -38.24 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.196 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.78 ' CE3' HD12 ' A' ' 202' ' ' ILE . 15.3 m95 -100.94 111.67 23.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.045 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.477 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.1 m0 -107.07 144.61 33.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.806 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -93.49 145.41 24.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.061 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.411 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -155.05 157.14 27.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.052 -1.071 . . . . 0.0 113.021 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 49.6 tt0 -120.51 135.6 55.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.649 HD23 HG23 ' A' ' 181' ' ' ILE . 14.0 mt -92.66 -157.4 0.53 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -47.1 -27.87 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.409 . . . . 0.0 110.682 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -178.41 35.93 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.838 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -135.83 119.04 16.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.979 -179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.473 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -100.99 155.68 17.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.694 179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.602 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 170.07 162.16 21.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.81 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.78 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.7 pt -99.3 152.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.784 0.326 . . . . 0.0 110.549 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.864 ' CD2' HD23 ' A' ' 173' ' ' LEU . 24.8 p90 -167.66 159.45 9.93 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.992 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 203' ' ' PHE . 45.2 Cg_endo -68.53 110.99 2.42 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.166 1.911 . . . . 0.0 111.299 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.469 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.7 p -55.3 -23.18 22.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.218 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.3 -16.94 50.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -93.68 17.93 10.99 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.261 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.495 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.6 m -149.59 -168.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 111.526 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.414 ' N ' HG23 ' A' ' 208' ' ' VAL . . . -165.47 122.75 1.07 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.9 Cg_exo -46.56 128.58 12.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.164 . . . . 0.0 112.569 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.39 -67.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.0 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -59.01 -31.6 68.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 12.9 p 58.72 176.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.964 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.337 -0.839 . . . . 0.0 110.973 179.85 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.782 0.325 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 11.5 mmm 62.26 118.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -161.94 108.71 1.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.26 105.6 17.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.631 ' HG2' HD23 ' A' ' 183' ' ' LEU . 16.7 tptt -134.64 110.03 9.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -135.9 134.96 39.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 19.5 m -120.04 154.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.165 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.6 113.01 23.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.792 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -65.66 157.61 29.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.473 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.457 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.42 20.77 7.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.727 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 207' ' ' TYR . 0.3 OUTLIER -170.21 139.37 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.651 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.42 138.33 57.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 3.4 t80 -125.45 105.6 9.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -109.54 78.04 1.09 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.05 124.4 8.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -93.76 17.2 12.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.12 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.68 173.52 11.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.08 146.66 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.08 -34.52 5.38 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.383 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -93.86 135.4 35.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.332 . . . . 0.0 110.768 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.14 144.63 31.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.894 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.567 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.7 109.9 21.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.559 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.0 p90 -135.88 161.64 35.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.54 -166.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -78.59 136.13 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.29 16.81 54.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.75 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.839 ' CG ' HD21 ' A' ' 196' ' ' LEU . 65.6 t0 -78.49 118.25 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.729 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.55 100.47 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.875 HG12 HD23 ' A' ' 196' ' ' LEU . 3.6 mt -99.97 124.48 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.375 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.8 m -72.91 105.14 4.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.442 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.5 tp -51.04 123.63 9.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.374 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.74 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.8 mt -89.64 -53.82 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.507 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.718 ' ND2' HG22 ' A' ' 184' ' ' ILE . 6.1 m-80 -156.2 166.29 33.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 25.8 mtmt -126.91 50.45 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.579 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -55.39 -26.81 43.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 17.3 t70 -124.54 124.89 25.65 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.703 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 188' ' ' ASP . 8.3 Cg_endo -50.05 -23.91 10.05 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.183 . . . . 0.0 112.726 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 204' ' ' PRO . 8.2 m120 -106.56 -40.0 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.88 0.371 . . . . 0.0 111.323 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.971 ' CE3' HD12 ' A' ' 202' ' ' ILE . 19.3 m95 -98.16 109.7 22.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.273 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.551 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.8 m0 -107.46 142.73 36.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.026 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.815 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.99 147.0 23.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.877 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -153.38 159.67 28.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.054 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 199' ' ' ARG . 2.5 tt0 -112.01 134.45 53.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 110.969 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.875 HD23 HG12 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -112.66 72.1 0.76 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.812 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 196' ' ' LEU . 1.8 t-20 86.86 -28.13 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.637 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -177.55 -36.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.325 . . . . 0.0 111.271 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 0.0 OUTLIER -69.64 151.2 46.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.163 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.74 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -117.09 152.82 33.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.366 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 176.89 159.61 22.53 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 119.957 -1.116 . . . . 0.0 113.24 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.971 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -108.0 151.43 10.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.864 0.364 . . . . 0.0 110.778 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.632 ' CD2' HD23 ' A' ' 173' ' ' LEU . 13.2 p90 -165.12 155.55 12.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 190' ' ' ASN . 16.9 Cg_exo -66.59 105.97 1.0 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.364 2.042 . . . . 0.0 110.991 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.794 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.29 -24.51 4.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.337 . . . . 0.0 110.962 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -52.38 -21.32 3.48 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.895 0.379 . . . . 0.0 110.466 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -93.8 22.31 5.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.909 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 205' ' ' SER . 3.4 m -146.71 -169.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.997 0.427 . . . . 0.0 111.747 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.18 111.53 1.26 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.797 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 83.8 Cg_exo -47.0 124.6 8.98 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 112.553 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -103.52 -63.51 1.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.077 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -73.4 -20.01 60.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.161 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 11.0 p -54.51 -31.34 55.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.895 0.378 . . . . 0.0 111.057 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.9 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.4 p80 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.817 0.342 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtm -147.58 -77.35 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -121.23 99.78 6.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.936 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 t -83.14 153.32 24.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.885 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -150.03 130.66 14.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.935 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.854 ' CE1' HG23 ' A' ' 182' ' ' THR . 7.6 m-85 -118.8 -176.87 3.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 27.8 m -158.02 157.41 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.138 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -118.44 117.21 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 176' ' ' LYS . . . -67.14 152.19 46.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.507 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.498 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -109.56 -22.1 12.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.874 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -139.12 145.35 39.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.686 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.94 147.36 51.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.02 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.445 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 28.0 t80 -136.11 116.14 13.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -108.78 88.64 5.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.767 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.09 119.42 5.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.626 2.218 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -96.24 22.14 8.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.988 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -135.19 171.67 14.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.826 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 78.1 p -90.08 142.68 27.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 105.98 -32.21 7.61 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.16 134.15 34.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 0.0 110.786 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.852 HD23 ' CE1' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -81.33 148.36 29.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.002 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.688 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -101.05 112.41 24.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.512 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 203' ' ' PHE . 6.5 p90 -127.82 162.0 27.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 0.0 111.272 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 19.4 mmmt -117.99 -167.56 1.37 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.73 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.55 133.73 36.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.56 17.62 54.08 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.41 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -79.77 115.42 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.738 HG12 ' HD2' ' A' ' 158' ' ' PHE . 3.4 t -69.63 103.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.404 HG23 ' HG ' ' A' ' 196' ' ' LEU . 15.3 mt -98.61 144.8 11.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.488 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.854 HG23 ' CE1' ' A' ' 158' ' ' PHE . 3.3 m -93.74 95.95 9.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.478 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 193' ' ' GLU . 33.3 tp -47.13 124.34 6.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.637 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.545 HD12 ' CG ' ' A' ' 193' ' ' GLU . 31.4 mt -89.31 -39.78 12.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.655 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.94 172.68 1.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.875 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.443 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 44.3 mtmt -124.77 58.46 1.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.776 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -59.93 -20.49 57.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.27 119.52 13.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.658 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.17 -28.98 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.724 2.283 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -101.42 -46.48 4.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.952 0.406 . . . . 0.0 111.29 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.63 ' CE3' HD12 ' A' ' 202' ' ' ILE . 13.6 m95 -92.7 110.42 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.323 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.555 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.5 m0 -105.35 142.38 35.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.788 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 183' ' ' LEU . 1.0 OUTLIER -89.78 143.16 27.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.907 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.508 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -144.77 158.12 27.49 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.232 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.403 ' CG ' ' HG3' ' A' ' 200' ' ' ARG . 0.7 OUTLIER -128.49 109.05 11.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.259 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.404 ' HG ' HG23 ' A' ' 181' ' ' ILE . 12.5 mt -88.89 75.57 8.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.257 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.5 m120 73.78 -62.02 0.48 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.491 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -146.06 29.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.618 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.91 97.97 4.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.403 ' HG3' ' CG ' ' A' ' 195' ' ' GLN . 1.4 mpt_? -89.72 149.92 22.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.432 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.625 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 172.34 163.17 25.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.136 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.63 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.1 pt -111.38 148.17 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.941 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.852 ' CE1' HD23 ' A' ' 173' ' ' LEU . 3.6 p90 -170.18 163.52 6.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.078 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.24 111.41 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 111.525 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.611 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.7 OUTLIER -56.2 -21.15 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.233 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -59.11 -15.85 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.087 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -91.23 21.15 4.55 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 205' ' ' SER . 4.2 m -149.99 -171.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 111.718 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.84 115.04 1.83 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.499 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 68.5 Cg_exo -43.16 129.66 6.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.669 2.246 . . . . 0.0 112.899 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 212' ' ' ASN . 35.1 t80 -93.76 -78.92 0.42 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.688 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 214' ' ' ASN . 63.8 t30 178.91 35.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.324 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 158' ' ' PHE . 0.4 OUTLIER 64.94 -74.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.912 0.387 . . . . 0.0 111.089 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 212' ' ' ASN . 34.8 t30 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t60 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.919 0.39 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 10.9 mtm 60.37 19.66 9.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.203 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -94.46 97.72 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.82 0.343 . . . . 0.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.585 ' OG1' HG22 ' A' ' 182' ' ' THR . 9.6 t -74.1 131.18 41.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.834 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -106.96 124.85 50.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -89.12 142.43 27.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.672 HG12 ' HA ' ' A' ' 210' ' ' PRO . 4.3 m -124.72 156.2 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -114.61 118.85 34.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -72.39 150.22 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.417 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -110.83 -18.21 13.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.052 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.55 129.88 19.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.702 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.95 152.81 22.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.441 ' HB3' ' CE1' ' A' ' 175' ' ' PHE . 53.0 t80 -139.8 120.32 14.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -108.76 87.45 4.46 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.735 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 63.2 Cg_endo -75.95 121.15 6.06 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.581 2.187 . . . . 0.0 112.376 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -95.79 20.74 9.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.074 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -139.51 172.72 12.39 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.02 146.47 24.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.022 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.65 5.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.366 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -95.67 134.65 38.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.761 0.315 . . . . 0.0 110.778 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.743 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -79.0 145.28 34.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.931 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -96.83 113.94 25.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.348 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.6 p90 -133.0 175.28 9.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.431 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -128.52 -169.86 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.664 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 7.1 mtm-85 -76.32 139.59 41.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.072 0.463 . . . . 0.0 111.353 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.47 20.18 36.76 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.819 ' OD2' HD11 ' A' ' 196' ' ' LEU . 0.6 OUTLIER -83.82 121.57 27.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.348 . . . . 0.0 110.809 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.9 t -71.68 104.04 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 18.1 mt -99.96 137.77 26.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.394 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.585 HG22 ' OG1' ' A' ' 156' ' ' THR . 1.0 OUTLIER -90.92 96.49 10.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.447 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.793 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.5 OUTLIER -46.76 125.67 7.57 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.57 -179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.63 HD12 ' CG ' ' A' ' 193' ' ' GLU . 37.3 mt -89.29 -44.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.552 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -168.5 150.35 5.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.793 ' HG3' HD21 ' A' ' 183' ' ' LEU . 31.1 mtmt -110.35 49.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.1 -22.03 25.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -127.36 127.85 24.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.708 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.72 -19.68 25.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.554 2.169 . . . . 0.0 112.731 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -112.42 -32.74 6.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 111.465 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 202' ' ' ILE . 23.9 m95 -105.84 108.7 20.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.492 ' CD2' ' HB3' ' A' ' 205' ' ' SER . 44.8 m0 -107.19 138.66 42.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.63 ' CG ' HD12 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.502 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -148.84 158.07 27.52 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.126 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.406 ' HG3' ' HG3' ' A' ' 200' ' ' ARG . 1.0 OUTLIER -123.85 95.97 4.77 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.683 0.277 . . . . 0.0 111.283 -179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.819 HD11 ' OD2' ' A' ' 179' ' ' ASP . 5.9 mt -74.16 72.9 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.254 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 4.3 m120 72.61 -63.13 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.1 28.54 1.53 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.741 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 6.3 mmt180 -129.49 103.72 7.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.114 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.546 ' HG2' HD13 ' A' ' 184' ' ' ILE . 1.9 mtt85 -90.69 149.3 22.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.608 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 167.88 162.0 18.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.961 -1.114 . . . . 0.0 113.021 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.884 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.74 149.96 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.853 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.743 ' CD2' HD23 ' A' ' 173' ' ' LEU . 19.7 p90 -164.07 150.34 9.63 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.141 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.74 110.14 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.216 1.944 . . . . 0.0 111.041 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.492 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 2.8 p -56.08 -20.54 17.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.461 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -61.24 -17.08 51.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 0.0 110.62 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -92.92 16.6 12.22 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.213 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 203' ' ' PHE . 2.8 m -149.17 -169.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.192 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.55 119.54 1.56 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.672 ' HA ' HG12 ' A' ' 159' ' ' VAL . 88.5 Cg_exo -47.72 126.33 12.49 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.445 2.097 . . . . 0.0 112.502 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -101.05 -70.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 54.58 40.38 31.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.988 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 p 49.95 76.68 0.13 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.124 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.857 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.799 0.333 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.59 173.09 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -170.25 133.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.919 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.482 HG22 ' H ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -88.07 176.25 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.528 ' HD2' HD22 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -105.07 103.07 12.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.518 ' HD2' HG11 ' A' ' 180' ' ' VAL . 3.3 m-85 -104.68 120.29 41.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 210' ' ' PRO . 30.6 m -122.78 139.14 50.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.499 ' OE1' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -102.78 129.03 49.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.786 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.492 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -76.26 144.88 40.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.451 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 0.66 56.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.508 ' CE1' ' CG ' ' A' ' 207' ' ' TYR . 0.1 OUTLIER -158.44 -163.14 1.22 Allowed 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.784 0.326 . . . . 0.0 110.805 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.71 145.39 42.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.449 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 10.3 t80 -130.68 113.93 14.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -114.49 76.21 3.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.869 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.23 123.48 6.13 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.601 2.201 . . . . 0.0 112.471 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -94.8 18.6 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.08 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -120.64 170.54 9.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.367 . . . . 0.0 110.752 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 p -89.96 142.79 27.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 106.26 -32.23 7.55 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.433 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.54 133.71 35.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 0.0 110.792 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.66 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.0 OUTLIER -80.49 157.43 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.751 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.584 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -106.66 113.45 26.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.932 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.521 ' HB2' HD11 ' A' ' 181' ' ' ILE . 1.8 p90 -134.39 154.62 51.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -110.88 -169.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.23 134.65 49.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.344 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 57.89 20.51 41.17 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.666 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.819 ' CG ' HD21 ' A' ' 196' ' ' LEU . 67.9 t0 -80.62 110.53 16.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.518 HG11 ' HD2' ' A' ' 158' ' ' PHE . 33.8 t -69.51 105.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.887 HG12 HD23 ' A' ' 196' ' ' LEU . 2.6 mt -103.22 125.21 57.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.361 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 79.0 m -73.57 105.83 5.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.428 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.575 HD21 ' HG3' ' A' ' 186' ' ' LYS . 0.7 OUTLIER -51.61 127.88 21.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.603 -179.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.697 HD13 ' HG2' ' A' ' 200' ' ' ARG . 25.4 mt -89.64 -40.69 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.476 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 2.6 p30 -177.94 155.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.575 ' HG3' HD21 ' A' ' 183' ' ' LEU . 35.4 mtmt -107.64 54.37 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.767 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -58.43 -18.71 30.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.088 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -132.8 118.47 15.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.693 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -42.07 -28.95 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.745 2.297 . . . . 0.0 113.135 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -106.36 -42.76 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 111.376 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.904 ' CE3' HD12 ' A' ' 202' ' ' ILE . 12.6 m95 -94.88 106.83 18.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.257 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.53 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.9 m0 -101.54 142.48 32.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.563 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.609 ' CG ' HD12 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -89.29 145.87 25.09 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.409 ' HA2' HG13 ' A' ' 184' ' ' ILE . . . -152.39 162.37 29.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.2 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.514 ' O ' HG23 ' A' ' 181' ' ' ILE . 2.4 tt0 -112.67 140.98 46.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.716 0.293 . . . . 0.0 110.904 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.887 HD23 HG12 ' A' ' 181' ' ' ILE . 0.2 OUTLIER -120.44 71.16 0.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.887 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 196' ' ' LEU . 1.9 t-20 86.09 -23.2 0.15 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.725 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 177.54 -36.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.655 0.264 . . . . 0.0 111.063 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 195' ' ' GLN . 2.5 ptt-85 -69.85 153.28 43.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.178 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.697 ' HG2' HD13 ' A' ' 184' ' ' ILE . 5.5 mtm-85 -119.89 152.38 37.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.12 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.66 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 178.74 158.92 22.21 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.717 -1.23 . . . . 0.0 113.392 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.904 HD12 ' CE3' ' A' ' 191' ' ' TRP . 2.7 pt -108.27 150.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.505 ' CD2' ' CZ ' ' A' ' 175' ' ' PHE . 2.1 p90 -170.1 162.67 6.51 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.71 110.28 1.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.458 2.105 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.53 ' HB3' ' CD2' ' A' ' 192' ' ' TRP . 1.2 p -57.59 -19.63 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 111.134 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.79 -12.74 38.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.627 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . 0.508 ' CG ' ' CE1' ' A' ' 163' ' ' PHE . 0.3 OUTLIER -89.83 13.94 13.22 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.54 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 161' ' ' ALA . 2.9 m -144.89 -169.04 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.994 0.426 . . . . 0.0 111.55 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.28 113.85 2.67 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.875 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 159' ' ' VAL . 81.4 Cg_exo -46.14 109.84 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.609 2.206 . . . . 0.0 112.574 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -89.95 -67.61 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 61.66 74.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.56 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.37 -170.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.956 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.0 m170 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.822 0.344 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 4.7 mmt -92.57 -174.97 3.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -133.72 103.11 5.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.23 134.4 33.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.989 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -149.97 128.23 12.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.947 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.452 ' HD1' HG12 ' A' ' 180' ' ' VAL . 67.1 m-85 -133.27 142.84 48.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' HA ' ' A' ' 210' ' ' PRO . 14.3 m -128.35 154.84 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.079 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -112.08 114.4 27.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.7 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -70.09 154.23 42.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.531 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.21 20.74 7.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.74 179.42 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -170.16 139.68 1.82 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.629 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -68.12 138.33 55.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.948 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 5.1 t80 -127.15 109.42 11.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.002 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -109.68 84.18 3.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.785 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.4 ' CB ' ' HB2' ' A' ' 172' ' ' GLU . 74.3 Cg_endo -77.01 116.4 4.2 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.69 2.26 . . . . 0.0 112.48 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -80.83 -26.48 37.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.686 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -96.48 174.76 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.809 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.97 151.84 21.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.015 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 112.87 -36.55 4.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' A' ' 167' ' ' PRO . 87.6 mt-10 -95.17 138.77 32.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.709 0.29 . . . . 0.0 110.723 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.675 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -82.59 147.26 28.69 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.757 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.534 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.47 22.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.767 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.458 ' CE1' ' CB ' ' A' ' 165' ' ' PHE . 2.2 p90 -135.81 157.98 45.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.985 0.422 . . . . 0.0 111.16 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -109.32 -169.74 1.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.54 136.2 39.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 111.219 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.93 15.89 58.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.688 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.44 ' OD2' HD13 ' A' ' 196' ' ' LEU . 62.8 t0 -79.5 118.13 21.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' A' ' 158' ' ' PHE . 38.3 t -69.77 97.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.7 138.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.27 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 m -86.2 99.11 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.607 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.0 tp -49.5 123.57 7.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.396 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.61 HD13 ' HG2' ' A' ' 200' ' ' ARG . 29.0 mt -89.44 -39.02 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.3 p30 -177.55 173.24 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.814 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.444 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 35.1 mtmt -123.28 55.97 1.2 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -55.39 -22.96 22.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -135.74 130.32 18.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.717 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.69 -21.81 20.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.643 2.229 . . . . 0.0 112.624 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -108.38 -36.38 6.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.909 0.385 . . . . 0.0 111.24 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.929 ' CE3' HD12 ' A' ' 202' ' ' ILE . 20.6 m95 -103.02 110.55 22.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.486 ' HB3' HD11 ' A' ' 183' ' ' LEU . 44.0 m0 -106.38 140.82 38.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.944 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.83 149.59 22.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.416 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -153.79 159.28 28.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.74 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -124.34 118.91 27.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 111.181 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 173' ' ' LEU . 13.0 mt -102.77 97.06 7.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.536 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 79.65 -55.14 0.4 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.069 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -159.62 -36.33 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.3 ptm85 -69.47 141.09 54.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.975 0.417 . . . . 0.0 111.333 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.61 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -109.4 160.38 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.467 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.675 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 174.36 159.67 21.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.192 -1.004 . . . . 0.0 113.015 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.929 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.4 pt -106.3 151.8 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.747 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.597 ' CE1' HG11 ' A' ' 208' ' ' VAL . 13.8 p90 -165.55 151.2 8.31 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -59.65 111.47 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.264 1.976 . . . . 0.0 111.174 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.462 ' HB3' ' CG ' ' A' ' 192' ' ' TRP . 3.1 p -55.84 -21.54 20.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 111.197 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -61.34 -17.75 55.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.494 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.29 17.87 12.04 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.292 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.597 HG11 ' CE1' ' A' ' 203' ' ' PHE . 3.2 m -148.7 -168.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 111.356 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.1 114.57 1.3 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.606 ' HA ' HG12 ' A' ' 159' ' ' VAL . 87.0 Cg_exo -47.2 124.39 8.97 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.463 2.109 . . . . 0.0 112.589 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -99.21 -68.84 0.79 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 61.91 81.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.647 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.1 m -57.62 -77.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.899 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.8 t60 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.792 0.329 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -77.4 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.34 100.64 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 9.5 t -95.92 123.1 39.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 111.46 4.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.544 ' HD2' HG12 ' A' ' 180' ' ' VAL . 84.9 m-85 -103.54 133.23 48.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 210' ' ' PRO . 16.4 m -122.07 153.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.072 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.14 113.13 24.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.458 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.477 ' HA ' HG12 ' A' ' 208' ' ' VAL . . . -65.72 157.19 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.557 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 208' ' ' VAL . 0.3 OUTLIER -126.22 19.55 7.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.929 179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -170.23 140.26 1.88 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.68 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.99 137.17 53.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.98 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.443 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 7.2 t80 -129.06 109.78 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.944 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -110.87 79.2 1.79 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.784 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.09 115.99 3.86 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.54 2.16 . . . . 0.0 112.509 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -80.06 -26.45 39.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.91 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -85.33 170.69 12.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.5 m -89.93 148.83 22.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 110.75 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.414 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -93.4 130.97 39.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.671 0.272 . . . . 0.0 110.745 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD23 ' CD2' ' A' ' 203' ' ' PHE . 0.1 OUTLIER -77.84 147.88 34.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.805 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.597 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.58 112.25 24.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.5 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.528 ' CB ' HD11 ' A' ' 181' ' ' ILE . 1.6 p90 -131.3 155.57 46.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.077 0.465 . . . . 0.0 111.544 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -112.31 172.12 7.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.467 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 135.83 57.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.226 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.52 23.7 55.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.885 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -84.44 123.24 30.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.826 0.345 . . . . 0.0 110.863 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.544 HG12 ' HD2' ' A' ' 158' ' ' PHE . 37.1 t -73.12 94.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.737 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.528 HD11 ' CB ' ' A' ' 175' ' ' PHE . 27.7 mt -89.98 143.04 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.347 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.4 m -90.82 98.63 11.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.502 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.852 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -50.03 124.4 10.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.442 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.52 HD12 ' CG ' ' A' ' 193' ' ' GLU . 25.1 mt -89.7 -39.51 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.594 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 193' ' ' GLU . 3.2 p30 -177.76 172.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.442 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 46.9 mtmt -121.99 56.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.679 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -57.16 -21.72 34.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.139 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 38.7 t70 -137.09 121.61 12.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.667 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.79 -28.16 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.716 2.278 . . . . 0.0 112.949 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -102.78 -44.71 5.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 0.0 111.23 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.984 ' CE3' HD12 ' A' ' 202' ' ' ILE . 24.1 m95 -94.03 108.75 20.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.187 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.501 ' HB3' HD11 ' A' ' 183' ' ' LEU . 43.4 m0 -104.32 141.8 35.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.852 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.8 OUTLIER -89.99 146.35 24.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.205 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -151.86 158.36 27.74 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.915 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.07 107.13 11.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.481 HD12 ' HA ' ' A' ' 175' ' ' PHE . 0.7 OUTLIER -87.54 95.59 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.601 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 23.4 t30 77.39 -59.03 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -152.09 -38.37 0.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.547 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -69.62 138.6 53.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.902 0.382 . . . . 0.0 111.221 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.492 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -107.31 162.42 13.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.573 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.646 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 171.95 161.94 23.34 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.869 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.984 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.6 pt -106.24 153.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.67 ' CD2' HD23 ' A' ' 173' ' ' LEU . 16.1 p90 -169.36 148.72 3.58 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.126 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.45 109.82 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.276 1.984 . . . . 0.0 111.384 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 208' ' ' VAL . 2.0 p -54.35 -23.11 14.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.316 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -61.04 -16.13 40.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.29 22.19 6.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.298 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 205' ' ' SER . 4.1 m -149.87 -168.7 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.737 0.304 . . . . 0.0 111.407 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -157.41 111.52 1.86 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.909 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 159' ' ' VAL . 85.5 Cg_exo -47.86 121.73 6.21 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.48 2.12 . . . . 0.0 112.613 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -98.41 -68.24 0.81 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.961 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 11.6 t30 61.75 74.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -58.25 -175.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.935 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.851 0.358 . . . . 0.0 111.449 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 23.5 mtm -105.71 -34.01 7.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.74 137.18 47.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.2 t -96.25 147.26 23.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -104.68 168.02 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.969 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -144.14 111.94 6.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 210' ' ' PRO . 25.8 m -106.64 152.02 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.067 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.46 112.84 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.798 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 208' ' ' VAL . . . -64.97 155.71 33.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.536 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.478 HD23 ' CA ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -114.86 -12.41 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.101 179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.52 132.0 19.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.627 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.04 143.6 31.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.953 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.446 ' CB ' ' CE1' ' A' ' 175' ' ' PHE . 9.8 t80 -127.74 109.48 11.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.59 78.9 1.6 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.875 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.17 123.91 6.94 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.608 2.205 . . . . 0.0 112.383 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -94.48 18.22 11.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.001 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -129.71 173.1 10.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.5 m -90.15 145.88 24.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 109.54 -34.45 5.48 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.391 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -93.64 134.35 36.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.668 ' CB ' ' HA3' ' A' ' 201' ' ' GLY . 0.1 OUTLIER -81.61 147.94 29.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.654 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.539 ' N ' HD12 ' A' ' 173' ' ' LEU . . . -94.77 110.34 22.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 175' ' ' PHE . 1.8 p90 -133.52 152.96 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 111.209 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -103.22 -168.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.78 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -79.1 134.74 36.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.963 0.411 . . . . 0.0 110.988 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.88 18.61 54.23 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.418 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.738 ' OD1' HD21 ' A' ' 196' ' ' LEU . 62.7 t0 -80.85 119.2 23.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.743 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.8 t -69.71 99.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.568 HG21 HD21 ' A' ' 173' ' ' LEU . 4.9 mt -93.99 140.6 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.326 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.1 m -87.41 100.87 13.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.517 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 193' ' ' GLU . 32.8 tp -51.21 123.77 10.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.421 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.564 HD13 ' HG2' ' A' ' 200' ' ' ARG . 31.2 mt -89.58 -39.59 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.625 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.35 172.18 2.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 192' ' ' TRP . 33.0 mtmt -127.07 57.12 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.75 -22.02 61.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.073 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 191' ' ' TRP . 1.6 t70 -132.78 117.22 15.05 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.723 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -40.17 -29.94 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.922 2.415 . . . . 0.0 113.168 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -100.49 -48.99 4.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.994 ' CE3' HD12 ' A' ' 202' ' ' ILE . 28.0 m95 -89.82 108.11 19.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.117 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.534 ' HB3' HD11 ' A' ' 183' ' ' LEU . 45.0 m0 -104.68 142.46 34.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.966 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.831 ' O ' HD12 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -89.87 145.52 25.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.248 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 184' ' ' ILE . . . -149.95 158.92 27.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.874 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -123.57 118.63 27.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.729 0.3 . . . . 0.0 111.235 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.738 HD21 ' OD1' ' A' ' 179' ' ' ASP . 4.4 mt -103.55 97.78 7.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.513 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 79.36 -55.71 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.174 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -159.25 -36.94 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.394 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.5 ptm85 -69.61 141.95 53.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.304 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.564 ' HG2' HD13 ' A' ' 184' ' ' ILE . 0.0 OUTLIER -109.51 162.37 14.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.494 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 173' ' ' LEU . . . 173.78 161.25 23.57 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.176 -1.012 . . . . 0.0 112.91 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.994 HD12 ' CE3' ' A' ' 191' ' ' TRP . 1.5 pt -108.39 153.68 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.371 . . . . 0.0 110.859 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . 0.557 ' CE1' HG11 ' A' ' 208' ' ' VAL . 15.5 p90 -170.03 151.91 4.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.37 106.89 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.188 1.925 . . . . 0.0 110.984 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.825 ' O ' HG22 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -51.35 -23.46 3.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.648 0.261 . . . . 0.0 111.037 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -51.74 -21.74 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.928 0.394 . . . . 0.0 110.508 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.38 23.1 4.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.711 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 205' ' ' SER . 3.7 m -147.11 -167.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.93 0.395 . . . . 0.0 111.625 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.21 110.02 1.25 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.844 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 159' ' ' VAL . 87.6 Cg_exo -47.98 113.17 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.505 2.137 . . . . 0.0 112.532 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -93.54 -66.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 27.2 t30 61.7 74.56 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.636 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 79.4 p -58.27 174.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.1 p30 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.916 179.991 . . . . . . . . 0 0 . 1 stop_ save_